2

Acknowledgments
We would like to extend our sincere thanks to the following sponsors fortheir support and generous contribution to ASPIRE 2024:

Platinum Supporter

Gold Supporter

Silver Supporter

Education Grant Supporter

Destination Supporter3

Table of Contents
5
6
7
8

11

15

20

22

26

27
27

32
32
45
54

62

82

83

84

107

4

Welcome Message

Message from the President of ASPIRE

Message from the Chair, Local Organising Committee

Message from the Chair, ASPIRE 2024 Scientific Committee

About the Host

General Information
Site Plan

Programme at a Glance
Scientific Programme•Pre-congress Courses
Thursday, 23 May 2024

•Main Congress

Friday, 24 May 2024

Saturday, 25 May 2024
Sunday, 26 May 2024

Poster Overview

Exhibition Floor Plan
Exhibitor List

Sponsor and Exhibitor Profiles
Authors Index

5

Welcome Message
President of ASPIRE
It is my great pleasure to welcome you to the 13th Annual
Congress of ASPIRE in Manila, the pearl of the Orient andplace of wisdom. We will all have the opportunity to learn, notonly from our prestigious invited speakers but also from eachother and I am confident that each and every one of you willtake back at least three pearls of wisdom to the workplacesof your home country. The enthusiastic local organizing
committee have prepared an exciting social programme andI invite you to consider some of the pre congress courses andtours. The trade display is a vital part of our knowing what
equipment, medications and consumables are available tooptimise the provision of the care of our patients.
I look forward to renewing old friendships and stimulating
debate and discussion.

Dr Clare Boothroyd
ASPIRE President

6

Welcome Message
Local Organising Committee
Mabuhay!

Covid-19 may have cancelled ASPIRE 2020 in Manila, but weare back and are more excited than ever! On behalf of the over
110 million Filipinos, we invite everyone to come and participate
at the 13th Congress of the ASPIRE in Manila on 23 – 26 May
2024 at the Philippine International Convention Center (PICC)
to learn and be updated with the latest on reproductive
medicine while immersing in friendly and fun Filipino culture.
We are designing an exciting scientific program with themost important topics which shall be presented by the mostcelebrated experts. Let us all emerge from the shackles of thepandemic and storm ASPIRE 2024 to its limits! Let us learn
from the pre-congress courses, the keynote lectures, andyour choice of simultaneous sessions. Visit our exhibits andnetwork with colleagues. Present your groundbreaking papers!
In between, get a taste of Philippine cuisine, embrace Filipino
culture, and visit the best of Manila for tourism and shopping.
Finally, if you have some extra days, tour the Philippines’
famous white-sand beaches and world-renowned heritage
sites, and experience the Philippines as you have never done so
before!
Indeed, it is more fun in the Philippines! See you all soon!

Professor Virgilio M. Novero Jr, MD
Chair, ASPIRE 2024 Local Organizing Committee

7

Welcome Message
ASPIRE 2024 Scientific Committee
I am delighted that the 13 th Congress of the Asia PacificInitiative on Reproduction will be held in Manila, Philippines
on 23 – 26 May 2024. The scientific program promises tobe another exciting one, to provide an update on the latest
developments. It will also be ever more inclusive, with direct
input from our two newly formed SIGs in nursing andcounselling. There will also be a most attractive social program
to suit everyone. So, do come and join us in Manila!

Professor Tin-Chiu Li
Chair of the ASPIRE 2024 Scientific Committee

8

9

10

About the Hosts

About ASPIRE
Established in 2001 by Bruno Lunenfeld and P C Wong, the Asia PacificInitiative on Reproduction (ASPIRE) is devoted to enriching patient carequality, with a specific emphasis on fertility services within the Asia-Pacificregion.
Our fundamental objective is to elevate awareness and comprehensionof the various treatment options available for infertility, empowering
healthcare professionals to effectively guide their patients towards seeking
and embracing such treatments.
We foster an inclusive environment for professionals in this field toshare insights and experiences, while also honing their expertise througheducational programs like masterclasses, webinars, and certificate courses.
Furthermore, our 8 Special Interest Groups (SIGs) provide platforms forcomprehensive discussions and knowledge sharing.
A source of pride for us is our official journal- “Fertility and Reproduction,”
which was launched in 2019. The journal serves as vital platform forresearchers to share their studies and papers, facilitating the exchange
of knowledge within the field. It also plays a significant role in providing
young researchers with an avenue to showcase their research papers andcontribute to the collective understanding.
www.aspire-reproduction.org

11About the Hosts
ASPIRE Executive Board
President

Dr. Clare Boothroyd

President-Elect

Dr. Haroon Latif

Immediate Past President

Professor Tin Chiu Li

Secretary General

Professor Chii-Ruey Tzeng

Treasurer

Professor Nares Sukcharoen

Vice Presidents

Dr. Duru Shah
Professor Li Rong

Members

Professor Atsushi Tanaka
Professor Neil Johnson
Professor Jung Ryeol Lee
Professor Arthur Chang

Co-Opted Members

Professor Maruf Siddiqui
Dr. R Muharam Natadisastra

Editor-in-Chief

Professor Gab Kovacs

Advisor

Professor PC WongASPIRE 2024 Scientific Committee
Scientific Chair

Professor Tin Chiu Li

Scientific Members

Dr. Clare Boothroyd
Professor Chii-Ruey Tzeng
Dr. Haroon Latif
Professor Virgilio Novero
Professor Eileen Manalo
Professor Yutaka Osuga
Mrs. Carmel Carrigan

12About the Hosts
ASPIRE 2024 Local Organizing Committee

Chairman

Dr. Virgilio M. Novero, Jr.
(PSRM President 2010 & ASPIRE Vice Pres.)

Co-Chairs

Dr. Angela S. Aguilar,(Past PSRM President & ASPIRE Country Rep)
Dr. Romerico F. Torres,(PSRM President 2023 & ASPIRE Country Rep)

PSRM Board

Dr. Debby P. Songco
Dr. Margaret Joyce A. Cristi-Limson
Dr. Gia C. Pastorfide
Dr. Ma. Victoria R. Tan
Dr. Ma. Isidora Margarita Yap-Garcia
Dr. Allen Gideon R. Tan

Past Presidents

Dr. Marinella Agnes G. Abat
(PSRM President 2020)
Dr. Debbie Guani Dy-Meguizo(PSRM President 2021)

Angela S.
Aguilar, MD

RESEARCH

Gia C. Pastorfide, MD
Ma. Isidora Margarita Yap-Garcia, MD
Dr. Joy Jimenez Bautista, MD
Mona Ethellin Lim Yiu, MD
Marian Capco-Dichoso, MD
Maria Delina E. De Chavez-Nueva, MD
Jeromie M. Mindoro
Sheryll A. Beltran-Carullo, MD
Marie Janice S. Alcantara-Boquiren, MD
Gia C. Pastorfide, MD
Ma. Isidora Margarita Yap-Garcia, MD
Dr. Joy Jimenez Bautista, MD
Mona Ethellin Lim Yiu, MD
Marian Capco-Dichoso, MD
Maria Delina E. De Chavez-Nueva, MD
Jeromie M. Mindoro
Sheryll A. Beltran-Carullo, MD
Marie Janice S. Alcantara-Boquiren, MD

Angela S. Aguilar, MD

PHYSICALARRANGEMENTS

Leedah RanolaNisperos, MD

Marie Grace
Geremillo
Cruz, MD

Carmela Joy P. Aquino-Cabral, MD
Dianne A. Manzano, MD
Lizel DES Enguillo, MD
Ma. Sheryll R. De Jesus, MD

REGISTRATION

Michelle
EnriquezGamboa, MD

Heidy G.
Dy-Fernandez,
MD

Mailyn T. Panganiban, MD
Grace B. Caras-Torres, MD
Geralyn M. De Vera-Sumugat, MD Julie Del
Rosario Lim, MD

SOCIALS

Marinella Agnes
S. Garcia-Abat,
MD

Mary Joyce B.
Flores-Medina,
MD

Anthony Marc B. Ancheta, MD
Danilo Jose C. Milla, MD
Ma. Isidora Margarita Yap-Garcia, MD
Ednalyn T. Ong-Jao, MD
Anna Belen Ignacio-Alensuela, MD
Judith S. Galang-Perez, MD
Maria Delina E. De Chavez-Nueva, MD

SPEAKERS'BUREAU/HOSPITALITY & TOURS

Marites A.
Barrientos, MD

Mona Ethellin L.
Yiu-Senolos, MD

Marie Josephine Conifedd G. Almaria, MD
Maria Reichenber C. Arcilla, MD
Yvette Marie C. Manalo-Mendoza, MD

13

14

General Information
General Information
Date

Thursday-Sunday, 23-26 May 2024

Venue

Philippine International Convention Center (PICC)
PICC Complex, 1307 Pasay City, Metro Manila, Philippines

Websitehttps://www.aspire2024.com

Theme

Pearls of Wisdom in Reproductive Medicine:
Towards Personalisation and Improving Access

Host

Asia Pacific Initiative on Reproduction (ASPIRE)

Co-HostPhilippine Society for Reproductive Medicine (PSRM)

Language

English is the official language of the Congress. All presentation will be made in English

Internet Access

PICC provides free Wi-Fi, and attendees are more than welcome to use the service.
Wi-Fi SSID: PICC (No password required)

Admission Badges

Admission badges will be provided upon registration at the Congress venue. Delegates are requested to wear theirbadges for identification purposes and to gain admission to various sessions and exhibitions.

Congress
Kit

Opening/
Closing
Ceremony

Welcome
Reception

Faculty

✓

✓

✓

✓

Delegate

✓

✓

✓

✓

Accompanying
Person
Exhibitor

One foreach
exhibitor

Media

✓

Staff

✓

Cocktail Hour/ Exhibition
Coffee Breaks
Area

Scientific
Programme

Company
Symposium

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

Only if thesponsor has
your own symposium✓✓

Please reach out to the staff if any assistance is needed.

Certificate of Attendance / Presentation

Certificates of attendance will be available to all delegates in electronic form upon completion of the post-congress
feedback form. The feedback form will be sent via registered email.

Congress Abstracts

The Congress E-Abstract book is available on the congress website. Please note that the file is password protected.
The password for accessing the abstract book is: ASPIRE2024

15

Registration Counter Opening Hours (Including information and tour desk)
Date

Opening Hours

Thursday, 23 May

07:00-17:00

Friday, 24 May

06:30-19:00

Saturday, 25 May

06:30-18:00

Sunday, 26 May

07:00-12:30

Speaker Ready Room
Date

Opening Hours

Thursday, 23 May

07:00-17:00

Friday, 24 May

07:00-19:00

Saturday, 25 May

07:00-17:00

Sunday, 26 May

07:00-11:30

Location

Upper Lobby, Delegation Building

Location

Banquet Hall 1, Secretariat Building

The speaker ready room is the location for speakers to upload and review their slides for presentation. Staff areavailable to provide assistance and answer questions. Speakers are reminded to have slides uploaded at least 3
hours prior to the session time.

Exhibition Opening Hours
Date

Opening Hours

Friday, 24 May

08:00-20:00

Saturday, 25 May

08:00-18:00

Sunday, 26 May

08:00-12:00

Location

Exhibition Area, Reception Hall

Congress Meal Timings

Lunch will be served at the following times and locations:
Date

Served time

Location

PCC1: 12:30pm
Thursday, 23 May

PCC2: 12:30pm

Exhibition Area, Reception Hall

PCC5: 11:50am
Friday, 24 May

12:15-13:45

Saturday, 25 May

11:45-13:15

16

Delegate Lounge & Outside of Meeting Room 5,
Secretariat BuildingCoffee Break Timing

Coffee breaks will be served at the following times and locations:
Date

Served time

Location

10:00-11:00

Thursday, 23 May

Delegate Lounge, Secretariat Building

14:30-15:30
10:00-10:45

Friday, 24 May

Exhibition Hall (Reception Hall)

16:45-17:30
09:30-10:15

Saturday, 25 May

14:45-15:30

Sunday, 26 May

10:40-11:10

Social Functions
Date

Time

Function

Venue

Friday, 24 May

19:00-20:00

Welcome Reception

Saturday, 25 May

17:00-18:00

Cocktail Hour

Saturday, 25 May

19:30-21:30*Faculty Dinner (Invite only)

Exhibition Hall (Reception Hall)
Illustrado Resataurant*Details will be available in the Faculty Dinner invite card

Poll Participation for Controversy Session / Debates

Please note that live polling will be conducted during the Controversy Session and the Debates to enhance
participant engagement. Polling will be carried out through the ASPIRE 2024 Mobile Application. Delegates areencouraged to download the mobile application prior to the sessions.

Pre & Post Tour

Dive into Manila's rich culture, breathtaking nature, and vibrant city life with our exclusive Pre and Post Congress
Tours at ASPIRE 2024. For detailed tour information, registration, and pricing, please visit our website:
https://www.aspire2024.com/ or you may register and get assistance at the Information desk.

Medical Service
Date

Opening Hours

Thursday, 23 May

09:00-18:00

Friday, 24 May

08:00-20:00

Saturday, 25 May

07:30-18:00

Sunday, 26 May

07:30-12:30

Location

Outside Plenary Hall and Delegate Lounge

If you feel uncomfortable during the congress, please seek support from Congress Staff or directly approach the
medical team for assistance.

17

Congress Security
Date

Opening Hours

Thursday, 23 May

09:00-18:00

Friday, 24 May

08:00-20:00

Saturday, 25 May

07:30-18:00

Sunday, 26 May

07:30-12:30

Location

Outside Plenary Hall and Delegate Lounge

Lost & Found

If you find a lost item, please bring it to the Information Desk (Upper Lobby, Delegation Building) and provide details
about where it was found and other relevant information.

ASPIRE 2024 Mobile Application

Here’s to a seamless experience at ASPIRE 2024. Download the ASPIRE 2024 Mobile App and be able to:✓ View and customize your congress schedule✓ View speakers’ biographies✓ View congress abstracts✓ View details of our exhibitors and sponsors✓ Interact with speakers and other delegates via the in-house communication app✓ Participate in sessions polling and survey✓ Interact and earn points for a chance to win prizes

How to download?

Scan QR Code below to download or search “ASPIRE 2024” on the Apple Store/Google Play StoreAPPLE STOREGOOGLE PLAY

Launch the application and log-in
Sign in either:► With your registered account and password from the ASPIRE 2024 registration system► Using your primary email and the pin code provided in the congress reminder

18

19

20

Site Plan

21

22

23

PROGRAM AT A GLANCE
Session Categories (color label)

Opening and Closing Award Ceremonies

How-to Sessions / Round Table
Luncheon / Debates

Concurrent - Clinical Sessions

Company Symposium

Bruno Lunenfeld Lecture / Closing
LectureFree communications

Concurrent - Scientific Sessions

Social Functions

Keynote Lecture

Exchange Sessions

Concurrent - General Sessions

ASPIRE Annual General Meeting

Thursday, 23 May 2024
Building
ROOM

Meeting Room 20900 Pre-Congress Course 51800 Andrological Solutions toComplex Problems

2nd Floor, Secretariat Building

Meeting Room 3

Meeting Room 5

Meeting Room 6

Pre-Congress Course 1
Cutting Edge Topics
of Endometriosis andAdenomyosis

Pre-Congress Course 2
Perfecting ICSITechniques and Improving
Outcomes (Hands-on)

Pre-Congress Course 4
Research & Publication

Friday, 24 May 2024
Building

Plenary Hall

VENUE

Plenary Hall

0800 0830

Opening and Award
Ceremony

0830 0900

Bruno Lunenfeld Lecture
What is the Future of
Reproductive Surgery in
the World of ART

0900 0930

Keynote Lecture 1
MenopauseManagement:
Coming Full Circle

0930 1000

Keynote Lecture 2
Growing the Best
Embryos The Factors That Count

Pre-Congress Course 3
Reproductive Loss

Mezzanine Level,
Reception Hall

2nd Floor, Secretariat Building
Meeting Room 2-3

24

ASPIRE Special Interest Groups (SIGs)

Meeting Room 4

Meeting Room 5

Meeting Room 6

Meeting Room 7

Meeting Room 8

Theatrette (ExhibitionHall)Coffee Break / Poster Viewing / Exhibition
Venue: Exhibition Hall (Reception Hall)

1000 1045

ASPIRE SIG Session
1010 - 1030 : Artificial
Intelligence (AI)

Coffee-break sponsored by1045 - Company Symposium 1 by
1215
MERCK
Shining a Light on
Constellations of ART
Outcomes and Health
Economics

Concurrent Session 1
PCOS

Concurrent Session 2
Genetic Issues of Male
Infertility

Concurrent Session 3
Patient Centred CareFree Communication 1
Presentations of the
Shortlisted
Oral Abstracts for the
ASPIRE 2024 Best Oral
Awards (PART 1)

Free Communication 2- ART, Basic Research- ART, Clinical- ART, Laboratory

Free Communication 3
ART, Laboratory

Lunch / Poster Viewing / Exhibition
Venue: Exhibition Hall (Reception Hall)

1215 1345

Company Presentation
by GOLDQUESTBIOTECHNOLOGIES INC.
1130 - 1200
Nikon Microscopy
Technological Solutions
for ART
ASPIRE SIGs Sessions
1225 - 1245 : Embryology
1255 - 1315 : Andrology
1325 - 1345 : Psychology
and Counselling

1345 1515

Company Symposium 2
by Vitrolife Group
Excellence in IVF:
Improving Outcomes
Through Optimized
Embryo Culture,
Evaluation and Genetics

Concurrent Session 4
Current Research inControversial Areas

Concurrent Session 5
Reproductive Genetics

Concurrent Session 6
Cutting Edge in Fertility
Preservation

Free Communication 4
Counselling, Ethics andPsychosocial

Free Communication 5
Uterine Disorders andEndometriosis

1515 1645

Company Symposium 3
byAbbottRevisiting LPS: The Roleof Progestogens in Early
Pregnancy and Improving
Outcomes

Concurrent Session 7
Endometrial Receptivity

Concurrent Session 8
Cryopreservation fromthe Testes

Debate 11515 - 1615 (60mins)
AI and Automation Will
Replace Embryologists

Free Communication 7
PCOS

Free Communication 8
Female Infertility

Free Communication 6 Company Presentation by
Gynaecology and Surgery FUJIFILM Irvine Scientific
1400 - 1430
The Role of Body Mass
Index in IVF Success:
Strategies for Clinical andLaboratory PracticeFree Communication 9
ART, Clinical(Polling will be facilitated via
the Congress Mobile App)
Global Journal Club
1620 - 1705 (45mins)
What Are the Recent
RCTs in the
Asia Pacific Region?
Coffee Break / Poster Viewing / Exhibition
Venue: Exhibition Hall (Reception Hall)

1645 1730

ASPIRE SIG Session
1700 - 1720 :Endometrium and
Implantation

Coffee-break sponsored by1730 1900

Concurrent Session 9
PGT-A/PGT-M

Concurrent Session 10
Minimal Invasive
Gynaecology Surgery

Korean Session
Disruptive Innovations toEnhance ART Patient
Care

Concurrent Session 11
Psychosocial Pearls of
WisdomFree Communication 10
ART, ClinicalFree Communication 11
Reproductive Genetics

Welcome Reception @ Exhibition Hall (Ground Level, Reception Hall)
Join us for an evening of conversations and connections. Grab a drink and indulge in delectable snacks as you mingle.

1900 2000

25

Free Communication 12- Fertility Infertility- Fertility Preservation

Saturday, 25 May 2024
Building

Plenary Hall

VENUE

Plenary Hall

0715

Young InvestigatorAwardees Presentations
0715 - 0800

0730 0800

0800 0830

Keynote Lecture 3
Future of Reproductive
Genetics

0830 0900

Keynote Lecture 4
Endometrial Preparation
for Frozen Embryo
Transfer:
Do Natural Cycles Have
Better Outcomes?

0900 0930

Keynote Lecture 5
Epigenetic Regulation of
Decidualization in Human
Endometrium

Meeting Room 2-3

Meeting Room 4

Meeting Room 5

How-To Session 1
How to Avoid ObstetricComplications Arisingfrom ART Treatments

How-To Session 2
Surgical Tutorial (Videosession) Various Techniques of
Hysteroscopic
Myomectomy

How-To Session 3
How to Get That Elusive
Sought-After Job

1145 1315

1315 1445

Meeting Room 6

Meeting Room 7

Meeting Room 8

Coffee Break / Poster Viewing / Exhibition
Venue: Exhibition Hall (Reception Hall)

0930 1015

1015 1145

Mezzanine Level,
Reception Hall

2nd Floor, Secretariat Building

Company Symposium 5
byFerring Pharmaceuticals
Science Meets Practice:
Using Real-World
Evidence to Optimise ART
Outcomes

Concurrent Session 12
Congenital Uterine
Anomalies

Concurrent Session 13
Lab Monitoring

Concurrent Session 14
Individualization of ART
Treatment

Lunch / Poster Viewing / Exhibition
Venue: Exhibition Hall (Reception Hall)

Company Symposium 6
byOrganon
Advancing Science in
Women’s Health26

Concurrent Session 15
Concurrent Session 16
Clinical Issues in
Accreditation in Assisted
Male Infertility Treatment Reproductive Techniques:
Ensuring Excellence in
IVF Clinics & Embryology
Practice

Free Communication 13
Presentations of the
Shortlisted
Oral Abstracts for the
ASPIRE 2024 Best Oral
Awards (PART 2)

ASPIRE SIG Session
0940 - 1000 :Reproductive
Endocrinology (includes
PCOS)
Free Communication 14
Male Fertility

Free Communication 15- Counselling, Ethics andPsychosocial- NursingRound Table Luncheon Discussion
1200 - 1300
Mezzanine Level, Outside Reception Hall
(Lunch included - Ticketed Event)Concurrent Session 17
Improving Access Low-Cost Development
and Strategies

Free Communication 16- Regenerative Medicine
and Stem Cells- Uterine Disorders andEndometriosis- Gynaecology andSurgery

Theatrette (Exhibition
Hall)

Free Communication 17
Preimplantation
Screening and Diagnosis

ASPIRE SIGs Sessions
1200 - 1220 : Fertility
Preservation
1230 - 1250 :Endometriosis
1300 - 1320: Reproductive
NursesFree Communication 18
ART, ClinicalCoffee Break / Poster Viewing / Exhibition
Venue: Exhibition Hall (Reception Hall)1445 1530
1530 1700

1700 1800

Controversy Session
Controversies Session
2024

Concurrent Session 18
Endometriosis

Cocktail Hour @ Exhibition Hall
(Ground Level, Reception Hall)

Concurrent Session 19
Artificial Intelligence (AI)Concurrent Session 20
Fertility Nurse Beyond the Clinic

Free Communication 19
ART, Clinical

ASPIRE SIG Session
1500 - 1520 :Reproductive Surgery
Free Communication 20- PCOS- Ovary and Ovarian
BiologyFree Communication 21- Endocrinology, Clinical- Endocrinology,
Laboratory- Male Infertility

ASPIRE Annual General
Meeting
Faculty Dinner - Ticketed Event

1900 2100

Sunday, 26 May 2024
Plenary Hall

VENUE

Plenary Hall

Meeting Room 2-3

Meeting Room 4

Meeting Room 50730 0800

Young InvestigatorAwardees Presentations

How-To Session 4
Surgical Tutorial (Videosession) - Useful Tips
for Hysteroscopic
Surgery (Other Than
Myomectomy)

How-To Session 5
How to Prepare for
Critical or Near-Miss
Event

Fertility Counts

0800 0830

Keynote Lecture 6
Fertility Preservation for
the Young and Old

0830 0900

Keynote Lecture 7
Male Infertility:
Past, Present, and Future0910 1040

Philippine Session
ART in the Philippines

Concurrent Session 21
ART - Managing theDifficult IVF Patient

Debate 20910 - 1010 (60mins)
Surrogacy is a Better
Option Than Uterine
Transplant

Concurrent Session 22
Editor’s Choice

Meeting Room 6

Meeting Room 7

ISAR Session
Improving Success Rates
in Special Scenarios - An
ISAR Session

Free Communication 22- Embryology- Preimplantation
Screening and Diagnosis(Polling will be facilitated via
the Congress Mobile App)
Coffee Break / Poster Viewing / Exhibition
Venue: Exhibition Hall (Reception Hall)1040 1110
1110 1140

Closing Lecture
Advancements in
Reproductive Medicine:
Did It Improve Outcome?

1140 1210

Closing and Award
Ceremony27

Mezzanine Level,
Reception Hall

2nd Floor, Secretariat Building

Building

Meeting Room 8

Theatrette (Exhibition
Hall)

28

Scientific Programme
Pre-Congress Courses | Thursday, 23 May 2024

Cutting Edge Topics of Endometriosis and Adenomyosis
Venue: Meeting Room 3, Secretariat Building, PICC

This course aims to provide the participant with an overview of new developments in the field of endometriosis
management. Current knowledge on the molecular and genetic basis of endometriosis provides insights into
the origin of the disease, the clinical course and possible future innovative therapy. Controversies in the medical
and surgical management of endometriosis will be tackled including the optimal approach to each of its various
phenotypes as well as the strategies needed to manage associated infertility.

Learning Objectives

By the end of this course, participants will:
1. Gain an overview of the molecular, genetic and epigenetic mechanisms in the development of endometriosis.
2. Discover the role of the microbiome in the pathogenesis of endometriosis.
3. Determine the value of conflicting and complimentary medical and surgical treatment approaches.
4. Understand the application of Assisted Reproductive Technologies (ART) in preserving, and restoring the fertility ofwomen with endometriosis.
Register promptly as there are limited places for this in-demand course. The topics are relevant to and useful in theclinical practice not only of the reproductive medicine specialist but also of the general gynaecologist as well.
This course is jointly organized by the ASPIRE Endometriosis SIG and the Reproductive Surgery SIG.
Time

Programme outline

Speaker

0900 – 0915 Introduction by Workshop Chairperson

Huang Xiaowu (China)

Personalised Medicine for Women in
0915 – 1000 Endometriosis (including epigenetics aspect,
new drugs etc)

Hsien-Ming Wu (Taiwan)

1000 – 1045 The Role of the Microbiome in Endometriosis

Yasushi Hirota (Japan)

Chair

Yutaka Osuga (Japan)

Coffee Break1030 - 1100
1100 – 1145

Fertility Preservation Prior to Surgery for
Women with Endometriosis

Dayong Lee (Korea)

1145 – 1230

Different Surgical Approaches to Treat
Ovarian Endometrioma

Angela Aguilar (Philippines)

Chyi-Long Lee (Taiwan)

Lunch

1230 - 1330
1330 – 1415

Is Surgery Beneficial for Treating Deep
Endometriosis associated with Infertility?

Chih-Feng Yen (Taiwan)

1415 – 1500

Role of Medical Treatments Before and After
Surgery

Neil Johnson (New Zealand)

Huang Xiaowu (China)

Coffee Break

1500 – 1530

Debate: Adenomyosis Surgery Is Necessary in Fertility Management
1530 – 1700
1700 - 1715

Motion: For

Yasushi Hirota (Japan)

Chih-Feng Yen (Taiwan) &Motion: Against

Mukhri Hamdan (Malaysia)

Rashida Begum (Bangladesh)

Closing Remarks

Yutaka Osuga (Japan)29Pre-Congress Courses | Thursday, 23 May 2024

Perfecting ICSI Techniques and Improving Outcomes (Hands-on)
Venue: Meeting Room 5, Secretariat Building, PICC

The course aims to comprehensively cover the evolution of Intracytoplasmic Sperm Injection (ICSI) in assisted
reproductive technology. Participants will learn about the setup for ICSI, including micromanipulators, microscopes,
automation tools, and robotic systems. Various ICSI techniques, such as IMSI and PICSI will be explored, with a focus
on perfecting ICSI skills. Timing considerations during an ICSI cycle and gamete selection criteria will be emphasized.
Additionally, participants will discover how Key Performance Indicators (KPIs) can be implemented to enhance ICSI
outcomes and training programs. The course will also delve into the integration of Artificial Intelligence (AI) in ICSI,
highlighting its role in improving gamete and embryo assessments. Overall, participants will gain practical insights
and hands-on experience in the latest advancements shaping the field of ICSI.
This course is organized by the ASPIRE Endometriosis SIG.

Time

Programme outline

Speaker

0900 – 0905 Introduction by Workshop Chairperson

Keshav Malhotra (India)

0905 - 0920 The Evolution of ICSI

Ryan Rose (Australia)

0920 – 0935 Setup for ICSI (Micromanipulators, Microscopes & Automation)

Sweelian Liow (Singapore)0935 – 0955 Types of ICSI (IMSI,PICSI,PIEZO,ROBO)

Elaine Pasamba (Philippines)

0955 - 1015

Timing Is Everything, When to Do What During an ICSI Cycle

Keshav Malhotra (India)

1015 – 1030

Can Oocyte Activation Help All ICSI Failure Cases?

Thomas Ebner (Austria)
Coffee Break1030 – 1040
1040 – 1100

Perfecting ICSI Technique

Sweelian Liow (Singapore)1100 – 1120

Robotics and Artificial Intelligence in ICSI

Thomas Ebner (Austria)

1120 - 1140

Gamete Selection for ICSI: What’s Normal and What’s Abnormal

Cecilia Sjoblom (Australia)

1140 – 1200

How to Implement KPIs and Use Them to Improve ICSI Outcome and Training

Tiencheng Arthur Chang (Taiwan)

1200 - 1230

Panel Discussion - Different scenarios for ICSI

Chair: Krishna Mantravadi (India)
All Faculty

1230 - 1330

Lunch

13:30-18:00

Practical Workshop - Improving ICSI Outcomes30

Pre-Congress Courses | Thursday, 23 May 2024

Research and Publication

Venue: Meeting Room 6, Secretariat Building, PICC

This course is specifically tailored for younger authors who are eager to enhance their skills in planning, conducting,and presenting research, as well as navigating the complexities of academic publishing. Whether you’re a graduate
student embarking on your first research project or an early-career researcher looking to refine your publishingstrategy, this course aims to provide you with the knowledge and tools necessary to excel in the world of academia.
Throughout the course, we will explore each stage of the research and publication journey. Led by experienced
researchers and publishing professionals, this course combines theoretical insights with practical tips and exercises toempower you on your journey towards becoming a successful author.
This course is offered free of charge, ensuring that cost is not a barrier to accessing valuable educational resources.

Time

Programme outline

Speaker

0900 – 0905 Welcome and Introduction

Gab Kovacs (Australia)

0905 – 0945 Planning Research

Budi Wiweko (Indonesia)

0945 – 1025

Ben Mol (Australia)

Conducting Research & Data Management

Chair

Gab Kovacs (Australia)

Coffee Break1025 – 1045

1045 - 1125

Presenting Research

Neil Johnson (New Zealand)

1125 – 1205

Writing the Research paper

Kurt Barnhart (USA)Gab Kovacs (Australia)

1205 – 1245

Publishing the Research paper

Gab Kovacs (Australia)

1245 - 1250

Closing Remark

Gab Kovacs (Australia)31Pre-Congress Courses | Thursday, 23 May 2024

Reproductive Loss

Venue: Meeting Room 6, Secretariat Building, PICC

In an ever-advancing world of reproductive technology, much attention continues to focus on narratives of “successful”
reproduction with clinic websites and social media flooded with images of cute and hugely longed for babies. IVF andfertility treatment provide much hope for individuals and couples longing to create their families, however, sadly as
yet for some, there is no cure for infertility.
Approximately one in four individuals and couples in the Asia Pacific who are trying to conceive will experience
Reproductive Loss. While many of these individuals and couples will go on to conceive without assistance, for thoseneeding the additional support of ART specialists, the experience of reproductive loss has begun before they walkthrough the doors of an ART clinic. But Reproductive loss may not end when patients walk through our clinic doors:
for some individuals and couples, reproductive loss is experienced after an already challenging IVF cycle; for others,
this loss comes as they are supported to re-imagine the creation of their family in a different way, through theassistance of donor gametes. And for yet others, their reproductive loss may mean being supported in managing theemotional and practical aspects of ending treatment without that longed for baby. Regardless of the circumstances,these losses are significant and real.
This pre-congress course will bring together a wealth of knowledge and experience from experts across the APAC
in the fields of psychology, counselling, and nursing, to help answer the question: How can we do better to delivercompassionate care, recognizing Reproductive loss in all its forms?
With expert presentations, including those focusing in less explored areas of Reproductive loss, the opportunity forpanel discussions with specialists in each discipline, and through the sharing of useful resources from a variety ofcountries in the Asia Pacific, this course will leave participants better equipped to deliver the compassionate carethat all those seeking ART deserve.
This course is jointly organized by the ASPIRE Reproductive Nurses & Psychology & Counselling SIG
Time1300 - 1310

Programme outline
Welcome and Introduction

Speaker

Chair

Carmel Carrigan (Australia) &Rebecca Kerner (Australia)

Overview of Reproductive Loss1310 – 1335

Miscarriage and Still birth

Celia Chan (Hong Kong)

1335 – 1400

Using Donor Gametes

Rebecca Moore (Australia)

1400 – 1425

Involuntary Childlessness

Tanja Faessler (Singapore)

1425 – 1440

Q&A

All Speakers

Carmel Carrigan (Australia)
Astor Tse (Hong Kong)

Coffee Break

1440 – 1500

Carmel Carrigan (Australia)
Adeline Ma (Hong Kong)
1500 - 1630

Panel Discussion

Tanja Faessler (Singapore)
Astor Tse (Hong Kong)
Sharon Lim (Singapore)
Celia Chan (Hong Kong)

1630 – 1700

Resource Guidelines Sharing

1700 - 1710

Closing Remark

32

Carmel Carrigan (Australia)
Carmel Carrigan (Australia)
Rebecca Kerner (Australia)

Gab Kovacs (Australia)

Pre-Congress Courses | Thursday, 23 May 2024

Andrological Solutions to Complex Problems
Venue: Meeting Room 2, Secretariat Building, PICC

In this course, we will be exploring innovative approaches and advanced techniques from the perspective of andrology.
Infertility poses a significant challenge for millions of couples worldwide, with male factor infertility being aprominent contributor to the struggle to conceive. However, recent advancements in andrology have opened new
avenues for diagnosis and treatment, offering hope to those facing this complex issue.
Learning Objectives
1. Evaluate the clinical effectiveness of new sperm selection techniques using microfluidics.
2. Investigate the feasibility of inducing in vitro spermatogenesis.
3. Identify essential considerations for urologists when submitting specimens to the IVF lab.
4. Assess the clinical utility of Piezo intracytoplasmic sperm injection (ICSI).
This course is jointly organized by the ASPIRE Andrology SIG and Global Andrology Forum (GAF).
Time

Programme outline

Speaker

0900 - 0905 Introduction by Workshop Chairperson

Atsushi Tanaka (Japan)

0905 - 0925 Microfluidics in Sperm Selection

Hong-Yuan Huang (Taiwan)

0925 - 0945

Gwo-Jang Wu (Taiwan)

The Challenge of in Vitro Spermatogenesis

0945 – 1000 Q&A Discussion

Chair

Virgilio Novero (Philippines)

All faculty above
Coffee Break

1000 - 1030
1030 - 1050

What Should Urologists Know Before Submitting theSpecimen to the IVF Lab?

1050 - 1100

Q&A Discussion

William J Huang (Taiwan)

Atsushi Tanaka (Japan)

Debate: Pros and Cons of Piezo ICSI
1100 - 1150

Motion: For

Kenichiro Hiraoka (Japan)

Motion: Against

Atsushi Tanaka (Japan)

Gwo-Jang Wu (Taiwan)

Lunch

1150 - 1300

Atsushi Tanaka (Japan)
Virgilio Novero (Philippines)
Rupin Shah (India)

VARICOCELE and ART:An In-Depth Symposium for Urologists and Reproductive Specialists
1300 – 1310

Varicocele - Controversies and Dilemmas : An Overview Rupin Shah (India)

1310 - 1320

What Is the Role of Imaging in the Diagnosis of Varicocele? Dennis Lusaya (Philippines)

1320 – 1330

Expected Outcomes of Varicocele Repair for Infertility

1330 – 1340

Is There a Role for Varicocele Ligation in Isolated Sperm
Raman Talwar (India)
Defects?

Ponco Birowo (Indonesia)

1340 – 1350

Prognostic Factors for a Successful Outcome After
Varicocele Repair

Marlon Martinez (Philippines)

1350 - 1400

Which Technique Is Better – Radiographic,
Laparoscopic, Conventional or Microsurgical?

Widi Atmoko (Indonesia)

1400 – 1410

Surgical Considerations – Unilateral or Bilateral? Ligate
Marlon Martinez (Philippines)
Gubernacular Veins?

1410 – 1420

Operative Video – Microsurgical, Doppler-Assisted,
Subinguinal Varicocelectomy

1420 - 1430

Recurrent Varicocele – Should It Be Treated?

Raman Talwar (India)
Dennis Lusaya (Philippines)
Coffee Break

1430 - 1500
1500 – 1510

Is There a Role for Varicocele Ligation When the Couple
Ponco Birowo (Indonesia)
Is Already Planning IVF-ICSI?

1510 – 1520

Is Varicocele Repair Useful in Case With High SpermDNA Fragmentation?

Raman Talwar (India)

1520 – 1530

Is There a Role for Varicocele Repair in Recurrent
Pregnancy Loss?

Widi Atmoko (Indonesia)

1530 – 1540

Is Varicocele Repair Indicated in Azoospermic Men?

Ponco Birowo (Indonesia)

1540 – 1550

Adolescent Varicocele – When Is Surgery Indicated?

Widi Atmoko (Indonesia)

1550 – 1600

Role of Varicocele Repair in Orchalgia and Hypogonadism Dennis Lusaya (Philippines)

1600 – 1630

Q&A Discussion

All faculty above

1630 - 1635

Closing Message

Rupin Shah (India)

33

Rupin Shah (India)

Main Congress | Friday, 24 May 2024
0800 – 0830

Opening and Award Ceremony

Plenary Hall

Welcome address
Clare Boothroyd (Australia)
0830 – 0900

Bruno Lunenfeld Lecture
Chairs:Plenary Hall

Tin-Chiu Li (Hong Kong)
Clare Boothroyd (Australia)

What is the Future of Reproductive Surgery in the World of ART
Anis Feki (Switzerland)
0900 – 0930

Keynote Lecture 1
Chairs:Plenary Hall

Virgilio Novero (Philippines)
Chii-Ruey Tzeng (Taiwan)

Menopause Management: Coming Full Circle
Eileen Manalo (Philippines)
0930 – 1000

Keynote Lecture 2
Chairs:Plenary Hall

Virgilio Novero (Philippines)
Chii-Ruey Tzeng (Taiwan)

Growing the Best Embryos - The Factors That Count
Cecilia Sjoblom (Australia)

1045 – 1215

Company Symposium by MERCK
Shining a Light on the Constellations of
ART Outcomes and Health Economics
Chair:

Romerico Torres (Philippines)

Understanding the Fertility Landscape in APAC - Where to From Here?
David Humphreys (USA)
Gonadotrophins Under the Spotlight
Michael Costello (Australia)
Unlocking the Value of Fertility Medicines using Health Economic Studies
Chris Skedgel (United Kingdom)

34

Plenary Hall

Main Congress | Friday, 24 May 2024
1045 – 1215

Concurrent Session 1
PCOS

Chairs:Meeting Room 2-3

Madhuri Patil (India)
Robert Lahoud (Australia)

PCOS, Obesity and ART - Optimizing Outcome
Mei-Jou Chen (Taiwan)
PCOS & ART – Increasing Efficiency, Reducing Complications
Miyuki Harada (Japan)
Are PCOS Patients More Prone to Early Pregnancy Loss?
Eileen Manalo (Philippines)

1045 – 1215

Concurrent Session 2
Genetic Issues of Male Infertility

Chairs:Meeting Room 4

Sweelian Liow (Singapore)
Ponco Birowo (Indonesia)

Genetic Testing of the Infertile Male - What is New?
Khaleeq Ur Rehman (Pakistan)
Elevated Sperm DNA Fragmentation - What Works, What Doesn’t?
Raman Tanwar (India)
Sperm DNA Fragmentation Assay for Live Human Sperm During ICSINatan Tzvi Shaked (Israel)

1045 – 1215

Concurrent Session 3
Patient Centred Care

Chairs:Rebecca Kerner (Australia)
Emily Liu (New Zealand)

Nurse-Led Patient Centred Care in Fertility
Carmel Carrigan (Australia)
Pearls of Wisdom - Fertility Nursing in the Philippines
Riza Lim-See (Philippines)
Modern Technology Broadening Patient’s Access to Fertility Care and Support
Adeline Ma (Hong Kong)

35

Meeting Room 5

Main Congress | Friday, 24 May 2024
1045 – 1215

Free Communication 1
Presentations of the Shortlisted Oral Abstracts for the
ASPIRE 2024 Best Oral Awards (PART 1)
Chairs:

Shinyong Moon (Korea)
Jaideep Malhotra (India)

Judges:Tiencheng Arthur Chang (Taiwan)
Jung Ryeol Lee (Korea)
Ben Mol (Australia)
Gendie Lash (Australia)Louise Hull (Australia)

Meeting Room 6

THREE-DIMENSIONAL BIOPRINTED GELMA HYDROGEL CULTURE SYSTEM EMULATING THE
OVIDUCT ENVIRONMENT FOR ENHANCED PREIMPLANTATION EMBRYO DEVELOPMENT
Jae Ho Lee (Korea)
DEVELOPMENT OF CHILDREN BORN FROM INTRACYTOPLASMIC SPERM INJECTION WITHASSISTED OOCYTE ACTIVATION
Nam Nguyen Thanh (Vietnam)
EFFECT OF MEMBRANE ELASTICITY OF HUMAN OOCYTE ON FERTILIZATION AND EMBRYODEVELOPMENT FOLLOWING INTRACYTOPLASMIC SPERM INJECTION BY PIEZO-ICSI
Hayata Nakajo (Japan)
ADDRESSING UTERINE FACTOR INFERTILITY: FACILITATING AN INTERNATIONALCOLLABORATION TO ACHIEVE AUSTRALIA ‘S FIRST LIVE BIRTH FOLLOWING UTERINETRANSPLANTATION.
Neill Kiely (Australia)
HIGHER CD16-/NKP46BRIGHT ENDOMETRIAL NK CELLS CAN PREDICT ONGOING PREGNANCYIN REPRODUCTIVE FAILURE WOMEN
Chuxian Mai (China)

Free Communication 21045 – 1215

ART, Basic ResearchART, ClinicalART, Laboratory
Chairs:Meeting Room 7

Rashida Begum (Bangladesh)
Kenji Ezoe (Japan)

THE OUTCOME OF 3 YEARS OF INTRAUTERINE INSEMINATION
Tiara Berliana Azzahra (Indonesia)
ASSOCIATION BETWEEN MATERNAL AGE AND CHROMOSOMAL ANEUPLOIDY IN IVF PATIENTSJason Tungadi (Indonesia)
ELEVATED MATRIX METALLOPROTEINASE-9 (MMP-9) AND DOWN-REGULATED TISSUE
INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) ACTIVITIES ARE INDEPENDENT OF THE LOWLEVELS MIR-183 IN ENDOMETRIOSIS
Kresna Mutia (Indonesia)
IN VITRO FERTILIZATION HAVE NO IMPACT ON SUSCEPTIBILITY TO EXPERIMENTAL ASTHMA IN
MICE OFFSPRING
Shuangying Liu (China)
NAT10-MEDIATED N4-ACETYLCYTIDINE OF RNA CONTRIBUTES TO TRANSLATIONALREGULATION OF OOCYTE QUALITY IN MODULATING MURINE LUPUS
Yun Xie (China)
OVARIAN RESERVE AND IVF OUTCOMES AFTER ETHANOL OVARIAN SCLEROTHERAPY IN
WOMEN WITH ENDOMETRIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Charise Mae Malabanan (Philippines)
EXPLORING NK CELL SUBSETS DENSITY IN WOMEN WITH REPRODUCTIVE FAILURE:
COMPARISON WITH FERTILE CONTROLSLu Chen (China)36

Main Congress | Friday, 24 May 2024
1045 – 1215

Free Communication 3
ART, Laboratory
Chairs:Meeting Room 8

Krishna Mantravadi (India)
Shezae Khan (Pakistan)EMBRYO EUPLOIDY RATE IN CORRELATION WITH MATERNAL AGE AND BLASTOCYST GRADE
Hau Lam (Vietnam)
DOUBLE TRIGGER IN COS: EMBRYO QUALITY AND SUCCESS RATE
Farah Alvi Ramadhani (Indonesia)
THE IMPACT OF PLATELET-RICH PLASMA ON BLASTOCYST FORMATION IN
LOW SPERM QUALITY IVF-ICSI CASES
Ivana Gokmaida Nababan (Indonesia)
THE PREVALENCE OF DARK EMBRYOS AFTER THAWING AND
THEIR CLINICAL PREGNANCY RATEHa Mai Linh (Vietnam)
AI ASSISTED SPERM DETECTION FOR NON-OBSTRUCTIVE AZOOSPERMIA SPERM SEARCHES.
Dale Goss (Australia)
ANALYSIS OF FERTILIZATION, DEGENERATION, AND BLASTOCYST FORMATION RATES AFTERCONVENTIONAL- AND PIEZO-ICSI BY EXPERIENCED AND INEXPERIENCED EMBRYOLOGISTS IN
AN EVALUATION OF 65,033 MII OOCYTES
Hideaki Watanabe (Japan)
PARTENTAL INHERITANCE OF MONOPRONUCLEAR BLASTOCYSTS FROM ICSI CYCLES AND
RELATED MORPHOKINETIC TRAITS
Yuanlin Ma (China)

1130 - 1200

Company Presentation by GOLDQUESTBIOTECHNOLOGIES INC.
Nikon Microscopy Technological Solutions for ART

1345 - 1515

Company Symposium by Vitrolife Group
Excellence in IVF: Improving Outcomes Through Optimized Embryo Culture,
Evaluation and Genetics
Chair:

Cecilia Sjoblom (Australia)

A Radical Approach to Stress Reduction in Culture? Riding the Antioxidant Wave.
Daniel Morgan (Australia)
External Validation of iDAScore 2.0 for Selecting Day 3 Embryos for Transfer:
A Multicenter, Large Sample, Retrospective Study
Jia-Hong Zhu (China)
Embryo Transfer Using EmbryoGlue for Patients With History of ART Failure
Koji Nakagawa (Japan)Your Leading Global Partner in Genetic Solutions
Kathryn Gebhardt (Australia)

37

Theatrette,
Mezzanine,
Exhibition Hall
(Reception Hall)

Plenary Hall

Main Congress | Friday, 24 May 2024
1345 - 1515

Concurrent Session 4
Current Research in Controversial Areas
Chairs:Meeting Room 2-3

Ji-Hyang Kim (Korea)
Navdeep Singh Pannu (Malaysia)

Kisspeptin - The New Kid on the Block
Hsien-Ming Wu (Taiwan)
Revisiting Endometrium Scratch
Neil Johnson (New Zealand)
Ovarian Rejuvenation – Is There a Role of PRP and Stem Cells?
Chii-Ruey Tzeng (Taiwan)
1345 - 1515

Concurrent Session 5
Reproductive Genetics
Chairs:Meeting Room 4

Rong Li (China)
Maria Victoria Romualdez-Tan (Philippines)

1345 - 1415

Factors in the IVF and Genetic Testing Labs Contributing to PGT Outcomes
Tiencheng Arthur Chang (Taiwan)

1415 - 1445

Aneuploidy and Mosaicism in Human Early Embryos
Liying Yan (China)

1445 - 1515

Embryos Screening Strategy for Carrier with Chromosome Structure Rearrangement
Yuan Gao (China)

1345 - 1515

Concurrent Session 6
Cutting Edge in Fertility Preservation
Chairs:Jung-Ryeol Lee (Korea)
Virgilio Novero (Philippines)

1345 - 1415

From Ovarian Tissue Cryopreservation to Artificial Ovary:
How Far Can Technology Really Go?
Paweena Thuwanut (Thailand)

1415 - 1445

Using Post-Mortem Uterus for Transplantation
Rebecca Deans (Australia)

1445 - 1515

Generating Mature Sperm from Immature Testicular Tissues
Kai Hong (China)

38

Meeting Room 5

Main Congress | Friday, 24 May 2024
1345 – 1515

Free Communication 4
Counselling, Ethics and Psychosocial
Chairs:Meeting Room 6

Sharon Lim (Singapore)
Rebecca Kerner (Australia)

FROM "I" TO "WE", TURNING "I"LLNESS TO "WE"NESS: EXAMINING THE COUPLE IDENTITY
AND DYADIC COPING AMONG CHINESE INFERTILE COUPLES IN HONG KONG
Tess Tung Kwan (Hong Kong)
THE IMPACT OF PSYCHOLOGICAL COUNSELING ON PREGNANCY AMONG THE ART PATIENTSSCREENING BY THE SCREENIVF: A PROSPECTIVE COHORT STUDY
Tomoe Koizumi (Japan)
UNEARTHING THE COMPLEXITIES OF EMPATHIC FAILURE: AN INVESTIGATION INTO FEAR
OF DEATH AND GRIEF COMMUNICATION TOWARDS BEREAVED PARENTS AMONG CHINESE
ADULTS
Ngai Ling Chris Ng
CASE SERIES ON SWYER SYNDROME AN THE IMPORTANCE OF HOLISTIC MANAGEMENT
Janmarie Gabrielle Maano (Philippines)
ABANDONMENT OF FERTILITY-SPARING SURGERY:
A CASE OF BILATERAL OVARIAN CANCER IN A 28-YEAR OLD NULLIGRAVID
Margaret Joyce Cristi-Limson (Philippines)
INVESTIGATING INDIAN OOCYTE DONORS’ MOTIVATION, PERSONALITY TYPE,
AND EMOTIONS IN REGARDS TO OOCYTE DONATION
Kedar Ganla (India)
COUPLES PRESENTING TO THE INFERTILITY CLINIC- DO THEY REALLY HAVE INFERTILITY?
- THE UNEXPLORED STORIES OF NON-CONSUMMATION
Sujoy Dasgupta (India)
1345 - 1515

Free Communication 5
Uterine Disorders and Endometriosis
Chairs:Meeting Room 7

Emily Liu (New Zealand)
Keiji Kuroda (Japan)

ANALYSIS OF THE THERAPEUTIC EFFECTS OF HYSTEROSCOPIC POLYPECTOMY USING
HYSTEROSCOPIC TISSUE REMOVAL SYSTEM (MYOSURE) ON CHRONIC ENDOMETRITIS WITHENDOMETRIAL POLYPSKeiji Kuroda (Japan)
ORAL PROBIOTIC SUPPLEMENTATION SUSTAINS THE RICHNESS OF CERVICAL MICROBIOTA
Wei-Fang Chang (Taiwan)
THE EFFECT OF LONG-TERM DIENOGEST USE ON BONE MINERAL DENSITY: A SYSTEMATIC
REVIEW AND META-ANALYSIS
Shayne Fajutagana (Philippines)
PRACTICES AND EXPERIENCES OF OBSTETRICIAN-GYNECOLOGISTS IN THE DIAGNOSIS AND
MANAGEMENT OF ENDOMETRIOSIS IN THE PHILIPPINES
Bernadette Ann Alcazaren (Philippines)
EVERY BREATH YOU TAKE: A CASE REPORT ON THORACIC ENDOMETRIOSISMary Camille Yulo (Philippines)
PREGNANCY OUTCOMES IN PATIENTS WITH ADENOMYOSIS GIVEN GNRH AGONIST BEFOREEMBRYO TRANSFER
Ednalyn Ong-Jao (Philippines)
ASPIRE CONSENSUS ON THE STRUCTURE OF CARE IN ENDOMETRIOSIS –NETWORKS/CENTRES OF EXPERTISE
Siriruthai Amnatbuddee (Thailand)

39

Main Congress | Friday, 24 May 2024
1345 – 1515

Free Communication 6
Gynaecology and Surgery
Chairs:Meeting Room 8

Suyash Naval (India)
Herbert Situmorang (Indonesia)

FERTILITY-SPARING VNOTES OVARIAN CYSTECTOMY: A COMPARISON OF CONVENTIONALLAPAROSCOPIC VNOTES AND ROBOTIC VNOTES USING SINGLE-PORT SYSTEM
Charise Mae Malabanan (Philippines)
EMERGENCY CERVICAL CERCLAGE AND GESTATIONAL OUTCOMES:A RETROSPECTIVE COHORT STUDY
Nguyen Viet Dung (Vietnam)“ALL THE TOOLS IN THE BOX” A COMPREHENSIVE AND ETHICAL APPROACH TO CESAREAN
SCAR ECTOPIC PREGNANCY A CASE REPORT
Priscilla Alameda (Philippines)
DISTAL VAGINAL AGENESIS PRESENTING WITH FECAL RETENTION FROMAN ABDOMINOPELVIC MASS
Patrick Jose Padilla (Philippines)
RECURRENT PREGNANCY LOSS IN COMPLETE SEPTATE UTERUS WITH DUPLICATED CERVIXAND LONGITUDINAL VAGINAL SEPTUM: A CASE REPORT AND REVIEW OF THE LITERATURE
Beatriz Eusebio (Philippines)
OPEN PORT PLACEMENT LAPAROSCOPIC CYSTECTOMY FORPERSISTENT OVARIAN MASS IN PREGNANCY
Kristine Joy Ramos (Philippines)
SQUAMOUS CELL CARCINOMA ARISING WITHIN A MATURE CYSTIC TERATOMA OF THE OVARY
IN A 31-YEAR-OLD FEMALE: A CASE REPORT
Kissler Jean Romarate (Philippines)
1400 - 1430

Company Presentation by FUJIFILM Irvine Scientific
Uterine Disorders and Endometriosis

Theatrette,
Mezzanine,
Exhibition Hall
(Reception Hall)The Role of Body Mass Index in IVF Success: Strategies for Clinical and Laboratory Practice
He Cai
1515 - 1645

Company Symposium by Abbott
Revisiting LPS: The Role of Progestogens in Early Pregnancy and
Improving Outcomes
Chair:Plenary HallAngela Aguilar (Philippines)

ART in Asia: Perspective on Current Practices
Rudie Frederick Mendiola (Philippines)
The Role of Progestogens in ART
Georg Griesinger (Germany)
1515 - 1645

Concurrent Session 7
Endometrial Receptivity
Chairs:Meeting Room 2-3

Koji Nakagawa (Japan)
Rohina Gul (Pakistan)

New Challenges in Endometrial Receptivity
Dominique De Ziegler (France)
Does Insulin Resistance Have a Role in Recurrent Pregnancy Loss and Implantation Failure?
Louise Hull (Australia)
The Utility of microRNAs Testing in Endometrium Receptivity in ART
Wen-Jui Yang (Taiwan)

40

Main Congress | Friday, 24 May 2024
1515 - 1645

Concurrent Session 8
Cryopreservation from the Testes

Meeting Room 4

David Chan (Hong Kong)
William Huang (Taiwan)

Chairs:1515 - 1545

Pediatric Testicular Tissue Cryopreservation: Current StatusKai Hong (China)

1545 - 1615

Generation of Spermatozoa From Spermatogonial Stem Cells: An Update
Pradeep G Kumar (India)

1615 - 1645

Sperm Cryopreservation of Very Low Sperm Numbers
Atsushi Tanaka (Japan)

1515 - 1615

Debate 1

Meeting Room 5

Tiencheng Arthur Chang (Taiwan)
Krishna Mantravadi (India)

Chairs:1515 - 1615

AI and Automation Will Replace Embryologists
For: Catherine Racowsky (USA)Against: Cecilia Sjoblom (Australia)

1620 - 1705

Global Journal Club

Meeting Room 5

Clare Boothroyd (Australia)
Kurt Barnardt (USA)

Chairs:What Are the Recent RCTs in the Asia Pacific Region?
Panelists:

1515 – 1645

Ben Mol (Australia)
Ho Manh Tuong (Vietnam)
Richard Paulson (USA)Zi-Jiang Chen (China)

Free Communication 7
PCO
Chairs:Meeting Room 6

Madhuri Patil (India)
Robert Lahoud (Australia)

OVERWEIGHT AND OBESITY DETERMINED BY BODY MASS INDEX CRITERIA FOR ASIANPOPULATIONS ADVERSELY AFFECT ASSISTED REPRODUCTIVE OUTCOMES AMONG CHINESEWOMEN WITH POLYCYSTIC OVARY SYNDROME
Ruimin Zhao (China)
THE EARLY DEVELOPMENT OF OFFSPRING FROM WOMEN WITH POLYCYSTIC OVARYSYNDROME: PROSPECTIVE COHORT STUDY FROM CHINA
Qi Cao (China)
NOVEL GLP-1 RECEPTOR AGONIST PLUS METFORMIN REGIMEN FOR ASIAN POLYCYSTIC OVARYSYNDROME PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF
EFFICACY AND SAFETY
Gezta Nasafir Hermawan (Indonesia)
POLYCYSTIC OVARY SYNDROME AND PHYSICAL ACTIVITY: A BIDIRECTIONAL TWO-SAMPLE
MENDELIAN RANDOMIZATION STUDY
Luyang Zha (China)
LEAN POLYCYSTIC OVARIAN SYNDROME (PCOS) HAS BETTER RESPONSES TO RECOMBINANT
FOLLICLE-STIMULATING HORMONE COMPARED TO OBESE PCOS DURING OVARIANSTIMULATION FOR IN VITRO FERTILIZATION
Muhammad Ikhsan (Indonesia)
COMPARISON OF OOCYTE MATURATION IN GNRH-ANTAGONIST PROTOCOL TRIGGER BYHCG OR GNRH-AGONIST IN PCOS PATIENTS
Rohina Gul (Pakistan)
COMBINED USE OF LETROZOLE, CABERGOLINE AND GNRH ANTAGONIST TO PREVENTOVARIAN HYPERSTIMULATION SYNDROME COMPLETELY IN POLYCYSTICOVARIAN SYNDROME TREATMENT.
Yuya Makino (Japan)

41

Main Congress | Friday, 24 May 2024
1515 – 1645

Free Communication 8
Female Infertility
Chairs:Meeting Room 7

Rashid Latif Khan (Pakistan)
Margaret Joyce Cristi-limson (Philippines)

UNRAVELING ENDOMETRIAL MICROBIOTA DISORDER AND ITS INTERACTION WITHENDOMETRIAL RECEPTIVITY IN RECURRENT IMPLANTATION FAILURE
Fen-ting Liu (China)
PREGNANCY OUTCOME OF ASHERMAN’S SYNDROME PATIENT WITH INFERTILITY AFTERINTRAUTERINE ADHESIOLYSIS COMBINED MULTI-THERAPEUTIC STRATEGY.
Dinh Hoang (Vietnam)
FERTILITY POLICY AND PRACTICE: THE APAC FERTILITY AND FAMILY SCORECARDDavid Humphreys (USA)RELATIONSHIP BETWEEN THE AREA/PERIMETER OF EMBRYO IMPLANTATION REGION AND THE
PREGNANCY OUTCOME
Yutong Wang (China)
IS FOLLITROPIN DELTA A PROMISING TREATMENT FOR OVARIAN STIMULATION OF POORRESPONDERS IN IVF?
Anh Dang (Vietnam)
CHRONIC ENDOMETRITIS ; AN IMPACT ON INFERTILITY, IMPLANTATION FAILURE AND
RECURRENT PREGNANCY LOSS- BANGLADESH PERSPECTIVE !
SHAMSUN NAHAR LUCKY (Bangladesh)
THE IMPACT OF ORAL MULTINUTRIENT SUPPLEMENTATION ON FERTILITY OUTCOMES IN INVITRO FERTILIZATION OR INTRACYTOPLASMIC SPERM INJECTION (IVF/ICSI) IN MALAYSIANPOPULATION– A PROSPECTIVE CONTROLLED STUDY
Gopinath Muruti (Malaysia)
1515 – 1645

Free Communication 9
ART, Clinical
Chairs:Meeting Room 8

Mariam Faruqui (Bangladesh)
Somjate Manipalviratn (Thailand)

A COMPARISON OF PREGNANCY OUTCOMES AND CONGENITAL MALFORMATIONS IN
OFFSPRING BETWEEN PATIENTS UNDERGOING INTRACYTOPLASMIC SPERM INJECTION AND
CONVENTIONAL IN VITRO FERTILIZATION: A RETROSPECTIVE COHORT STUDYNan Zhang (China)
HOW TO DEFINE IN-VITRO FERTILIZATION SUCCESS: A DELPHI CONSENSUS AMONG CHINA
EXPERTS
Yang Wang (China)
LEVOTHYROXINE IMPROVES THE OUTCOMES OF IN VITRO FERTILIZATION-EMBRYO TRANSFER(IVF-ET) IN WOMEN WITH ADENOMYOSIS AND THYROID AUTOIMMUNITYSong Yang (China)
THE EFFICACY BETWEEN DIFFERENT ENDOMETRIAL PREPARATION PROTOCOLS FOR FROZENEMBRYO TRANSFER IN PATIENTS WITH CESAREAN SECTION SCAR DEFECT
Van T T Tran (Vietnam)
CAN LOW-DOSE ASPIRIN BEFORE AND DURING THE FIRST TRIMESTER IMPROVE PREGNANCYOUTCOMES AFTER FROZEN EMBRYO TRANSFER?
Weilin Wang (China)
CONTROLLING MULTIPLE PREGNANCIES AND OPTIMIZING ASSISTED REPRODUCTIVETECHNOLOGY (ART) QUALITY CONTROL MANAGEMENT IN BEIJING
Lixue Chen (China)
FLEXIBLE PROGESTIN-PRIMED VERSUS GNRH ANTAGONIST PROTOCOL: COMPARISION OF
CLINICAL OUTCOME AND EMBRYO MORPHOKINETICS
Thanh Dao Huy (Vietnam)42

Main Congress | Friday, 24 May 2024
1730 - 1900

Concurrent Session 9

Plenary Hall

PGT-A / PGT-M
Chairs:Keshav Malhotra (India)
Rudie Frederick Mendiola (Philippines)

Why Do Euploid Embryo Not Always Implant
Danilo Cimadomo (Italy)
PGT-A Diagnosis of Euploid, Mosaic, Segmental Aneuploid, and Aneuploid:
How Do You Navigate These Results?
Jason Franasiak (USA)All-in-One PGT Testings
Richard Choy (Hong Kong)
1730 - 1900

Concurrent Session 10
Minimal Invasive Gynaecology Surgery
Chairs:Meeting Room 2-3

Jacqueline Chung (Hong Kong)
Chyi-Long Lee (Taiwan)

Prevention of Adhesions or Recurrence During Hysteroscopic Surgeries
Maria Antonia Habana (Philippines)
Laparoscopic Cervical Cerclage
Xiaowu Huang (China)
An Experience on Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES)
Suyash Naval (India)
1730 – 1900

Korean Session
Disruptive Innovations to Enhance ART Patient Care

Meeting Room 4

Evolving to Improve Ovarian Stimulation with Gonadotropins
Chair: Shin Yong Moon (Korea)
For High Responders
Dong Soo Park (Korea)
For Normal & Poor Responders
Il Hae Park (Korea)
Panel Discussion
Kyong Wook Yi (Korea)
Fresh Versus Frozen Embryo Transfers in Assisted Reproduction
Chair: Kwang-Rae Kim (Korea)
Advantages of Fresh Transfers
Minhee Lee (Korea)
Advantages of Frozen Transfers
Se Jeong Kim (Korea)
Panel Discussion
Myungsin Kim (Korea)
Jiyoung Choi (Korea)
1730 - 1900

Concurrent Session 11
Psychosocial Pearls of Wisdom
Chairs:Meeting Room 5

Celia Chan (Hong Kong)
Carmel Carrigan (Australia)

Patient Centred Care - Focusing on Psychosocial
Tanja Faessler-Moro (Singapore)
Compassionate Closure: Navigating End of Treatment Discussions with Transparency
Rebecca Kerner (Australia)
Third Party Reproduction
Sharon Lim (Singapore)43

Main Congress | Friday, 24 May 2024
1730 - 1900

Free Communication 10
ART, Clinical
Chairs:Meeting Room 6

Sean Sokteang (Cambodia)
Debby Songco (Philippines)

PREVALENCE AND OUTCOMES OF RESCUED FROZEN-THAWED CYCLES WITH LOW SERUM
PROGESTERONE CONCENTRATION: A CROSS-SECTIONAL STUDY IN VIETNAM
Minh P.K. Huynh (Vietnam)
ALTERED D-DIMER VALUES IN PATIENTS WITH UNEXPLAINED FAILURE DURING EUPLOID
CRYOTRANSFERS
Yi-Hsin Wu (Taiwan)
MACHINE LEARNING MODEL FOR PREDICTION OF CUMULATIVE ONGOING PREGNANCY AFTER
12 MONTHS OF IVF TREATMENT
C Tri Nguyen (Vietnam)
PREDNISOLONE AND CLEXANE THERAPY (“THE BONDI PROTOCOL”) FOR REPEATED IVF
FAILURE
Gavin Sacks (Australia)
THE OUTCOME OF PLATELET-RICH PLASMA INTRAUTERINE INFUSION IN THIN ENDOMETRIUM
AND RECURRENT IMPLANTATION FAILURE PATIENTSSarah Susanto (Indonesia)
ASSESS THE PROGRESSION OF LH CONCENTRATION IN PROGESTIN-PRIMED OVARIANSTIMULATION
Than Thach Trong (Vietnam)
PREDICTING OOCYTES RETRIEVAL NUMBERS, BLASTOCYST NUMBERS AND LIVE BIRTH IN IVF
TREATMENT CYCLE USING MACHINE LEARNING CLASSIFIER
JenYu Wen (Taiwan)
1730 - 1900

Free Communication 11
Reproductive Genetics
Chairs:Meeting Room 7

Maria Victoria Romualdez-Tan (Philippines)
Raden Muharam (Indonesia)

EXPLORING THE DYNAMICS OF CHROMOSOMAL ABNORMALITIES IN HIGH-QUALITY EMBRYOSFROM FERTILE COUPLES: A COMPREHENSIVE ANALYSIS OF CHROMOSOMES 13, 18, 21, X AND Y
Shezae Khan (Pakistan)
CASE SERIES REPORT: PREIMPLANTATION GENETIC TESTING WITH
HLA-MATCHING IN VIETNAM
Phuong Nguyen T.M. (Vietnam)
PGT-M FOR THALASSEMIA AND SEVERAL OTHER GENETIC DISEASES:A RETROSPECTIVE DESCRIPTIVE STUDYThi Thu Cuc Bach (Vietnam)
GENETIC ANALYSIS RESULTS IN PATIENTS WITH NON-OBSTRUCTIVE AZOOSPERMIA
Viet Dinh Huu (Vietnam)
EXPRESSION LEVELS OF HSA-MIR-375-3P MAY BE INDICATIVE OF PROGESTERONE SENSITIVITY
IN IVF PATIENTS WITH DISPLACED WINDOW OF IMPLANTATION
Eric Pok Yang (Taiwan)
POLYMORPHISM OF FSHB GENE VARIANT RS6169 AND LHB GENE VARIANT RS1056917 IN
INDONESIAN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
Hilma Putri Lubis (Indonesia)

44

Main Congress | Friday, 24 May 2024
1730 - 1900

Free Communication 12
Fertility Infertility
Fertility Preservation
Chairs:Meeting Room 8

Ming-Jer Chen (Taiwan)
Koji Nakagawa (Japan)

A RETROSPECTIVE ANALYSIS OF UTERINE ADMINISTRATION OF OIL-BASED CONTRAST AT TIME
OF DIAGNOSTIC LAPAROSCOPY AND HYSTEROSCOPY
Ashleigh Smith (Australia)
PERINATAL OUTCOMES OF ASSISTED REPRODUCTIVE TECHNOLOGY IN CANCER SURVIVORS
Yume Kobayashi (Japan)
ETHICAL DILEMMAS IN OOCYTE DONATION: EXPLORING ATTITUDES, MOTIVATIONS,AND THE INFLUENCE OF FINANCIAL COMPENSATION AMONG SOCIALOOCYTE FREEZERS
Sylvia Ross (Australia)
FROM DIAGNOSIS TO PRESERVATION: UNDERSTANDING BREAST CANCER FERTILITY
TREATMENT DECISIONSNeill Kiely (Australia)
PATTERNS OF USE FOR MEDICARE-FUNDING ASSISTED SPERM CRYOPRESERVATIONACROSS AUSTRALIA: THE REGIONAL VARIANCES SINCE INTRODUCTION.
ARE THERE LESSONS TO BE LEARNED FOR THE ASIA-PACIFIC REGION?
Emma Stehr (Australia)
FACTORS ASSOCIATED WITH AWARENESS ON SOCIAL EGG FREEZING AMONG NULLIGRAVID
FILIPINO WOMEN OF REPRODUCTIVE AGE: A CROSS SECTIONAL STUDY
Olive Joyce Alabado-Lindero (Philippines)
ASPIRE CONSENSUS ON FERTILITY PRESERVATION IN ENDOMETRIOSIS
Siriruthai Amnatbuddee (Thailand)

45

46

Main Congress | Saturday, 25 May 2024
0715 – 0800

Young Investigator Awardee Presentations
Chairs:Plenary Hall

Haroon Latif (Pakistan)
Gab Kovacs (Australia)

BEYOND BLACK-BOX MODELS: EXPLAINABLE AI FOR EUPLOIDY EMBRYO PREDICTION AND
PATIENT-CENTRIC CONSULTATION
Thi-My-Trang Luong (Vietnam)
DNA METHYLATION, A NEW PERSPECTIVE TO EVALUATE EMBRYO QUALITY IN ASSISTEDREPRODUCTIVE TECHNOLOGY
Xuelong Yao (China)
EFFECT OF POST-WARMING CULTURE TIME OF VITRIFIED-WARMED OOCYTE ONEMBRYOLOGICAL OUTCOMES
Thanh Pham N.D. (Vietnam)
0730 – 0800

How-To Session 1
Chair:

Meeting Room 2-3

Ming-Jer Chen (Taiwan)

How to Avoid Obstetric Complications Arising from ART Treatments
Maria Victoria-Tan (Philippines)
0730 – 0800

How-To Session 2
Chair:

Meeting Room 4

Maria Antonia Habana (Philippines)

1345 - 1415

Surgical Tutorial (Video session) - Various Techniques of Hysteroscopic Myomectomy
Herbert Situmorang (Indonesia)

0730 – 0800

How-To Session 3
Chair:

1345 - 1415
0800 – 0830

Meeting Room 5

Marinella Abat (Philippines)

How to Get That Elusive Sought-After Job
Neil Johnson (New Zealand)

Keynote Lecture 3
Chairs:Plenary Hall

Rong Li (China)
Haroon Latif (Pakistan)

Future of Reproductive Genetics
Junhao Yan (China)
0830 – 0900

Keynote Lecture 4
Chairs:Rong Li (China)
Haroon Latif (Pakistan)

1345 - 1415

Endometrial Preparation for Frozen Embryo Transfer:
Do Natural Cycles Have Better Outcomes?
Richard Paulson (USA)0900 – 0930

Keynote Lecture 5
Chairs:1345 - 1415

Plenary Hall

Rong Li (China)
Haroon Latif (Pakistan)

Epigenetic Regulation of Decidualization in Human Endometrium
Norihiro Sugino (Japan)

47

Plenary Hall

Main Congress | Saturday, 25 May 2024
1015 - 1145

Company Symposium by Ferring Pharmaceuticals
Science Meets Practice: Using Real-World Evidence toOptimise ART Outcomes
Chair:Plenary HallMaria Victoria Romualdez-Tan (Philippines)

Opening Address
Maria Victoria Romualdez-Tan (Philippines)
Tailoring Ovarian Stimulation According to Patient Profile
Joop Laven (Netherlands)
Clinical Trials and Real-World Evidence: Closing the Knowledge Gaps
Georg Griesinger (Germany)
Improving ART Outcomes in the Context of a Demographic Crisis
II-Hae Park (Korea)
Q&A and Closing Remarks
Maria Victoria Romualdez-Tan (Philippines)
1015 - 1145

Concurrent Session 12
Congenital Uterine Anomalies
Chairs:Meeting Room 2-3

Navdeep Singh Pannu (Malaysia)
Chih-Feng Yen (Taiwan)

T-Shaped Uterus
Rebecca Deans (Australia)
Management of Bicornuate Uterus
Dongmei Song (China)
Management of Obstructive Congenital Uterine Anomalies
Zhu Lan (China)
1015 - 1145

Concurrent Session 13
Lab Monitoring
Chairs:Meeting Room 4

Krishna Mantravadi (India)
Shezae Khan (Pakistan)

Real Time Monitoring of Embryology Labs
Catherine Racowsky (USA)
Cryo Storage Monitoring
Kenji Ezoe (Japan)
Learning from Other Labs Disasters
Adrianne Pope (Australia)
1015 - 1145

Concurrent Session 14
Individualization of ART Treatment
Chairs:Robert Lahoud (Australia)
Maruf Siddiqui (Bangladesh)

Individualization of Ovarian Stimulation
Ivan Sini (Indonesia)
Individualization of Luteal Phase Support: Where Are We?
Dayong Lee (Korea)
Optimal Endometrial Preparation for Frozen Embryo Transfer
Lan N Vuong (Vietnam)

48

Meeting Room 5

Main Congress | Saturday, 25 May 2024
1015 - 1145

Free Communication 13
Presentations of the Shortlisted Oral Abstracts for the
ASPIRE 2024 Best Oral Awards (PART 2)
Chairs:

Shinyong Moon (Korea)
Jaideep Malhotra (India)

Judges:Tiencheng Arthur Chang (Taiwan)
Jung Ryeol Lee (Korea)
Ben Mol (Australia)
Gendie Lash (Australia)Louise Hull (Australia)

Meeting Room 6

IDENTIFYING THE NOVEL MUTATIONS IN TERATOZOOSPERMIA BY UTILIZING WHOLE EXOMESEQUENCING
Ying-Hung Lin (Taiwan)
SPECIFIC MICROBIOMES AFFECT STEROIDOGENESIS AND MITOCHONDRIAL FUNCTION IN
LEYDIG CELLSJae Ho Lee (Korea)
NEXT-GENERATION PGT: COMBINED GENOME AND TRANSCRIPTOME ANALYSIS
Sijia Lu (China)
CERVICAL SECRETION DNA METHYLATION TESTING IS FEASIBLE TO SERVE AS A
NON-INVASIVE BIOMARKER FOR SUCCESSFUL IMPLANTATION PREDICTION INFROZEN-THAWED EMBRYO TRANSFER TREATMENT
Yi-xuan Lee (Taiwan)
THE CONSEQUENCE OF SINGLE SESSION PSYCHOLOGICAL COUNSELING AT THE BEGINNING
OF FERTILITY TREATMENT ON THE PREGNANCY: A RETROSPECTIVE COHORT STUDY USING
COX PROPORTIONAL HAZARDS REGRESSION.
Kumiko Tanaka (Japan)
1015 - 1145

Free Communication 14
Male Fertility
Chairs:Meeting Room 7

Pradeep G Kumar (India)
William Huang (Taiwan)

ROBOTIC EXCISION OF A LARGE PROSTATIC UTRICLE CYST WITH MICRODISSECTIONTESTICULAR SPERM EXTRACTION PRESENTING AS PRIMARY INFERTILITY AND RECURRENTORCHITIS
Michelangelo Cobangbang (Philippines)
ULTRA-MORPHOLOGICAL CHARACTERIZATION OF SPERMATOZOA WITH HEADABNORMALITIES
Hongxiang Wang (China)
EFFECT OF MALE FACTORS ON EMBRYO PLOIDY AND THE EFFICACY OF PREIMPLANTATIONGENETIC TESTING: A SECONDARY ANALYSIS OF A MULTICENTER CLINICAL TRIAL
Weilin Wang (China)
EVALUATING THE OUTCOMES OF MICRODISSECTION TESTICULAR SPERM EXTRACTION IN MEN
WITH SEVERE TESTICULAR ATROPHY
Van Tuan Nguyen (Vietnam)
CONTROLLED MICRO-MOTOR DEVICE: A FUTURISTIC METHOD IN ASSISTED REPRODUCTIVETECHNOLOGYSamuel Lionardi (Indonesia)
EVALUATE THE INFLUENCE OF SERUM TESTOSTERONE LEVELS ON THE SPERM RETRIEVALRATE IN NON-OBSTRUCTIVE AZOOSPERMIA PATIENTS UNDERGOING MICRO-TESE
Van Tuan Nguyen (Vietnam)
TO DETERMINE THE EFFECT OF MALE AGE ON SPERM PARAMETERS AND EMBRYODEVELOPMENT
Zahra Ali (Pakistan)49

Main Congress | Saturday, 25 May 2024
1015 - 1145

Free Communication 15- Counselling, Ethics and Psychosocial- Nursing
Chairs:Meeting Room 8

Adeline Ma (Hong Kong)
Tanja Faessler-Moro (Singapore)"IS HAVING NO CHILDREN STILL UNFILIEL IN HONG KONG?" CHANGE IN TRADITIONAL VALUEOF CHILDBEARING IN HONG KONG DURING COVID-19: A NETWORK APPROACH
Tess Tung Kwan (Hong Kong)
UNDERSTANDING THE MULTIFACETED NATURE OF ATTITUDES TOWARDS MISCARRIAGEAMONG CHINESE ADULTS: EXPLORING THE ROLE OF CULTURAL BELIEFS AND SOCIALSUPPORT
Shuwen Zhang (China)
UNVEILING THE MENTAL HEALTH LANDSCAPE OF WOMEN WITH REPRODUCTIVE HEALTHISSUES IN HONG KONG: A CROSS-SECTIONAL STUDY ON HELP-SEEKING BEHAVIOR
Ngai Ling Chris Ng (Hong Kong)
TRANSFER OUTCOMES AND PATIENT SATISFACTION OF HIGH-RISK DIABETES CASES:
A BRIEF RETROSPECTIVE EVALUATION
Thi Huyen Nguyen (Vietnam)
1200 - 1300

Round Table Luncheon Discussion

Mezzanine Level,
Outside Reception
Hall

Future Standards of Care of Infertility Associated Endometriosis
Anis Feki (Switzerland)
Sexual and Ejaculatory Problems in Infertile Couples
Rupin Shah (India)
Fertility Preservation in Females - Expanding Indications
Claus Yding Andersen (Denmark)Controversies in Endometrial Preparation for Frozen Embryo Transfer?
Richard Paulson (USA)
What Strategies Can Upturn Human Fertility Rates?
Neil Johnson (New Zealand)
Revisit the Role of ERA and PGT-A in ART
Chii-Ruey Tzeng (Taiwan)
Management of an ART Cycle in Hyper Responders
Duru Shah (India)
Updates on the Advancement of Clinical IVM
Lan N Vuong (Vietnam)
PGT-A: Analytic Validation, Clinical Validation, and Clinical Utility
Jason Franasiak (USA)Management of ART in Endometriosis
Dominique de Ziegler (France)
1315 - 1445

Company Symposium by Organon
Advancing Science in Women’s Health
Chair:

Danilo Milla (Philippines)

Welcome & Introduction
Danilo Milla (Philippines)
Debate: Fresh vs Frozen Embryo Transfer
Chair: Li Rong (China)
Lan N Vuong (Vietnam)
versus Atsushi Tanaka (Japan)
Insights into Post-Partum Haemorrhage
Esmeraldo Ilem (Philippines)

50

Plenary Hall

Main Congress | Saturday, 25 May 2024
1315 - 1445

Concurrent Session 15
Clinical Issues in Male Infertility Treatment
Chairs:Meeting Room 2-3

Somjate Manipalviratn (Thailand)
Gwo-Jang Wu (Taiwan)

Non-Surgical Treatment for Non-Obstructive Azoospermia
Koji Shiraishi (Japan)
Which Anti-oxidants for Male Infertility Actually Work?
Christopher Ho Chee Kong (Malaysia)
Updates on Surgical Sperm Retrieval Techniques
Ponco Birowo (Indonesia)
1315 - 1445

Concurrent Session 16
Accreditation in Assisted Reproductive Techniques:
Ensuring Excellence in IVF Clinics & Embryology Practice
Chairs:Meeting Room 4

Tiencheng Arthur Chang (Taiwan)
Romerico Torres (Philippines)

Introduction to Accreditation in ART: Why It Matters
Adrianne Pope (Australia)
Standards and Best Practices for IVF Clinic Accreditation
Masahide Shiotani (Japan)
Certification of Clinicians & Embryologists: Elevating Professional Excellence
Haroon Latif Khan (Pakistan)1315 - 1445

Concurrent Session 17
Improving Access - Low-Cost Development and Strategies
Chairs:Meeting Room 5

Nusrat Mahmud (Bangladesh)
Ho Manh Tuong (Vietnam)

Infertile Patient’s Health Seeking Behaviour and Availability of IVF Services
Huang Zhongwei (Singapore)
Cost Effectiveness Analysis of Affordable IVF: A Current Evidence
Rudie Frederick Mendiola (Philippines)
Time to Pregnancy and Perinatal Outcome in Affordable IVF
Budi Wiweko (Indonesia)

Free Communication 161315 - 1445

- Regenerative Medicine and Stem Cells- Uterine Disorders and Endometriosis- Gynaecology and Surgery
Chairs:Meeting Room 6

Sunita Tandulwadkar (India)
Chung-Hsien Sun (Taiwan)

NEW INSIGHTS ABOUT RISK FACTORS OF CESAREAN SCAR PREGNANCY: CONSIDERING THE
INFLUENCE OF PRIOR CESAREAN SECTION AND PERINATAL COMPLICATIONS
Chao Wang (China)
LAPAROSCOPIC OOPHOROCYSTECTOMY FOR OVARIAN TERATOMA IN A PATIENT WITH
ANTI-NMDA RECEPTOR ENCEPHALITIS
Hannah Faye Magdoboy-Derla (Philippines)
DDX4-POSITIVE OOGONIAL STEM CELLS IN PREMATURE OVARIAN INSUFFICIENCY RATMODELS TREATED WITH PLATELET RICH PLASMA: GENE EXPRESSION AND
IMMUNOHISTOCHEMISTRY EVALUATION
Roza Silvia (Indonesia)
PREGNANCY OUTCOMES OF MINIMAL STIMULATION IN VITRO FERTILIZATION IN PATIENTSWITH PELVIC ENDOMETRIOSIS
Fides Marie Francisco (Philippines)
EFFECTS OF GNRH AGONIST PLUS LETROZOLE PRETREATMENT ON FROZEN EMBRYO
TRANSFER OUTCOMES IN PATIENTS WITH ADENOMYOSIS
Xinna Chen (China)
THE EFFICACY, SAFETY, AND TOLERABILITY OF DOPAMINE AGONISTS FOR WOMEN WITHENDOMETRIOSIS-ASSOCIATED INFERTILITY: A SYSTEMATIC REVIEW
Leonila Estole-Casanova (Philippines)

51

Main Congress | Saturday, 25 May 2024
1315 - 1445

Free Communication 17
Preimplantation Screening and Diagnosis
Chairs:Meeting Room 7

Kyong Wook Yi (Korea)
Rohina Gul (Pakistan)

NONINVASIVE PGT: EXPERIENCES FROM 6 YEARS OF CLINICAL STUDIES AND APPLICATIONS
Sijia Lu (China)
EFFECT OF BMI ON EMBRYO PLOIDY AND CLINICAL OUTCOMES IN WOMEN UNDERGOING
PGT-A: A SECONDARY ANALYSIS OF A MULTI-CENTER RANDOMIZED CONTROLLED TRAIL
Jie Li (China)
PREIMPLANTATION GENETIC TESTING MAY SERVE AS A MODEL TO STUDY THE EFFECT OF
ADVANCED MATERNAL AGE ON ENDOMETRIAL RECEPTIVITY AND THE CONSEQUENTIAL
PREGNANCY OUTCOMES
Xiyao Liu (China)
CLINICAL OUTCOMES OF PATIENTS WHO UNDERWENT THE TRANSFER OF MOSAIC EMBRYO
Trung Nguyen Thanh (Vietnam)
EVALUATION OF MOSAIC EMBRYO TRANSFER OUTCOMES: A RETROSPECTIVE COHORT STUDYThi Hai Hoang (Vietnam)
ADVANCED PGT-M STRATEGIES FOR DE NOVO MUTATIONS: OVERCOMING CHALLENGES IN
THE ABSENCE OF A PROBANDMin Xiao (China)
INCREASING THE PGT-A SUCCESS RATE BY DETERMINING THE MITOCHONDRIAL SCORE IN A
SINGLE TROPHECTODERM BIOPSY
Pritta Ameilia Iffanolida (Indonesia)
1315 - 1445

Free Communication 18
ART, Clinical
Chairs:Meeting Room 8

Keiji Kuroda (Japan)
Mariam Faruqui (Bangladesh)

LIVE BIRTH AFTER PERSONALIZED EMBRYO TRANSFER IN A CASE OFEMBRYO-ENDOMETRIAL DYSSYNCHRONY DIAGNOSED BY ENDOMETRIO
Jorge Norberto Miguel Romualdez-Tan (Philippines)
PREGNANCY OUTCOME OF UNEXPLAINED RECURRENT IMPLANTATION FAILURE WOMEN WITH
ELEVATED PERIPHERAL NATURAL KILLER CELLS: DOES TREATMENT WITHPREDNISONE MATTER?
Zhonghong Zeng (China)
PREGNANCY, MATERNAL AND NEONATAL OUTCOMES OF TWIN PREGNANCY COMPARED WITHSINGLETON PREGNANCY AFTER IN-VITRO FERTILIZATION
Krista Marie Pacifico (Philippines)
PREGNANCY OUTCOMES OF PRE-IMPLANTATION GENETIC TESTING FOR ANEUPLOIDY AMONGWOMEN OF ADVANCED MATERNAL AGE AT CARMI: A RETROSPECTIVE COHORT STUDYMargaret Joyce Cristi-limson (Philippines)
DISPLACEMENT OF IMPLANTATION WINDOW AND ENDOMETRIAL RECEPTIVITY IN RECURRENTIMPLANTATION FAILURE PATIENTS WITH IMMUNOLOGIC DISTURBANCES
Xinna Chen (China)
LOCAL DATA ON THE IMPACT OF ENDOMETRIOSIS ON PREGNANCY OUTCOMES OFIVF PATIENTSGia Pastorfide (Philippines)

52

Main Congress | Saturday, 25 May 2024
1530 - 1700

1530 - 1700

Controversy Session

Plenary Hall

Controversies Session 2024
Chair:

Clare Boothroyd (Australia)

Panelists:

Louise Hull (Australia)
JunHao Yan (China)
Ivan Sini (Indonesia)
Neil Johnson (New Zealand)
Virgilio Novero (Philippines)
Richard Paulson (USA)Lan N Vuong (Vietnam)
Jaideep Malhotra (India)

Concurrent Session 18
Endometriosis
Chairs:Meeting Room 2-3

Yutaka Osuga (Japan)
SiHyun Cho (Korea)

Fertility Preservation in Endometriosis – When and How?
Dominique De Ziegler (France)
Ovarian Stimulation in Endometriosis – PPOS or GnRHa?
Angela Aguilar (Philippines)
Is Surgery Beneficial for Treating Deep Endometriosis associated with Infertility?
Chih-Feng Yen (Taiwan)
1530 - 1700

Concurrent Session 19
Artificial Intelligence (AI)
Chairs:Meeting Room 4

Nandita Palshetkar (India)
Mi-Kyung Chung (Korea)( CLINICAL )Will Artificial Intelligence Assist the Clinician in the Future?
Duru Shah (India)( EMBRYOLOGY )Application of AI and the Big DataAn Analytics in Clinical IVF in Non-invasive Way to Predict Aneuploidy
Lee Chun-I (Taiwan)( SPERM )New Emerging Methods for Sperm Selection in ARTs
David Chan (Hong Kong)
1530 - 1700

Concurrent Session 20
Fertility Nurse - Beyond the Clinic
Chairs:Meeting Room 5

Crystal Hui (Hong Kong)
Rebecca Moore (Australia)

Presentation Skills - Tips and Techniques
Carmel Carrigan (Australia)
Setting up of a National Association for Reproductive Nurses and the Importance ofa Professional Body
Astor Tse (Hong Kong)
Reading, Understanding and Leading Nursing Research for Nurses
Maria Cecilia E Punzalan (Philippines)

53

Main Congress | Saturday, 25 May 2024
1530 - 1700

Free Communication 19
ART, Clinical
Chairs:Meeting Room 6

Rashida Begum (Bangladesh)
Ming-Jer Chen (Taiwan)

SIGNIFICANCE OF SERUM DAY-3 PROGESTERONE LEVEL AFTER VAGINAL ADMINISTRATION OF
DIFFERRENT PROGESTERONE REGIMENS IN HORMONE REPLACEMENT CYCLES FOR FROZENEMBRYO TRANSFER
Fu-Tsai Kung (Taiwan)
LEVERAGING MACHINE LEARNING FOR PREDICTIVE ANALYSIS OFPREGNANCY OUTCOMES IN CLINICAL DATA
Hyejun Lee (Korea)
IMPACT OF DIFFERENT ENDOMETRIAL PREPARATION PROTOCOLS ON PREGNANCYOUTCOMES IN UNEXPLAINED RECURRENT IMPLANTATION FAILURE PATIENTS UNDERGOINGFROZEN EMBRYO TRANSFER: A RETROSPECTIVE COHORT STUDYDan Mo (China)
COMPARING DYDROGESTERONE VERSUS MEDROXYPROGESTERONE IN PROGESTIN-PRIMEDOVARIAN STIMULATION (PPOS) IN IVF/ICSI PATIENTS : A SYSTEMATIC REVIEW
Alisha Nurdya Irzanti (Indonesia)
FOLLITROPIN DELTA VERSUS CONVENTIONAL STIMULATION IN
POOR OVARIAN RESERVE PATIENTS: A RETROSPECTIVE ANALYSIS
Phan Ngọc Quý (Vietnam)
EFFECTS OF INTRAUTERINE PERFUSION OF AUTOLOGOUS PLATELET-RICH PLASMA ON
CLINICAL OUTCOMES IN RECURRENT IMPLANTATION FAILURE PATIENTS WITH NON-THIN
ENDOMETRIUM UNDERGOING FROZEN-THAWED EMBRYO TRANSFER
Xiaohui Liu (China)
PREGNANCY OUTCOMES BETWEEN FROZEN SINGLE ELECTIVE BLASTOCYST TRANSFER AND
FROZEN DOUBLE BLASTOCYST TRANSFER IN WOMEN UNDER 35 YEARS OLD
Hoang Van Ai (Vietnam)
1530 - 1700

Free Communication 20- PCOS- Ovary and Ovarian Biology
Chairs:Meeting Room 7

Romerico Torres (Philippines)
Enrico Gil Oblepias (Philippines)

BODY MASS INDEX, LH:FSH RATIO, AND SERUM ANDROGENS LEVELS IN LEAN WOMEN WITH
POLYCYSTIC OVARIAN SYNDROME
Oki Riayati (Indonesia)
WAIST CIRCUMFERENCE COUPLED WITH INSULIN LEVEL FOR PREDICTING CARDIOVASCULARRISK IN WOMEN WITH PCOS
Amalia Shadrina (Indonesia)
DIAGNOSIS AND FOLLOW-UP OF ABNORMAL GLUCOSE METABOLISM WITH HEMOGLOBIN A1C
IN CHINESE WOMEN WITH POLYCYSTIC OVARY SYNDROME
Min Tan (China)
ASSOCIATION OF METABOLIC SYNDROME WITH TYG INDEX IN INFERTILE WOMEN WITH PCOS
Viet Nguyen Sa Le (Vietnam)
THE ASSOCIATION OF POLYCYSTIC OVARY SYNDROME WITH DEMOGRAPHIC
CHARACTERISTICS AND MATERNAL OUTCOMES IN FILIPINO PREGNANT WOMEN: A
RETROSPECTIVE CROSS-SECTIONAL STUDY IN A SINGLE TERTIARY HOSPITAL
Jamielou Dizon (Philippines)
IMPACT OF IRON OVERLOAD ON FOLLICULAR DEVELOPMENT IN PATIENTS WITH
OVARIAN ENDOMETRIOSIS
yaoqiu wu (China)
THE OVARY-RESIDENT NK CELLS MITIGATE OVARIAN AGINGXUE JIAO (China)

54

Main Congress | Saturday, 25 May 2024
Free Communication 21
1530 - 1700

- Endocrinology, Clinical- Endocrinology, Laboratory- Male Infertility
Chairs:Meeting Room 8

Ji-Hyang Kim (Korea)
Gwo-Jang Wu (Taiwan)

THE SCLERAL FEATURE IN INFERTILE WOMEN MAY BE RELATED TO OVARIAN RESPONSE IN
CONTROLLED OVARIAN STIMULATION
Ying Song (China)
RISK FACTORS OF RECURRENT IMPLANTATION FAILURE:
A CASE-CONTROL STUDY AFTER AGE MATCHING
Can Wang (China)
UNRAVELING THE INTERPLAY OF STRESS, BODY MASS INDEX, AND PHYSICAL ACTIVITY ON
FEMALE MEDICAL STUDENTS' MENSTRUAL CYCLES: A COMPARATIVE ANALYSIS DURING AND
AFTER THE PANDEMIC
Atika Mahira Yanfaunnas (Indonesia)
EVALUATION OF HABITUAL LIFESTYLE, SEMEN, AND REPRODUCTIVE HORMONE LEVELSAMONG MEN FROM AN ANDROLOGY CLINIC IN NORTH VIETNAM
Tuong Thi Van Thuy (Vietnam)
THE EFFECTS OF GLYCYRRHIZA GLABRA EXTRACT IN HIGH-FAT DIET-INDUCED OBESE MALE
MICE: A CONTROLLED EXPERIMENTAL STUDY
Tin Nguyen (Vietnam)
EFFECT OF PLATELET-RICH FIBRIN LYSATE ON THE IMPROVEMENT OF HUMAN SPERM
MOTILITY: A CASE SERIES
Thy-Phuong Nguyen (Vietnam)
COMPARATIVE PROTEOMIC ANALYSIS OF IMMOTILE SPERMATOZOA AND
ASTHENOZOOSPERMIC SEMEN SAMPLE: EXPLORING KEY BIOMARKER PROTEINSIMPLICATED TO SPERM MOTILITY
Nirlipta Swain (India)

55

Main Congress | Sunday, 26 May 2024
0730 – 0800

Young Investigator Awardee Presentations
Science Meets Practice: Using Real-World Evidence toOptimise ART Outcomes

Plenary Hall

Haroon Latif (Pakistan)
Maruf Siddiqui (Bangladesh)

Chairs:

PLATELET-RICH PLASMA (PRP) IMPROVES SPERM QUALITY IN SPERM PREPARATION AND AS A
CRYOPROTECTANT
Samuel Lionardi (Indonesia)
AN ANALYSIS OF TRUSTWORTHINESS OF RANDOMISED CLINICAL TRIALS ON GROWTHHORMONE IN POOR OVARIAN RESPONDERS.
Michael Le (Australia)
0730 – 0800

How-To Session 4
Chair:

Meeting Room 2-3

Chung-Hsien Sun (Taiwan)

Surgical Tutorial (Video session) - Useful Tips for Hysteroscopic Surgery (Other Than Myomectomy)
Xu Dabao (China)
0730 – 0800

How-To Session 5
Chair:

Meeting Room 4

Eileen Sy (Philippines)

How to Prepare for Critical or Near-Miss Event
Tuan Lam (Vietnam)
0730 – 0800

Fertility Counts
Chair:

Clare Boothroyd (Australia)

Panelists:

Neil Johnson (New Zealand)
Ho Manh Tuong (Vietnam)
Kamthorn Pruksananonda (Thailand)

Meeting Room 5

Individualization of Luteal Phase Support: Where Are We?
Dayong Lee (Korea)
Optimal Endometrial Preparation for Frozen Embryo Transfer
Lan N Vuong (Vietnam)
0800 – 0830

Keynote Lecture 6
Chairs:Jung-Ryeol Lee (Korea)
Nares Sukcharoen (Thailand)

0800 - 0830

Fertility Preservation for the Young and Old
Claus Yding Andersen (Denmark)0830 – 0900

Keynote Lecture 7
Chairs:Plenary Hall

Jung-Ryeol Lee (Korea)
Nares Sukcharoen (Thailand)Male Infertility: Past, Present, and Future
Rupin Shah (India)

56

Plenary Hall

Main Congress | Sunday, 26 May 2024
0910 - 1040

Philippine Session
ART in the Philippines
Chairs:Plenary Hall

Leonardo Almeda (Philippines)
Des Cabling (Philippines)

Surgical Sperm Retrieval in the Philippines - A 13-Year Review
Dennis Lusaya (Philippines)
Control Ovarian Stimulation in Filipinos - Past Practices, Current Trends and Future Directions
Virgilio Novero (Philippines)
Social Egg Freezing Among Filipino Women - Social and Cultural Aspects
Maria Jesusa Banal-Silao (Philippines)
0910 - 1040

Concurrent Session 21
ART - Managing the Difficult IVF Patient
Chairs:Meeting Room 2-3

Mukhri Hamdan (Malaysia)
Tanzeem Chowdhury (Bangladesh)

The Old IVF Patient: An Evidence-Based Approach
Jung Ryeol Lee (Korea)
The Obese IVF Patient
Duru Shah (India)
The Patient with Recurrent Implantation Failure Can We Currently Offer Interventions of Proven Value?
Lan N Vuong (Vietnam)
0910 - 1010

Debate 2
Chairs:Meeting Room 4

Maruf Siddiqui (Bangladesh)
Nares Sukcharoen (Thailand)

Surrogacy is a Better Option Than Uterine Transplant
For: Kamthorn Pruksananonda (Thailand)
Against: Rebecca Deans (Australia)
0910 - 1040

Concurrent Session 22
Editor’s Choice
Chairs:Gab Kovacs (Australia)
Budi Wiweko (Indonesia)

Artificial Intelligence and Its Role in ART - Laboratory Perspective
Haroon Latif (Pakistan)
New Technology in PGT Especially Using Non-invasive Methods
Chun-Kai Chen (Taiwan)
Testing and Treatment of Endometrial Receptivity
Gendie Lash (China)

57

Meeting Room 5

Main Congress | Sunday, 26 May 2024
0910 - 1040

ISAR Session
Improving Success Rates in Special Scenarios - An ISAR Session
Chairs:Meeting Room 6

Tin Chiu Li (Hong Kong)
Madhuri Patil (India)
Sujata Kar (India)

Unchain the Melody of Myomectomy
Sunita Tandulwadkar (India)
Fertility Preservation in Breast Cancer Patients
Nandita Palshetkar (India)
Tic Tok Y - Cracking the Code of Paternal Ageing
Ameet Patki (India)
Q&A and Concluding Remarks
0910 - 1040

Free Communication 22- Embryology- Preimplantation Screening and Diagnosis
Chairs:Meeting Room 7

Keshav Malhotra (India)
Sweelian Liow (Singapore)

CORRELATION BETWEEN AN AUTOMATIC CLASSIFICATION ALGORITHM APPLIED ON
CLEAVAGE STAGE EMBRYOS AND PREGNANCY OUTCOMES AFTER SINGLE VITRIFIED-WARMED
BLASTOCYST TRANSFER
Hop Vu Dinh (Vietnam)
CLINICAL SIGNIFICANCE OF PRONUCLEAR SIZE AND ORIGIN IN HUMAN ZYGOTES:A TIME-LAPSE OBSERVATIONAL STUDY
Tsubasa Takahashi (Japan)
ELEVATED CHROMOSOME INSTABILITY IS ASSOCIATED WITH DEFECTIVE TELOMERE REPAIR IN
AGED OOCYTESJunjiu Huang (China)
THE EFFECT OF GROWTH HORMONE ON THE EUPLOID RATE AND MORPHOKINETIC SIGNATURE
OF BLASTOCYSTS IN PATIENTS WITH ADVANCED MATERNAL AGE :A RANDOMIZED CONTROLLED TRIAL
Yilun Sui (China)
NON-INVASIVE METABOLIC IMAGING REVEALS INCREASED METABOLIC ACTIVITY IN
BLASTOCYSTS OF EQUIVALENT EMBRYO MORPHOLOGY DURING AGING.
Fabrizzio Horta (Australia)
COMPARISON OF ISOTHERMAL AND PCR-BASED WHOLE GENOME AMPLIFICATIONSTRATEGIES FOR COMBINED PREIMPLANTATION GENETIC TESTING OF MONOGENIC AND
CHROMOSOMAL DISORDERS
Samuel Chong (Singapore)
COMPARISON OF PGT-A RESULTS BASED ON PATIENT AGE AND BLASTOCYST GRADE
Yuya Makino (Japan)
1110 – 1140

Closing Lecture
Chairs:Virgilio Novero (Philippines)
Clare Boothroyd (Australia)

Advancements in Reproductive Medicine:
Did It Improve Outcome?
Anis Feki (Switzerland)

58

Plenary Hall

Instruction for Oral Presenters
Submission of Presentations Onsite

Oral presenters must upload their PowerPoint slide presentations at the Speakers Ready Room, situated in Banquet
Hall 1 on the 2nd floor of the Secretariat Building, at least 3 hours prior to their scheduled presentation.

Speaker Ready Room
Date

Opening Hours

Thursday, 23 May

07:00-17:00

Friday, 24 May

07:00-19:00

Saturday, 25 May

07:00-17:00

Sunday, 26 May

07:00-11:30

Location

Banquet Hall 1, Secretariat Building

Presentation Guidelines
Category

Presentation

Q&A

Total Presentation
Duration

Young Investigator Awardees

10 minutes

5 minutes

15 minutes

Shortlisted Top 10 Oral Presentations

10 minutes

5 minutes

15 minutes

Regular Oral Presentations

8 minutes

4 minutes

12 minutes•

For PowerPoint presentations (or any other PC-based application), please bring them on a USB Memory stickand upload them in the Speakers Ready Room, located in Banquet Hall 1 on the 2nd floor of the Secretariat
Building, at least 3 hours before your scheduled presentation.

•

Please ensure that when creating your PowerPoint slides, the font size is large enough to be visible from therear of the meeting rooms. Additionally, remember to format your PowerPoint slide presentation in Landscape
Format (Slide ratio: 16:9) and NOT Portrait.

•

The congress computer runs on the Windows system and is equipped with Microsoft Office 2013 (or later
versions).

•

If you are including video films or embedding animations (GIF) in your slides, please test them in the meetingroom where your lecture is scheduled during a coffee or lunch break before your session, at least 30 minutes
prior to the start of the session – even after checking in the Speakers’ Ready Room.

•If you have multimedia files "embedded" in your PowerPoint, make sure to save them on the same memorystorage device as your presentation. If the media file is not included with the PowerPoint presentation file, theequipment will not be able to play the media file.

59Mac users:
You may use your own Macintosh laptop with an advance notice to the ASPIRE Secretariat. If this is the case, you willneed to provide a VGA/HDMI adaptor on your own for external signal and advise the AV technician to run a test atleast 30 minutes prior to your session.
In order to use MAC presentations on a PC compatible computer please note that you will need to follow the
instructions below:
1. Use a common font, such as Arial, Times New Roman, Verdana etc. (special fonts might be changed to a default
font on a PowerPoint based PC).
2. Insert pictures as JPG files (and not TIF, PNG or PICT - these images will not be visible on a PowerPoint
based PC).
3. 3Use a common movie format, such as AVI, MPG and WMV. MOV files from QuickTime will not be visible on a
PowerPoint based PC.
4. Keynote files will be required to be played back with a Mac computer. If using Keynote, please inform theCongress Secretariat in the Speakers’ Ready Room well in advance of your talk.

Non-standard presentation formats:
For non-standard presentations means such as “Prezi” or web links, please present to the Speakers’ Preparation
Room well in advance of your talk.

Getting Ready for Your Presentation Onsite•

Please gather in your session room at least 10 minutes before the session starts.

•

Verify the date, time, room, and order of your presentation in the final program.

•

Sit near the front of the room for easy access to the stage.

•

Please keep your presentation to the time allocated to be fair to all speakers and to keep the programmerunning on time.

•

If any changes or corrections to your presentation details are needed, promptly inform the room manager
stationed in the session room.

60

Instruction for Poster Presenters

Poster Set-up and Presentation Schedule•

Posters will be displayed on the Mezzanine Level, Exhibition Hall (Reception Hall).

•Kindly ensure that you display your poster on the designated board corresponding to your assigned board
number.

•Presenters are REQUIRED to be positioned by their posters for discussion during the scheduled time in thefollowing table.

•

All posters will be evaluated by a judging panel nominated by ASPIRE. Shortlisted Posters will be advised on
Saturday, 25 May 2024.

•

Results of the Best 5 Poster Presentation Award will be announced at the Congress Closing and Award
Ceremony on Sunday, 26 May 2024.

Content

Date

Time

Poster Set-up

Friday, 24 May• 09:00 - 10:00

Poster Presentation
Day 1

Poster Presentation
Day 2
Poster Presentation
Day 3
Poster Dismantle*• 10:00 - 10:45
Friday, 24 May• 12:15 - 13:45• 16:45 - 17:30• 09:30 - 10:15

Saturday, 25 May• 11:45 - 13:15• 14:45 - 15:30

Sunday, 26 May• 10:40 - 11:10

Sunday, 26 May• 11:15 - 12:00* Congress Secretariat will remove and dispose all posters that were not removed after 12:00 on
Sunday, 26 May 2024.

61

Poster Preparation Technical Specifications•

Poster Board Size: 1 meter in width and 2 meters in height.

•

Your poster needs to be prepared in PORTRAIT orientation.

•

We recommend that your poster does not exceed 0.9 meters in width and 1.2 meters in height.

•

Posters is preferred to be prepared on a single sheet or alternatively on multiple smaller sheets.

•

Allocate the top of the poster for the Title and Authors as indicated on the submitted abstract.

•

Ensure that the font size, illustrations, etc., are sufficiently clear to be legible from a distance of two meters.

•

Double-sided tape will be provided in the poster area for affixing posters. The use of paste, glue, thumbtacks,
or staples is strictly prohibited. Staff members will also be available in the poster area to assist you in locating
your poster board. Authors are responsible for putting up their own posters.

62

63

ART, ClinicalP-1

NEW INSIGHT OF LIPIODOL FLUSH ON PREGNANCY OUTCOME IN WOMEN WITH RECURRENT IMPLANTATIONFAILURE UNDERGOING IVF/ICSI: A PROPENSITY SCORE-MATCHED STUDY
Author: Miss Zhonghong Zeng1,2, PhD. Dan Mo1,2, Ms. Yueqi Leng2, Ms. Yanmin Zhang2, Ms. Lansi Wei1, Ms. Yuxing Luo1,
Ms. Xin Liu1, PhD. Ping Zhou2, Mr. Xiaojun Yu2,3, Ms. Xin Sui2, Prof Rong Li2, Prof Wenhong Ma1,4,5, Prof Yihua Yang1

P-2

PREDICTION MODEL OF ECTOPIC PREGNANCY RISK AFTER IN VITRO FERTILIZATION/INTRACYTOPLASMIC
SPERM INJECTION
Author: Ms. Shilin Fang1, Dr. Tian Tian1, Ms. Xiaxuan Zhu1, Ms. Dina Jiesisibieke1, Ms. Nan Zhang1, Ms. Jinxi Ma1,
Ms. Shirong Xu1, Dr. Yuanyuan Wang1, Dr. Ping Liu1, Dr. Rong Li1, Dr. Jie Qiao1, Dr. Rui Yang1
Affiliation: 1Peking University Third Hospital, Beijing, China

P-3

IN THE FROZEN-THAWED BLASTOCYST TRANSFER CYCLE, COMPLETE REMOVAL OF THE ZONA PELLUCIDA
FROM THE BLASTOCYST BY ASSISTED HATCHING MAY IMPROVE THE IMPLANTATION RATE.

Author: 氏 Yutaro Kawaguchi1, Mrs. Akari Mukawa1, Mrs. Asami Mine1, Dr. Mayuko Kanatani1, Dr. Tetsuaki Kaku1,
Dr. Muneaki Kaku1, Dr. Toshihiro Fujiwara1, MsAiri Hamada2

P-4

OVARIAN STIMULATION WITH FOLLITROPIN DELTA FOR IVF IN PATIENT WITH POOR OVARIAN RESERVE
Author: Dr. ILHAE PARK1, Dr Hong-Gil Sun1, Dr Jae-Won Kim1, PhD Hee-Jun Chi1, M.J. Kim1, H.Y. Kim1, H. Hyun1,
S.Y. Park1

P-5

DOES THE NUMBER OF TOTAL BLASTOCYSTS CORRELATE WITH THE ANTI-MULLERIAN HORMONE (AMH) LEVEL?
Author: Dr. Mohamed Hatta Tarmizi1, Dr Yoke Ling Loh1, Dr Ana Vetriana A. Wahab1, Ms DK IntanNatasha Pg Bahar1,
Ms MuhaniMunee Peter1, Ms Michelle Jane Chin1, Ms Nur Asyiqin Yunos1, Ms Siau Yee Chin1, Ms MeeVoon Chiang1,
Dr Yee Tsing Cheong1

P-6

PREMATURE PROGESTERONE RISE IS ASSOCIATED WITH HIGHER CUMULATIVE LIVE BIRTH RATE WITH FREEZEALL STRATEGY
Author: Dr Yu Wang1, Dr. Ming-Jer Chen1, Dr. Yu-Chiao Yi1

P-7

MANAGEMENT AND PREGNANCY OUTCOME OF HETEROTOPIC INTERSTITIAL PREGNANCY AFTER IN VITROFERTILIZATION-EMBRYO TRANSFER: A RETROSPECTIVE CONSECUTIVE CASE SERIES STUDY
Author: Dr. Chao Wang1,2,3,4, Dr. Shuo Yang1,2,3,4, Prof. Caihong Ma1,2,3,4, Prof. Rong Li1,2,3,4, Prof. Ping Liu1,2,3,4, Prof. Jie Qiao1,2,3,4

64

P-8

ANOGENITAL DISTANCE CAN PREDICT OVARIAN RESPONSE IN CONTROLLED OVARIAN STIMULATION
Author: Dr. Ying Song1

P-9

DOES ARTIFICIAL OOCYTE ACTIVATION VIA CALCIUM IONOPHORE IMPROVE THE LIVE BIRTH RATE IN ICSIPATIENTS? A SYSTEMATIC REVIEW AND META-ANALYSIS ON EFFECTIVENESS AND SAFETY
Author: Ms. Jingqi Zhang1, Prof. Xiaoxi Sun1, Dr. Jing Fu1

P-10

PATIENTS’ SATISFACTION USING MONITORED SEDATION ANESTHESIA DURING OOCYTE PICK-UP: A SURVEY
DONE AT SABAHCARE FERTILITY CENTRE, KOTA KINABALU, SABAH.
Author: Dr. Mohamed Hatta Tarmizi1, Dr Rajesh Kumar MUNIANDY2, Mr Sikh Indra JEFFRY DIN3, Dr Yoke Ling LOH1,
Dr Ana Vetriana A WAHAB1, Dr Yee Tsing CHEONG1

P-11

DICHORIONIC DIAMNIOTIC TRIPLET PREGNANCY AFTER SINGLE BLASTOCYST TRANSFER - A CASE REPORT
Author: Dr Yee Tsing CHEONG1, Dr Yoke Ling LOH1, Dr Ana Vetriana A. WAHAB1, Dr Mohamed Hatta TARMIZI1,Miss MeeVoon CHIANG1, Miss Michelle Jane CHIN1, Miss Marcella MELTO POLO1, Miss Dk IntanSyafiqa Natasha PG BAHAR1,
Miss Nur Asyiqin YUNOS1

P-12

THE LANDSCAPE OF INFERTILITY TRIALS IN THE LAST DECADE
Author: Ms. Qian Feng1, Dr Wentao Li1, MsWanlin Li1, Mr. Salvatore Longobardi2, Prof. Thomas D’Hooghe 2,3,4,Prof. Ben Mol1,5

P-13

BLASTOCYST ANEUPLOIDY AND MOSAICISM RATES OF PROGESTIN-PRIMED OVARIAN STIMULATION (PPOS)COMPARED TO GnRH-ANTAGONIST PROTOCOL
Author: Ms. Truong Thanh Ngoc 1,3, Ms. Nguyen Thi Phuong Dung 1,3, Mr. Nguyen Le Duy3, Dr. Le Khac Tien 1,3,
Ms. Le Hoang Anh1,3, Dr. Huynh Gia Bao2,3, Associate Professor VuongThi Ngoc Lan3,4, Dr. Ho Manh Tuong2,3

P-14

INFLUENCE OF ENDOMETRIAL THICKNESS ON PREGNANCY OUTCOMES IN FROZEN-THAWED EMBRYO
TRANSFER USING THE PROGESTERONE-PRIMED OVARIAN STIMULATION PROTOCOL
Author: Ms. Yutong Wang1, Yajie Chang1, Xiaoyan Liang1

P-15

FACTORS AFFECTING CUMULATIVE LIVE BIRTH RATE AFTER IN VITRO MATURATION WITH PRE-MATURATIONSTEP (CAPA-IVM) IN PCOS PATIENTS
Author: Ms. Tran ThiHuyen Trang 1,2 , Mrs Le Hoang Anh 1,2 , Dr Ho Ngoc Anh Vu 2,3 , Mr Pham Duong Toan2,
Dr Ho Manh Tuong2,3, Assoc Prof VuongThi Ngoc Lan2,4

65

P-16

CHOOSING OPTIMAL REGIMEN OF FROZEN EMBRYO TRANSFER FOR LOW-QUALITY EMBRYOS
Author: Dr. Tsun Wen Hsiao1

P-17

OVARIAN STIMULATION IN IVF PATIENTS WITH POOR RESPONSE: THE IMPACT OF LETROZOLE ADJUNCTIVE
THERAPY WITH GONADOTROPINS
Author: Dr. Yiting Chen1, Professor Yung-Chieh Tsai1, Dr. Jen-Yu Wen1, Dr. Yi-Lun Lin1, Dr. Tsun-Wen Hsiao1

P-18

SWIM-UP VERSUS GRADIENT DENSITY IN SPERM PREPARATION FOR INTRAUTERINE INSEMINATION: A META-ANALYSIS
Author: Mr. Duy Nguyen1, Dr. Vinh Dang2, Ms. Tuyen Duong3, Dr. Tien Le4, Mr. Toan Pham1, Ms. Anh Vu1, Dr. Tuong Ho5,
Prof. Ben Mol2, Prof. Lan Vuong6

P-19

STIMULATION DURATION AND BLASTOCYST MORPHOLOGY IN ICSI CYCLE
Author: Dr. Liva Wijaya1, drAyang Halim1, Prof Budi Wiweko1,2, dr Boy Abidin1, dr Nadia Shafira1, drTribowo Hasmoro1,2,
MsOsmerita Sitohang1, drTheofilus Himawan1

P-20

COMPARING CLINICAL OUTCOMES BETWEEN FLEXIBLE AND FIXED PROGESTIN-PRIMED OVARIANSTIMULATION: A SYSTEMATIC REVIEW
Author: Prof. Raden Muharam1,2,3, Dr. Edward Christopher Yo1, Dr. Alisha Nurdya Irzanti1, Dr. Achmad Kemal Harzif1,2,3,
Dr. Mila Maidarti1,2,3, Dr. Gita Pratama1,2,3, Dr. Kanadi Sumapraja1,2,3, Prof. Andon Hestiantoro1,2,3, Prof. Budi Wiweko1,2,3

P-21

TO INVESTIGATE THE EFFECT OF ENDOMETRIOSIS ON ICSI OUTCOME AMONG INFERTILE WOMEN WITHOUTPREVIOUS HISTORY OF OVARIAN SURGERY
Author: Dr. Rohina Gul1

P-22

IN VITRO FERTILIZATION AND INTRACYTOPLASMIC SPERM INJECTION IN A HUMAN IMMUNODEFICIENCY VIRUS
SERODISCORDANT COUPLE PRESENTING WITH COMBINED MALE AND FEMALE INFERTILITY
Author: Dr. Julia Victoria Poblete1, Dr. Virgilio Joy Novero2

P-23

PPOS PROTOCOL: DECODING DYDROGESTERONE DOSE INFLUENCE
Author: Dr. Rahilah Ahmad Shukri1, Ms Nurul Izzah Ab Khalid, Dr MurizahMohd Zain

P-24

SUCCESSFUL DELIVERY FOLLOWING 11 YEARS OF HUMAN EMBRYO CRYOPRESERVATION IN PHILIPPINESETTING: A CASE REPORT
Author: Dr. Olive Joyce Alabado-Lindero1, Dr. Irene Yuchongtian-Sy2, Dr. Romerico Torres3, Dr. Michelle Enriquez-Gamboa4

66

P-25

INTRAUTERINE INFUSION OF AUTOLOGOUS PLATELET-RICH PLASMA (PRP) FOR THIN ENDOMETRIUM PRIOR TO
FROZEN EMBRYO TRANSFER (FET): A CASE SERIES
Author: Dr. Stephy Mae Villordon1,2, Dr. Maria Victoria Romualdez-Tan1,2, Dr. Asuncion Del Prado-Tremedal1

P-26

THE EFFECT OF DOUBLE STIMULATION PROTOCOL (DUOSTIM) IN POOR OVARIAN RESPONDERS: A SYSTEMATIC
REVIEW AND META-ANALYSIS
Author: Dr Diana Barretto1, Dr Mikaela Erlinda Bucu1, Dr Margaret Joyce Limson1

P-27

COMPARISON OF THE OUTCOMES OF DIRECT ASPIRATION AND FOLLICULAR FLUSHING DURING OOCYTERETRIEVAL IN PATIENTS UNDERGOING IN VITRO FERTILIZATION: A PROSPECTIVE COHORT STUDY
Author: Dr. Maria Reichenber Arcilla1, Dr. Virgilio, Jr. Novero1, Mr. Arnel D. Gamilde1, Ms. Rowena B. Beramende1,
Mr. Carl Alenn B. Parras1

P-28

THE CORRELATION BETWEEN ANTRAL FOLLICLE COUNT AND ANTI-MULLERIAN HORMONE WITH FOLLICLEOUTPUT RATE AND FOLLICLE-TO-OOCYTE INDEX ON COH IVF PROGRAM AT MORULA IVF CLINIC PONTIANAK-2023
Author: Mrs. Rina Nulianti1, Mr. Syahnural Lubis2

P-29

THE CORRELATION BETWEEN ANTRAL FOLLICLE COUNT AND ANTI-MULLERIAN HORMONE WITH FOLLICLEOUTPUT RATE AND FOLLICLE-TO-OOCYTE INDEX ON POR PATIENT IVF AT MORULA IVF CLINIC PONTIANAK-2023
Author: Mrs. Rina Nulianti1, Mr. Eddy Sutrisno2, Mr. Syahnural Lubis3

P-30

COMPARISON ON THE EFFECTS OF GNRH AGONIST AND HCG AS AN OVULATION TRIGGER ON PREGNANCYOUTCOME OF PATIENTS UNDERGOING IN VITRO FERTILIZATION
Author: Dr. Rudie Frederick Mendiola1, Dr. Ednalyn Ong-Jao2, Dr. Fides Francisco1, Anna Topacio1, John Del Rosario1,
Jane-Karla Torres1

P-31

ASSOCIATION OF MATERNAL AGE, INDICATIONS FOR TESTING AND BLASTOCYST MORPHOLOGY IN THE
OCCURRENCE OF ANEUPLOIDY IN PRE-IMPLANTATION GENETIC TESTING
Author: Dr. Lana Corinne Carpio1, Dr. Virgilio Novero Jr, Dr. Maria ReichenberArcilla

P-32

CASE REPORT: AN OUTCOME AFTER TRANSFER OF A MOSAIC EMBRYO
Author: Dr. Aida Riyanti1, DR. drhRini Widyastuti1, SSi, MbiomedPrittaAmeilia Iffanolida2, SSi Gita Salmah Nurasiah1

67

ART, Basic Research
P-33

INCIDENCE OF EMPTY ZONA PELLUCIDA: A TROUBLESHOOTING STRATEGY
Author: Ms. Mee Voon CHIANG1, Datuk Dr Mohamed Hatta TARMIZI1, Dr Yee Tsing CHEONG1, Dr Yoke Ling LOH1,
Dr Ana Vetriana A. WAHAB1, Ms Michelle Jane CHIN1, Ms Marcella MELTO POLO1, Ms Nur Asyiqin YUNOS1,
Ms DK Intan Natasha PG BAHAR1, Ms Muhani Munee PETER1, Ms Siau Yee CHIN1

P-34

UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMES INHIBITS FIBROSIS IN HUMANENDOMETRIAL STROMAL CELLS VIA MIR-140-3P/FOXP1/SMAD AXIS
Author: Prof. Mengling Song1

P-35

THE DECREASE OF REC8 AND STAG3 EXPRESSION AND ABNORMAL GEOMETRY OF SISTER KINETOCHORE IN
HUMAN OOCYTES WITH ADVANCED MATERNAL AGE
Author: Dr. Jifan Tan1, Professor Qiong Wang1

P-36

ENHANCEMENT OF MITOCHONDRIAL FUNCTION AND METABOLISM IN AGING FEMALE GERM CELLS BY
RECOMBINANT FOLLICLE-STIMULATING HORMONE AND RECOMBINANT LUTEINIZING HORMONE
Author: Dr. Li-Te Lin1, Dr. Chia-Jung Li1, Dr. Kuan-Hao Tsui1

P-37

FUNCTIONAL COMPETENCE OF HUMAN SPERMATOZOA CRYOPRESERVED WITH CRYOPROTECTANT-FREE
VITRIFICATION MEDIUM
Author: Prof. Guruprasad Kalthur1, Ms Shobitha Padmar1, Mrs Shreya Agrawal1, Prof Satish Adiga1

P-38

ELUCIDATING THE CRYOSUSCEPTIBILITY OF OOCYTES AND EMBRYOS DERIVED FROM MICE WITH DIETINDUCED OBESITY
Author: Dr. Sandhya Kumari M V1, Ms. VanishreeVasave Madhvacharya1, Dr. Satish Kumar Adiga2, Dr. Guruprasad Kalthur1

ART, Laboratory
P-39

EFFECT OF CYTOPLASM ABNORMALITY AND OOCYTE MATURATION RATE ON HUMAN IN VITRO FERTILIZATION
Author: Ms. Yeonju Lee1, Mr. Jaewon Cho1, Mrs. Jihye Jang1, Mrs. Soojeong Jeon1, Mrs. Sanghee Lee1, Mrs. Cheongmee Kim1,
Mrs. Eunhee Kang1

68

P-40

STUDY ON THE EFFECT OF ADDING SECRETOME ON SPERM QUALITY IMPROVEMENT BY SWIM-UP METHOD
Author: Ms. Laura Agnes Edessa Sibuea1, Mrs. Diana Novia1, Dr Binarwan Halim1

P-41

QUANTITATIVE CELL FREE DNA FROM SPENT CULTURE MEDIA AT 48 AND 54 HOURS AFTER CLEAVAGE STAGE OF EMBRYO
Author: Ms Pornsri Niransuk1

P-42

CASE REPORT: A SINGLE FROZEN DAY-5 COMPLEX MOSAIC BLASTOCYST TRANSFER LEADS TO SUCCESSFUL
CLINICAL PREGNANCY IN TESE COUPLE.
Author: Ms. Zhao Ying Lim1, Ms Mei Wei Lim1, Mr. Zhe Wei Yap1, Ms. Adelle Yun Xin Lim1, Dr. Wai Yew Leong1,
Dr. Colin Soon Soo Lee1, Dr. John Macpherson Keith1

P-43

CASE REPORT: SUCCESSFUL LIVE BIRTH AFTER A SINGLE FROZEN EMBRYO TRANSFER OF A DELAYED-DAY-5
LOW-RISK-MOSAIC BLASTOCYST.
Author: Ms. Zhao Ying Lim1, Ms. Mei Wei Lim1, Mr. Zhe Wei Yap1, Ms Adelle Yun Xin Lim1, Dr. Wai Yew Leong1,
Dr. Colin Soon Soo Lee1, Dr. John Macpherson Keith1

P-44

THE FORMATION OF THE OOCYTE SPINDLE IS ONE OF THE MOST IMPORTANT FACTOR IN DETERMINING THE
OPTIMAL TIMING FROM OOCYTE RETRIEVAL TO OOCYTE VITRIFICATION.

Author: 氏 Yutaro Kawaguchi1, Mrs. Asami Mine1, Dr. Mayuko Kanatani1, Dr. Tetsuaki Kaku1, Dr. Toshihiro Fujiwara1,
Dr. Muneaki Kaku1, MsAiri Hamada2

P-45

SPERM MORPHOLOGY AND BLASTOCYST RATE IN THE ICSI CYCLE
Author: Ms. Ayang Halim1, Ms. Liva Wijaya1, Prof. Budi Wiweko1,2, Mr. Boy Abidin1, Mr. Tri Bowo Hasmoro1, Mrs. Nadia Shafira1,
Ms. Osmerita Sitohang1, Mr. Theofilus Himawan1

P-46

IMPACT OF POST-WASH SPERM SURVIVAL ON ART OUTCOMES: A RETROSPECTIVE ANALYSIS
Author: Dr. Vasundara Jagannathan1

P-47

A STUDY ON EFFECTIVE VITRIFICATION TIME AND ASSISTED HATCHING IN IVF-ET PROGRAM
Author: Dr. Soomin Jung1, Dr Youjin Kim1, Prof. Youngbok Ko1, Dr. Sarah Jung1, Dr. Injung Son1

P-48

ZONA PELLUCIDA REMOVAL BY LASER RESULTED IN A SUCCESSFUL LIVE BIRTH: REPORT ON A CASE WITH
RECURRENT IMPLANTATION FAILURE DUE TO EMBRYONIC BACTERIA CONTAMINATION
Author: Others (Please specify in the next field) Son Truong Dang1, MSc. Huy Phuong Tran2, MSc. Anh Tuan Do1,
MSc. Phuong Thi Dao1, Dr. Thuan Duc Nguyen1, PhD. Xanh Thu Pham1

69

P-49

EMBRYO RESCUE: PRACTICAL CONSIDERATIONS AND IMPLEMENTATION IN A CLINICAL LABORATORY
Author: Mrs. Tania Tzelepis1, MsEve Glage1, Dr Kerri Johnson1, Dr Lynn Burmeister1

P-50

CAN PLOIDY STATUS OF BLASTOCYST BE IDENTIFIED BY KIDSCORE?
Author: MsKannappanPrithiSubatira, Ms SajakAzliana Abu Bakar, Ms Yee Siew Yin, Dr. KannappanPalaniappan

P-51

REVOLUTIONISING MALE INFERTILITY: UNVEILING THE IMPACT OF ARTIFICIAL OOCYTE ACTIVATION FOR
SEVERE SPERM DISORDERS AT HALIM FERTILITY CENTER
Author: Ms Carine Annabella Widjaja1, Dr Binarwan Halim1, Mrs Diana Novia1, Mrs Adelina Hutasuhut1, Dr Hilma Putri Lubis1

P-52

VERY SHORT EJACULATORY ABSTINENCE PERIODS INFLUENCE THE HIGH – QUALITY BLASTOCYSTDEVELOPMENT IN ICSI CYCLES: A PROSPECTIVE STUDY ON SIBLING BLASTOCYSTS
Author: Mrs Thu Hang Vu1, Mr. Long Do1, Mrs. Ngoc Tran1, Mrs. Quan Dang1, Mrs. Minh Vu1, Miss Hang Nguyen1

Counselling, Ethics and Psychosocial
P-53

DECISION-MAKING PATTERNS IN WOMEN DEALING WITH UNSUCCESSFUL IVF CYCLE: A QUALITATIVE STUDY
Author: Dr. Dan-Yuan Guo1, Professor Celia Hoi Yan Chan1

P-54

NAVIGATING THE COMPLEXITIES OF PARTIAL ANDROGEN INSENSITIVITY SYNDROME: A CASE STUDY ON
GENDER IDENTITY, FERTILITY CONCERNS, AND TREATMENT CHALLENGES
Author: Dr. Jessica Antoinette UERA1, Dr. Anna Belen Ignacio-Alensuela, Dr. ZedrixGallito

P-55

FERTILTY EDUCATION IN INDONESIA: WHERE ARE WE NOW?
Author: Dr. Berli Kusuma1, Dr. dr. Achmad Kemal Harzif1

70

Embryology
P-56

THE EFFECTS OF ARTIFICIAL SHRINKAGE BEFORE VITRIFICATION ON HUMAN BLASTOCYSTS
Author: Mr. Kazuki Ohata1, Mr. Tetsuya Miki1, Mr. Kenji Ezoe1, Dr. Keiichi Kato1

P-57

ASSOCIATION BETWEEN COVID-19 INFECTION AND PREGNANCY OUTCOMES IN FROZEN EMBRYO TRANSFERCYCLES
Author: Ms. Ji Gin Ku1, Ms Chee San Heong

P-58

A COMPARISON OF EMBRYO DEVELOPMENT, PLOIDY STATUS AND CLINICAL OUTCOMES BETWEEN FRESH AND
VITRIFIED OOCYTE
Author: Ms. Phuong Dao1

P-59

THE EFFECT OF HUMAN SERUM ALBUMIN CONCENTRATION IN BIPHASIC IN-VITRO MATURATION (CAPA-IVM)
Author: Ms. Ho Thi My Trang1,3, Ms. Le Hoang Anh1,3, Mr. Pham Duong Toan3, Mr. Pham Hoang Huy1,3, Dr. Le Long Ho1,3,
Dr. Le Khac Tien1,3, Dr. Ho Manh Tuong2,3, Assoc. Prof. Vuong Ngoc Lan3,4

P-60

ICSI AND CONVENTIONAL IVF, WHICH ONE SHOULD BE PREFERED FOR CASES OF PRE-IMPLANTATION GENETICTESTING?
Author: Mrs. Van Nguyen1

P-61

SLOW DEVELOPMENT, DIRECT CLEAVAGE OR REVERSE CLEAVAGE: DO THEY IMPACT ON BLASTOCYSTFORMATION?
Author: Mrs. Van Nguyen1

P-62

COMPLETELY HATCHED BLASTOCYSTS HAVE NO NEGATIVE EFFECT ON PREGNANCY OUTCOMES: A
RETROSPECTIVE COHORT STUDY OF SINGLE VITRIFIED-WARMED BLASTOCYST TRANSFER
Author: Ms. Trang Nguyen Thi Nhu1, Dr Lan Le Thi Phuong1, Dr Van Nguyen Thi Cam1, M.Sc Tran Tran Hue1,
Mr Hanh Truong Van1, Mr Quan Khuat Huu1

P-63

CASE REPORT: FIRST CLINICAL PREGNANCY IN MALAYSIA DERIVED FROM AN ULTRA-RAPID, SINGLE-STEPWARMING PROTOCOL
Author: Ms. Zhi Xuan Teng1

71

P-64

COMPARISON OF MORPHOKINETIC ALGORITHMS IN eSETS
Author: Ms. Yi Wei Cheng1, Ms. Michelle Sheng Rong Lim1, Dr Jang Jih Chen1

P-65

EMBRYO DEVELOPMENT THROUGH DELAYED INTRACYTOPLASMIC SPERM INJECTION (ICSI) ON LATE MATUREDOOCYTES
Author: Mr. Andre Andre1, Mr. Arief Boediono2, Mrs. Pitra Rahmawati1

P-66

CENTRIFUGATION-FREE SPERM SEPARATION DEVICE SURPASSES CONVENTIONAL DENSITY-GRADIENTCENTRIFUGATION IN ICSI CYCLES: HIGHER BLASTULATION, EUPLOIDY, AND LOWER MOSAIC RATESAuthor: Ms. SiowShein Chok1, Ms. Adelle Yun Xin Lim2, Dr Colin Soon Soo Lee3

P-67

SUPPLEMENTATION OF SECRETOME DERIVED FROM THE HUMAN UMBILICAL CORD MESENCHYMAL STEMCELLS (UC-MSCS) PROMOTES EMBRYO DEVELOPMENT AND IMPLANTATION
Author: Mr. Teerapong Prompunya1, Dr. Shu-Huei Kao1, Yuan-Ting Yang2

P-68

THE DETRIMENTAL IMPACT OF DNA FRAGMENTATION IMPACT ON EMBRYO DEVELOPMENT FOLLOWING THE
INTRA CYTOPLASMIC SPERM INJECTION
Author: Mr. Yassir Dzulfiqor1, Mrs. Gita S Nuraisah1, Ms. Diar T Dinanty1, Ms. Syifa G Rizki1, Mrs. Rini Widyastuti1,2,
Mr. Fachri A Prodjokusumo3, Mrs. Aida Riyanti1, Prof Budi Wiweko1,4

P-69

BROMODOMAIN EXTRA TERMINAL PROTEIN (BET) INHIBITOR JQ1 INTERFERES WITH SPERM OOCYTEINTERACTION AND REDUCED THE DEVELOPMENT POTENTIAL OF EARLY EMBRYOS
Author: Mrs. Keerthana Sandesh Suvarna1, Ms. JyolsnaPonnaratta Kunhiraman2, Ms. VanishreeVasave Madhvacharya2,
Prof Dr. Satish Kumar Adiga1, Prof Dr. Guruprasad Kalthur2

Endocrinology, Clinical
P-70

ONGOING PREGNANCY RATE WITH INTERVENTION AND EXPECTANT THERAPY IN PATIENTS WITH UNEXPLAINEDRECURRENT MISCARRIAGE: A PROSPECTIVE MULTICENTER COHORT STUDY
Author: Miss Ka Hing Kong1, Dr. Yingying Zhang1, Prof. Qiong Wang1, Prof. Peiyu Liu2, Prof. Yang Liao3, Prof. Xingming Zhong4,
Prof. Shushu Fan5, Prof. Lanqing Feng6, Prof. Yuxia Wang7

72

P-71

PSYCHOLOGICAL IMPACT ON EARLY ONSET OF LH SURGE IN WOMEN WITH RECURRENT PREGNANCY LOSS:PROSPECTIVE COHORT AND NESTED CASE-CONTROL STUDY
Author: Dr. Yingying Zhang1, Dr. Shuchen Long, Prof. Qiong Wang

P-72

DELAYED DIAGNOSIS OF KALLMANN SYNDROME: A CASE REPORT
Author: Dr. Cecilia Cabanag, Dr. Madonna Victoria Domingo1

P-73“WHEN TWO BECOME ONE: A DIAGNOSTIC DILEMMA” A RARE CONGENITAL MULLERIAN DUCT ANOMALYCAUSING HEMATOMETRA: ROBERT’S UTERUS
Author: Dr. Alyssa Marie Clemente1, Dr. Diana Rose Amodia1

P-74

PELVIC CONGESTION SYNDROME: A FORGOTTEN CAUSE OF CHRONIC PELVIC PAIN
Author: Dr. Yosep Sutandar1, Dr. Adi Sukrisno1, Dr. Fachri Razi1

Female Infertility
P-75

UTERINE TISSUE SUCTION TUBE: A NOVEL TREATMENT TOOL FOR MULTIPLE ENDOMETRIAL POLYPS IN IVF/ICSICYCLES
Author: Prof. Mengling Song1

P-76

CHARACTERISTICS OF ENDOMETRIAL STEM CELLS ACCORDING TO FERTILITY : EXPLORING THE DYNAMIC
INTERPLAY FOR OPTIONAL EMBRYO RECEPTIVITY
Author: Dr Youjin Kim1, Prof. Youngbok Ko1, Dr. Sarah Jung1, Dr. Injung Son1, Dr. Soomin Jung1

P-77

PREGNANCY OUTCOMES OF IN-VITRO FERTILIZATION ON INFERTILE WOMEN WITH HYDROSALPINX:RETROSPECTIVE COHORT STUDY
Author: Dr. Raymond Malvin Winata1, Dr. Louis Regan1, Dr. Jason Tungadi1, Dr. Farah Alvi Ramadhani1, Dr. Sarah Susanto1,
Dr. Tiara Berliana Azzahra1, Madam Pritta Amelia Iffanolida1, Madam Oki Riayati1, Mrs. Kresna Mutia1,
Madam Naylah Muna1, Dr. Dafi Yulinda1, Dr. Vita Silvana 1,2,3, Dr. Mila Maidarti 1,2,3, Dr. Achmad Kemal Harzif 1,2,3,
Dr. Gita Pratama1,2,3, Dr. Kanadi Sumapraja1,2,3, Prof. Raden Muharam1,2,3, Prof. Andon Hestiantoro1,2,3, Prof. Budi Wiweko1,2,3

73

P-79

THE EFFICACY OF OXYTOCIN ANTAGONISTS FOR REPEATED EMBRYO IMPLANTATION FAILURE: A CASE REPORT
Author: Dr. Meliana Jayasaputra1, Dr Amang Surya Priyanto1, Dr Ali Mahmud1

P-80

CLINICAL EFFICACY OF AUTOLOGOUS STEM CELL THERAPY IN ASHERMAN’S SYNDROME
Author: Prof. Jesmine Banu1

P-81"THE EFFECTIVENESS OF DHEA IN ENHANCING FERTILITY IN WOMEN WITH DIMINISHED OVARIAN RESERVE: A
PROSPECTIVE ANALYSIS"
Author: Dr. MosammatShahina Begum1, Dr. Mohammad Shaiful Islam2, Dr. Nahida Islam1, Dr. Tasnin Tazally1

Fertility Preservation
P-82

SEMINAL PLASMA MAINTAIN SPERM RECOVERY RATE AND INHIBIT INTRACELLULAR CALCIUM ION RAISINGDURING VITRIFICATION PROCEDURE
Author: Dr. Rini Widyastuti1,5, PhD Rangga Setiawan1, PhD Sigit Prastowo2, ProfesorArief Boediono3, Dr Aida Riyanti5,
Professor Budi Wiweko4,5

P-83

ANALYZING THE RATES OF SUCCESS AND UTILIZATION OF THREE CRYOPRESERVATION APPROACHES IN BREASTCANCER PATIENTS UNDERGOING FERTILITY PRESERVATION AND ITS IMPACT ON REPRODUCTIVE OUTCOMES
Author: Dr. Chao-ying Chen1, Dr. Ming-Jer Chen1, Dr. Yu-Chiao Yi1, MSc Hwa-Fen Guu1, MSc Yafang Chen1,
BS Li-Yu Chen1, Dr Jui-Chun Chang1

P-84

CHARACTERISTICS OF SOCIAL OOCYTE FREEZERS IN AUSTRALIA
Author: Dr. Sylvia Ross1, Associate Professor Alex Polyakov1,2, Dr Genia Rozen1,2, Franca Agresta2

P-85

ASSESSMENT OF FERTILITY PRESERVATION SERVICES AT THE INCEPTION OF THE VICTORIAN STATE-WIDE
PUBLIC FERTILITY SERVICE
Author: Dr. Michelle Emerson, Dr Sylvia Ross

74

P-86

ADVANCING ONCOFERTILITY: LESSONS LEARNT THAT SHAPE CLINICAL PRACTICE
Author: Ms Julia Spiteri1, Dr Neill Kiely1,2, Dr Tessa Morgan1,2, Dr Kaushalya Arulpragasam1,2, MsTejnei Vaishnav1,
Professor William Ledger1,2

P-87

SOCIAL OOCYTE FREEZING: KNOWLEDGE, ATTITUDES AND PERCEPTIONS OF FILIPINO FEMALE MEDICALSTUDENTS
Author: Dr. Charmaine Castro1, Dr. Gia Pastorfide2

P-88

GNRH AGONISTS IN THE PREVENTION OF PREMATURE OVARIAN FAILURE IN WOMEN OF REPRODUCTIVE AGE
WITH SLE ON CYCLPHOSPHAMIDE TREATMENT: EVIDENCE-BASED CASE REPORT
Author: Mr. Kristian Alda1, Dr Achmad KemalHarzif

P-89

IN-HOUSE FLOATING RACK VERSUS CONVENTIONAL LIQUID NITROGEN VAPOR EXPOSURE TECHNIQUE IN
HUMAN SPERM FREEZING: WHICH IS BETTER?_A PILOT STUDY
Author: Ms. Pham Dinh Song Thuong1, Ms. Bach Thi Huynh Thuy1, Ms. Nguyen Thuy Thuy Trang1, Ms. Hoang Thi Thu Huong1,
Mrs. Vo Nhu Thanh Truc1, Mr. Nguyen Anh Danh1, Mr. Mai Van Dien1

P-90

PCOS AND IVF SUCCESS RATES IN MELATI CLINIC HARAPAN KITA HOSPITAL
Author: Dr Cindikia Ayu Sholekha Hani1, Dr. Desty Putri Kristianingesti1, Dr. Agus Supriyadi2, Dr. Gde Suardana2,
Dr. Sudirmanto Tarigan2, Dr. Hadi Sjarbaini2, Dr. Mohammad Haekal2, Dr. Aidrus Abdul Muthalib2, Ms. Novita Prasetiawati2

Gynaecology and Surgery
P-91

SUCCESSFUL EMBRYO TRANSFER AND PREGNANCY OUTCOME AFTER CESAREAN SCAR DEFECT TREATMENTBY LAPAROSCOPIC OPERATION UNDER HYSTEROSCOPIC GUIDANCE
Author: Dr. Dinh Hoang1

P-92

UNILATERAL OVARIAN AND FALLOPIAN TUBE AGENESIS WITH EXTRAGONADAL DERMOID CYST
Author: Dr Bernadette Ann Alcazaren1, Dr Virgilio Jr. Novero

75

P-93

RARE OCCURRENCE OF OPERATIVE HYSTEROSCOPY INTRAVASCULAR ABSORPTION (OHIA) SYNDROME
AFTER TRANSCERVICAL RESECTION IN SALINE (TCRIS) FOR UTERINE SEPTUM: THE IMPORTANCE OF PROMPTDIAGNOSIS AND MANAGEMENT
Author: Dr. Venedict Earl Purisima1, Dr. Maria Victoria Romualdez-Tan1,2, Dr. Asuncion Del Prado-Tremedal1

P-94

ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS IN A YOUNG PRIMIPARA WITH AN OVARIANFOLLICULAR CYST
Author: Dr. Chinnie Onglatco-Salaya1, Dr. Concepcion Lovella Salcedo1, Dr. Florelie Gamarcha1

P-95

PREGNANCY IN A 24-YEAR-OLD WITH LOW TRANSVERSE VAGINAL SEPTUM: A CASE REPORT
Author: Dr. Christine Wacnag1, Dr. Dianne Manzano1

P-96

MATURE CYSTIC TERATOMA WITH MALIGNANT TRANSFORMATION TO SQUAMOUS CELL CARCINOMA OF THE
OVARY: A DIAGNOSTIC DILEMMA
Author: Dr. Carla Marquez1, Dr. Alberto Mercado, Dr. Esther Ganzon, Dr. Ruth Valeree Rubio

P-97

THE ANALGESIC APPLICATION OF ACUPUNCTURE IN INDUCED ABORTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Author: Miss Tsz Ching Yeung1, MsQianhan Xu1, Ms Lu Chen1, Prof. Jacqueline Pui Wah Chung1,2, Prof. Chi Chiu Wang1,3

P-98

CONSERVATIVE MANAGEMENT OF LEIOMYOMA WITH BIZARRE NUCLEI
Author: Dr. Juanito Vicente Villena1, Dr. Mona Ethellin Yiu-Senolos1

Male Fertility
P-99

MICROSURGICAL RECONSTRUCTION OF THE MALE DUCTAL SYSTEM IN THE PHILIPPINES
Author: Associ. Prof. Dennis Lusaya1

P-100

SPERM DNA FRAGMENTATION INDEX DID NOT ASSOCIATE WITH ASSISTED REPRODUCTIVE OUTCOMES:A COHORT RETROSPECTIVE STUDY OF 6087 IVF/ICSI CYCLES
Author: Mrs. Tingfeng Fang1, Mrs. Wenjun Wang1,2, Mrs. Yanhong Zhang3, Mrs. Wenchang Yu1,2, Professor Nengyong Ouyang1,2,
Mrs. Jinghua Chen1,2, Mrs. Haixia Liang1,2, Mrs. Huiling Zhong1,2, Professor Hui Chen1,2, Professor Yiu Leung Chan476

P-101

CLINCAL APPLICATION OF SPERM ULTRA-MORPHOLOGY ANALYSIS BY TRANSMISSION ELECTRON MICROSCOPY
IN SEMEN QUALITY ASSESSMENT
Author: Dr. Hongxiang Wang1, Dr. Yidong Liu1, Dr. MING ZHANG1, DR. KAI HU1, DR. YANG JIN1, DR. SHIRAN XU1,
DR. MUJUN LU1

P-102

ASSOCIATION BETWEEN SMOKING HABITS, SEMINAL OXIDATION-REDUCTION POTENTIAL, AND SPERM PARAMETERS
Author: Ms. Yuri Kasai1, Ms. Midori Ishii1, Mr. Satoshi Ueno1, Mr. Kenji Ezoe1, Mr. Tadashi Okimura1, Dr. Keiichi Kato1

P-103

EFFECT OF FSH AND LH ON SPERM RETRIEVAL IN NON-OBSTRUCTIVE AZOOSPERMIA AFTER TESTICULAR
SPERM ASPIRATION
Author: Dr. Kunwar Shahmir Khan1

P-104

EMBRYOLOGICAL AND CLINICAL OUTCOMES OF THE SPERM TAIL FLEXIBILITY TEST FOR SELECTION OFCOMPLETELY IMMOTILE TESTICULAR SPERMATOZOA IN INTRACYTOPLASMIC SPERM INJECTION
Author: Ms. Trang Nguyen Phan Cam1, Ms Viet Lai Thi Tuan1, Ms Linh Phan Thuy1, Ms Hien Le Thi Thu1, Mr Duc Nguyen Minh1

P-105

PREDICTORS OF SPERM RETRIEVAL BY TESTICULAR SPERM ASPIRATION (TESA) IN MEN WITH NONOBSTRUCTIVE AZOOSPERMIA
Author: Dr. Kunwar Shahmir Khan1

P-106

BODY COMPOSITION MAY AFFECT SPERM CONCENTRATION AND TOTAL MOTILE SPERM COUNT IN MALE
INFERTILITY WITH VARICOCELE
Author: Prof. Dicky Moch Rizal1, Jajar Setiawan1, Nandia Septiyorini1, Muhammad Azyan2, Farhan Sakundirasta Putra2,
Muhamad Hafiz Al Fathdry2

P-107

SUCCESSFUL MEDICAL MANAGEMENT OF AZOOSPERMIA IN KALLMAN SYNDROME
Author: Dr. Lana Corinne Carpio1, Dr Virgilio Novero Jr1

Menopause
P-108

CHARACTERISTICS OF RHEOENCEPHALOGRAPHY AND SOME ASSOCIATED FACTORS ON MENOPAUSAL WOMEN
Author: Dr. Tin Nguyen1,2, Prof. Kien Nguyen1, Dr. Long Tran1, Dr. An Le1, Dr. Thu Phung1, Ms. Truc Banh1, Mrs. Trang Vo2,
Dr. Michael Bodo3

77

Ovary and Ovarian Biology
P-109

BOOSTING MITOCHONDRIAL ACTIVITY AND METABOLISM IN AGING FEMALE GERM CELLS: SYNERGISTICEFFECTS OF DUAL ROCK AND ROS INHIBITION
Author: Prof. Kuan-Hao Tsui1,2, Chia-Jung Li Chia-Jung Li1,2

P-110

THE EFFECTS OF ANDALIMAN (ZANTHOXYLUM ACANTHOPODIUM DC.) METHANOLIC FRUIT EXTRACT ON
HISTOLOGICAL OVARY OF MICE (MUS MUSCULUS L.)
Author: Dr. Hilma Putri Lubis1, Prof. Muhammad Fidel Ganis Siregar1, Dr. Binarwan Halim1, Dr. Ichwanul Adenin1,
Mr. Elya Manik1

PCOS
P-111

LONG TERM FOLLOW-UP OF ADOLESCENTS WITH POLYCYSTIC OVARY SYNDROME LIKE SYMPTOMS
Author: Ms. MadhulikaaSarjapuram Niranjan1, Associate Professor Rebecca Deans1, Dr Brigitte Gerstl1

P-112

MODULATED MACROPHAGE POLARIZATION CONTRIBUTED TO LOW GRADE CHRONIC INFLAMMATION IN LEAN
AND OBESE PCOS
Author: Mrs. Naylah Muna1,2, Mrs. Oki Riayati1, Dr Daniel Dufort3, Dr Vita Silvana1,4,5, Mila Maidarti1,4,5, Achmad Kemal Harzif1,4,5,
Gita Pratama1,4,5, Kanadi Sumapraja1,4,5, R Muharam1,4,5, Budi Wiweko1,4,5, Heri Wibowo6, Andon Hestiantoro1,4,5

P-113

OBESITY RESULTS IN LOWER PROTEIN DISTRIBUTION IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME(PCOS) FOLLOWING PROGESTERONE THERAPY
Author: Mrs. Fazilah Abdul Hamid1

P-114

SERUM ANTI – MULLERIAN HORMONE LEVEL THRESHOLD AMONG INFERTILE FILIPINO WOMEN WITH
POLYCYSTIC OVARIAN SYNDROME
Author: Dr Mary Liezl Yu1, Dr Virgilio Novero1

P-115

EFFECT OF REPEATED CLOMIPHENE CITRATE ADMINISTRATION ON OVARIAN FUNCTION AND OOCYTE QUALITYIN OBESE AND PCOS CONDITIONS
Author: Ms. Jyolsna P K1, MsAmrutha Nedumbrakkad Kunnath1, Dr Satish Kumar Adiga2, Dr Guruprasad Kalthur1

78

Preimplantation Screening and Diagnosis
P-116

KIDSCORE DAY 5 ALGORITHM MAY PREDICT THE EUPLOIDY OF BLASTOCYSTS
Author: Ms. Trang Nguyen Phan Cam1, Ms Viet Lai Thi Tuan1, MsGiang Tran Thi1, Ms Tram Ngo Ngoc1, MrDat Cao Tien1,
Mr Duc Nguyen Minh1

P-117

CLINICAL OUTCOMES OF EMBRYO TRANSFER BASED ON MORPHOLOGICAL ASSESSMENT COMBINED WITH
NON-INVASSIVE PREIMPLANTATION GENETIC TESTING (NIPGT): A STUDY IN VIETNAM
Author: Mrs. Nhung Thi Hoang1, Mr. Huynh Van Nguyen1, Mr. Minh Dinh Pham1, Mr Thong Quang Nguyen2, Dr. Thao Thi Thu Huynh2

Regenerative Medicine and Stem Cells
P-118

GENE EXPRESSION DYNAMICS OF HUMAN ENDOMETRIAL STEM CELLS IN THE CONTEXT OF INFERTILITY FACTORS
Author: Umanthi Ranaraja2, Dr. Eun Young Kim1, Ryoung Eun Kim1, Su Min Chung3, Sa Rah Jeong3, Prof. You Jin Kim3,
Prof. Young Bok Ko3, Prof. Min Kyu Kim1,2

Reproductive Genetics
P-119

MULTI-OMICS REVEALS THE ROLE OF OSTEOPONTIN/SPP1 IN REGULATING OVARIAN AGING
Author: Prof. Kuan-Hao Tsui1,2, Associate professor Chia-Jung Li1,2

P-120

A CASE REPORT OF TWO SIBLINGS WITH COMPLETE ANDROGEN INSENSITIVITY SYNDROME
Author: Dr. Jana Kathryn Luz Go1, Dr. Marinella Agnes Abat2

P-121

INCIDENCE AND SEX RATIO IN CONGENITAL DEFECTS OF THE GASTROINTESTINAL TRACT IN CHILDREN BORN
AFTER ASSISTED REPRODUCTION.
Author: Dr. Antonin Sipek1,2,3,4, Dr. Vladimir Gregor1,2, Dr. Antonin Sipek Jr2,4,5, Dr. Jan Klaschka6, Dr. Marek Maly6,779

P-122

INCIDENCE AND SEX RATIO IN CONGENITAL HEART DEFECTS IN CHILDREN BORN AFTER ASSISTEDREPRODUCTION.
Author: Dr. Antonin Sipek Jr1,2,3,4, Dr. Vladimir Gregor1,4, Dr. Antonin Sipek1,3,4,5, Dr. Jan Klaschka6, Dr. Marek Maly6,7

Uterine Disorders and Endometriosis
P-123

REPRODUCTIVE OUTCOMES OF SINGLE FROZEN-THAWED EMBRYO TRANSFER IN PATIENTS WITHENDOMETRIOSIS AFTER PREIMPLANTATION GENETIC TESTING
Author: Dr. yanbo du1, Dr. Lei Yan1

P-124

DEEP INFILTRATING ENDOMETRIOSIS AFTER A TOTAL ABDOMINAL HYSTERECTOMY AND UNILATERALSALPINGO-OOPHORECTOMY: A CASE REPORT
Author: Dr. Juanito Vicente Villena1, Dr. Debby Songco1

P-125

THE ANTI-ANGIOGENIC EFFECT OF DOPAMINE AGONISTS IN THE REDUCTION OF PELVIC PAIN AND SIZE OFOVARIAN ENDOMETRIOMA, A SYSTEMATIC REVIEW
Author: Dr. Leedah Ranola-Nisperos, Dr. Hortensia Ferrero

P-126

A CASE REPORT ON PRIMARY SPONTANEOUS UMBILICAL ENDOMETRIOSIS ON A PREGNANT WOMAN
Author: Dr. Paula Claire Pulido, FPOGS FPSUOG MELANIE OMAR

P-127

UTERINE LEIOMYOMA IN 16- YEAR-OLD GIRL: A CASE REPORT
Author: Dr. Aldilyn Sarajan1, Dr ANGELA AGUILAR1

P-128

MANAGEMENT OF PYOCOLPOS COMPLICATING OBSTRUCTED HEMIVAGINA AND IPSILATERAL RENAL ANOMALY(OHVIRA) SYNDROME
Author: Dr. Patricia Fernandez1, Dr. Angela Aguilar1

P-129

A CASE OF CATAMENIAL PNEUOMOTHORAX WITH PELVIC ENDOMETRIOSIS MANAGED WITH ETONOGESTRELIMPLANT
Author: Dr Shayne Fajutagana1, Dr. Enrico Gil Oblepias180

P-130A RARE CASE OF EXTRAGENITAL MULLERIAN ADENOSARCOMA
Author: Dr. Pauline Beatriz Gonzaga1, Dr. Aida Bautista

P-131

A CASE REPORT ON CYSTIC ADENOMYOSIS PRESENTING AS MYOMA UTERI
Author: Dr. Marella Bugarin1, Dr. Marites Barrientos1

P-132

UMBILICAL ENDOMETRIOSIS: A CASE SERIES ON THE DIFFERENT APPROACHES IN MANAGEMENT
Author: Dr. Janelle Marie Doloiras1, Dr. Regina Paz Tan-Espiritu1

P-133

A DELICATE TWINNING: A HUGE MYOMA IN A PREGNANT WOMAN WITH BICORNUATE UTERUS
Author: Dr. Jann Finella Bianzon1, Dr. Judith Cabanela1

P-134

OVERCOMING DIFFICULTIES OF A MULTIFACETED ENTITY: PREGNANCY AFTER SURGICAL MANAGEMENT OF
BICORNUATE BICOLLIS WITH OBSTRUCTED HEMIVAGINA AND IPSILATERAL RENAL AGENESIS (OHVIRA)
Author: Ms. Christianne Salvador1, Mrs Yvonne Soriano1,2,3,4, Mrs Mary Eleanor Domingo1,2

P-135

COMPLETE SEPTATE UTERUS WITH DUPLICATED CERVICES AND LONGITUDINAL VAGINAL SEPTUM: A REPORT
OF 3 CASES IN PATIENTS SEEKING FERTILITY
Author: Dr. Krista Marie Pacifico1, Dr. Grace Caras-Torres1

P-136

HERLYN WERNER WUNDERLICH SYNDROME IN A 27-YEAR-OLD NULLIGRAVID: A CASE REPORT
Author: Dr. Julene Raphaelle Chan, Dr. Zedrix Gallito

P-137

PROFILE OF PATIENTS SEEN AT THE CENTER FOR ENDOMETRIOSIS OF THE UNIVERSITY OF THE PHILIPPINES –PHILIPPINE GENERAL HOSPITAL: A PRELIMINARY REPORT
Author: Dr Margaret Joyce Cristi-limson1

P-138

CONCURRENT INTRAUTERINE ADHESIONS WITH ADENOMYOSIS IN A NULLIPARA SEEKING FERTILITYMANAGEMENT: A CASE REPORT
Author: Dr. Norielle Castillo1, Dr. Mona Ethellin Yiu-Senolos1

P-139

MAYER-ROKINSTANKY-KUSTER-HAUSER SYNDROME: PICKING UP THE MISSING PIECES
Author: Dr. Nur Azleen Sidek1, Dr. Soe-na Choo1

81

82

Sponsors & Exhibitor
Exhibitor General Information
Congress Date Thursday-Sunday, 23-26 May 2024
Venue Philippine International Convention Center (PICC)
PICC Complex, 1307 Pasay City, Metro Manila, Philippines
Website https://www.aspire2024.com
Theme Pearls of Wisdom in Reproductive Medicine:
Towards Personalisation and Improving Access
Host Asia Pacific Initiative on Reproduction (ASPIRE)
Co-Host Philippine Society for Reproductive Medicine (PSRM)

Exhibition Information
Exhibition Opening Hours
Date

Time

Friday, 24 May

08:00-19:00

Saturday, 25 May

08:00-17:00

Sunday, 26 May

08:00-12:00

Venue
Exhibition Hall
(Reception Hall)

Social Function Schedule
Function

Date

Time

Venue

Welcome Reception

Friday, 24 May

18:30-20:00

Cocktail Hour

Saturday, 25 May

17:30-19:00

Reception Hall
Reception Hall

Download the ASPIRE 2024 Mobile Application
Search “ASPIRE 2024” on the Apple Store/GooglePlay Store

Launch the application and log-in
Sign in either:• With your registered account and password from the ASPIRE 2024 registration system• Using your primary email and the pin code provided in the congress reminder
Here’s to a seamless experience at ASPIRE 2024.
• View and customize your congress schedule• View speakers’ biographies• View congress abstracts• View details of our exhibitors and sponsors• Interact with speakers and other delegates via the in-house communication app• Participate in sessions polling and survey• Interact and earn points for a chance to win prizes

83

Exhibitor Floor Plan
Content identical to the Exhibition Manual.

84

Exhibitor List
Booth No.
A01
A02
A03
A04
A05
B02
B05
B06
B08
B09
B11
B12
B13
B14
B15
B19
B20
B21
B22
B23
B25
B30
B32
B33
B41
B42
B45
B46
B47
B49
C01
C05
C06
C07
C08
C10
D01
D04
D05
D06
D07
D08
D09
D10

Company
Vitrolife Group
Merck Pte Ltd
Ferring Pharmaceuticals
AbbottOrganonCariad Medical Technology Co.,Ltd.
ASPIRE 2025
Asia Pacific Initiative on Reproduction (ASPIRE)
Taiwan IVF GroupASTEC Co., Ltd.
Miltenyi Biotec
CPG HealthPhilippine Society of Reproductive Medicine
LensHooke
Binflux Inc.
Fujifilm Irvine Scientific
BRED Life Science Technology Inc.
Yikon Genomics (Suzhou) Co., Ltd
Inti Labs
Bio-Match Tech Limited
Reprolife Inc.
Towako Repro Biotech Center (Kato Repro Biotech Center)
Guangzhou Nvwa Life Technology Co., Ltd
Kitazato Corporation
Esco Lifesciences Group
IMT Matcher
Cryos International Sperm & Egg Bank
Medethix Incorporated
Generation Prime Medtech Pte. Ltd.
CooperSurgical
Hamilton Thorne GroupINTESCO - INVITECH
JingFang Precision Medical Device (Shenzhen) Co., Ltd
Shivani Scientific Industries Pvt. Ltd.
Lenus Pharma
LabIVF
Allwin Medical Devices, Inc.
Rainie's PearlKai Health, Inc
Goldquest Biotechnologies Inc.
Carl Zeiss Pte. Ltd.
Horizon Biochip Limited
Jewelry Express Davao
UNILAB INC. (Biofemme)85

Sponsor and Exhibitor Profiles
Platinum Sponsors
Booth Number A03

Ferring Pharmaceuticals
Contact Person

Kristel Lim

Contact Email(s)Kristel.lim@ferring.com

Contact Number+65 97861642

Company Address

168 Robinson Rd, #13-01 Capital Tower, Singapore 068912

Company website

www.ferring.com

Company profile

Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceuticalgroup committed to building families and helping people live better lives. We are leaders in
reproductive medicine and maternal health, and in areas of gastroenterology and urology.
We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology
intravesical gene therapy. Ferring was founded in 1950 and employs more than 7,000 people
worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating
subsidiaries in more than 50 countries which markets its medicines in over 100 countries.
Learn more at www.ferring.com, or connect with us on LinkedIn, Instagram, YouTube,
Facebook and X (Twitter).

Booth Number A02
Merck Pte Ltd
Contact Person

Hyun-Jung YooContact Email(s)hyun-jung.yoo@merckgroup.com

Contact Number+65 9247 2644

Company Address

2 Science Park Drive Ascent Building #05-01/12, Singapore 118222

Company website

www.merckgroup.com

Company profile

WE ARE MERCK. As a vibrant science and technology company, we believe that science isat the heart of everything we do. It drives the discoveries we make and the technology wecreate. The passion of our curious minds makes a positive difference in millions of people’s
lives every day. Discover how Merck uses science to drive human progress!
Our healthcare team is here for people at every step, helping create, improve, and prolong
life. Our goal is to discover personalized ways to treat the most challenging disease, such as
cancer, diabetes, cardiovascular, thyroid, and multiple sclerosis and to help people to achieve
their dream of becoming parents.
Everything we do is fueled by a belief in science and technology as a force for good. A
belief that driven our work since 1668 and will continue to inspire us to find more joyful andsustainable ways to live.
Building on our fertility expertise that goes back to 1906 we continuously generated fertility
innovation The treatment journey is challenging for patients, and we aim to make thisjourney as easy as possible for them. We drive innovation, and continuous scientific progressis the basis to improve ART outcomes for patients.
www.merckgroup.com

86Gold Sponsors
Booth Number A04

Abbott Laboratories (S) Pte. Ltd.
Contact Person

Teh Bing Sen / Dr. Joel Lao

Contact Email(s)Bingsen.teh@abbott.com; Joel.lao@abbott.com

Contact Number+65 82928319 / +65 90696651

Company Address

3 Fraser Street #23-28, DUO Tower, Singapore 189352

Company website

https://www.abbott.com.sg/

Company profile

Since 1970, Abbott in Singapore has been dedicated to helping people across the AsiaPacific region live healthier lives through a diverse range of science-based nutritional
products, diagnostic tools, medical devices and branded generic pharmaceuticals.

Booth Number A05
OrganonContact Person

Ethan Tu

Contact Email(s)Ethan.tu@organon.com

Contact Number+886-922-439-393

Company Address

Organon (Philippines) Incorporated
23/F Menarco Tower 32nd St. Bonifacio Global City, Taguig City 1634

Company website

https://www.organon.com/

Company profile

Organon is a global health care company formed to focus on improving the health of women
throughout their lives. Organon offers more than 60 medicines and products in women’s
health in addition to a growing biosimilars business anda large franchise of established medicines across a range of therapeutic areas. Organon
has a global footprint with significant scale and geographic reach, world-class commercial
capabilities.
At Organon, we are fully invested in listening to her needs and providing tools to help
navigate the fertility journey. The Organon portfolio has a long history and includes
medicines that have been used to treat infertility for over 20 years. We are now building onthat expertise with a renewed focus on delivering solutions that aim to meet her fertility
goals.
Over 8 million children have been born through fertility treatment since 1978. Women
dealing with infertility may face overwhelming amounts of information about treatment
choices, costs, and the emotional and physical challenges they may experience. We arekeenly aware of her journey, including the roles her loved ones and care team play. That’s
why we’re committed to providing treatments and resources that aim to meet the needs ofwomen.

87

Gold Sponsors
Booth Number A01
Vitrolife Group
Contact Person

Grace Wang / Chris LiuContact Email(s)gwang@vitrolife.com / jliu@vitrolife.com

Contact Number+86 135 8171 8527 / +86 13810005714

Company Address

Gustaf Werners gata 2 SE-421 32 Västra Frölunda, Sweden

Company website

www.vitrolife.com

Company profile

Dedicated to the reproductive-health market since 1994, we have grown by focusing on
product development, groundbreaking research, consistent quality control and acquisitionsof innovative companies in the industry. Based on science and advanced researchcapabilities, our aim is to deliver products and services for the entire reproductive-healthjourney, providing consistent performance and guaranteed quality.
Our solutions enable optimised procedures and workflow efficiency, helping clinics to deliver
outstanding results. The Vitrolife Group represents a competitive and profitable businesswith the best trained staff and optimal solutions for patient needs.
We take a holistic approach to reproductive health where we provide training, support and awide range of services for clinics and laboratories worldwide. We are recognised as a leading
knowledge provider in the industry as we work with both universities, research institutes,
networks and communities to secure and improve successful treatment outcomes.
We are very proud to deliver cutting edge solutions to clinics enabling people aroundtheworld to fulfil their dream of having a healthy baby.

88Silver Sponsors
Booth Number B49
CooperSurgicalContact Person

CooperSurgical Fertility Solutions

Contact Email(s)sales@coopersurgical.com

Contact Number+45 88744210

Company Address

Knardrupvej 2, 2760 Måløv, Denmark

Company website

www.fertility.coopersurgical.com

Company profile

At CooperSurgical, we are dedicated to accelerating solutions at life’s most importantmoments and are working to push the boundaries of what is possible to build a better
journey for all, to change fertility care for generations to come.
This means changing fertility standards, the fertility journey, and providing better accessglobally to fertility treatments.
We will do this by continuing to deliver solutions for different patients' needs, and bycollaborating closely with clinics worldwide to standardize, optimize and automize clinicalworkflows.
We will help clinics reach a higher level of efficiency and insight throughout the entire
fertility journey, by bringing scientifically based best practices into day-to-day care, utilizing
digital platforms and artificial intelligence.
This is how CooperSurgical, together with you, will help change fertility care. Not just today,
but for generations to come.
Visit our websites to find out more at fertility.coopersurgical.com.

Booth Number B47

GenerationprimeMedtech Pte. Ltd.
Contact Person

Yee Kwan

Contact Email(s)irene.kwan@generationprime.com

Contact Number+60122140870

Company Address

168 Robinson Rd, #12-79, Capital Tower, Singapore 068912

Company website

www.generationprime.com

Company profile

GenPrime is a pioneering network of clinics dedicated to elevate the reproductive healthexperience for intended parents. Our mission is to provide a seamless and integrated fertility
experience tailored to the unique needs of each family.
Currently, we operate two state-of-the-art fertility clinics: Ever Link Fertility Center in
Malaysia and Legend Fertility Center in Thailand, and a fertility wellness center in Singapore.
We also partner with a growing network of clinics across the region and globally, supporting
the patient experience as they navigate their reproductive health journeys. Our service teamincludes TaiOrient, a leading medical tourism company focused on fertility in Asia.
Backed by a robust global network of fertility experts and powered by innovative technology
in development with Rhea Labs, GenPrime is a modern reproductive health services
platform offering an integrated continuum of care. GenPrime is part of the Rhea FertilityGroup.

89

Exhibitors
Booth Number D01

Allwin Medical Devices, Inc
Contact Person

Dinh Vinh Quang

Contact Email(s)sales@allwinmedical.com / quang@allwinmedical.com

Contact Number+84 97 303 90 50

Company Address

3305 E. Miraloma Ave, #176, Anaheim, CA 92806

Company website

www.allwinmedical.com

Company profile

Allwin Medical Devices, Inc aims at providing quality womens health products like embryotransfer catheters, pickup needles, IUI catheters, vitrification straws and many more. Our
products are CE certified, US FDA cleared and MDSAP certified.
We prioritize excellence in every aspect of our operations, from research and development
to manufacturing and customer support. Driven by a vision to empower healthcare
professionals and enhance patient well-being, we strive for continuous improvement andinnovation in everything we do.

Booth Number B06

Asia Pacific Initiative onReproduction (ASPIRE)
Contact Person

ASPIRE Secretariat

Contact Email(s)secretariat@aspire-reproduction.org

Contact Number+6597874045

Company website

www.aspire-reproduction.org

Company profile

Established in 2001 by Bruno Lunenfeld and P C Wong, The Asia Pacific Initiative
onReproduction (ASPIRE) is devoted to enriching patient care qualit y, with a
specificemphasis on fertility services within the Asia-Pacific region.
Our fundamental objective is to elevate awareness and comprehension of thevarioustreatment options available for infertility, empowering healthcare professionals
toeffectively guide their patients towards seeking and embracing such treatments.
We foster an inclusive environment for professionals in this field to share insights
andexperiences, while also honing their expertise through educational programs
likemasterclasses, webinars, and certificate courses. Furthermore, our 10 Special
InterestGroups (SIGs) provide platforms for comprehensive discussions and knowledge
sharing.
A source of pride for us is our official journal- "Fertility and Reproduction," whichwaslaunched in 2019. The journal serves as vital platform for researchers to share
their studiesand papers, facilitating the exchange of knowledge within the field. It also
plays asignificant role in providing young researchers with an avenue to showcase theirresearchpapers and contribute to the collective understanding.

90

Booth Number B05
ASPIRE 2025
Contact Person

Congress Secretariat Chichi Chen

Contact Email(s)secretariat@aspire2025.com

Contact Number+886-2-8780-5688 #110

Company website

https://aspire2025.com/home/

Company profile

About ASPIRE 2025
The 14th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2025) is scheduled
to take place at the Suntec Convention & Exhibition Centre in Singapore from 1 - 4 May 2025.
Themed "Teaming Together: ASPIRE-Ing to Excellence," ASPIRE 2025 emphasizes ourdedication to fostering collaboration and striving for excellence in reproductive medicine.
The 2025 Congress offers a comprehensive scientific program, featuring sessions on
emerging special interest groups such as counselling and fertility nursing.
This event will take place at the Suntec Convention Center, renowned for its outstanding
facilities and convenient proximity to quality hotels, shopping areas, and dining establishments.
Singapore provides an ideal setting for us to reconvene, renewing our connections,friendships, and professional ties.
We look forward to your participation at ASPIRE 2025 in Singapore!

Booth Number B09
ASTEC Co., Ltd.
Contact Person

Astec Global Division

Contact Email(s)astec-japan@astec-bio.com

Contact Number+81-92-935-5666

Company Address

4-6-15 MinamizatoShime, Kasuya Fukuoka 811-2207 Japan

Company website

www.astec-bio.com/global/

Company profile

Japanese Precision & Reliability is at the heart of everything we do. Established in 1978,
Astec Bio designs, manufactures and sells state-of-the-art medical laboratory equipment
for the Assisted Reproductive Industry.
Our laboratory instruments are engineered with stringent quality control and customeroriented features, providing IVF laboratory professionals the safest and most stableenvironment for embryo development.
Our equipment is designed and manufactured in our ISO 13485 certified manufacturing facility inJapan and is backed by an unrivaled global distribution network of highly-trained professionals.
Astec Bio is headquartered in Fukuoka Japan with subsidiaries in Seoul South Korea,
Shanghai China and Boston USA.
Our vision is to shape a better future, one filled with joy and tranquility. We deeply relyon Science to reach this goal. For over 45 years, Astec has been a dependable partner for
universities, institutes, research laboratories, hospitals, and pharmaceutical companies
where science has been making a perceptible difference to build a better future for all.
We are determined to continue our support for the scientific community worldwide, who are
striving to make a difference to save lives and create a better future for generations to come.
Astec, will incubate the future with you.

91

Booth Number B15
Binflux Inc.
Contact Person

Mark Liu

Contact Email(s)service@binflux.com

Contact Number+886-25858586

Company Address

4F.-1, No. 9, Dehui St., Zhongshan Dist., Taipei City 10461, Taiwan

Company website

www.binflux.com

Company profile

Assisted reproduction technology digitization is a prevalent trend, and Binflux is dedicated todefining "Tomorrow’s IVF Software". Binflux'sInfans Total Solutions for IVF centers feature asuite of products, including an IVF Patient Journey App (CareU), Electronic Medical Records(EMR), a Clinic Management System (CMS) and an Electronic Witness System (EWS). Binflux
enhances its offerings with Artificial Intelligence (AI) and the Internet of Things (IoT) technology
for embryo evaluation and identification. This seamlessly integrates with the aforementioned
EMR, CMS and EWS, resulting in a cutting-edge and unique solution.
Infans' EMR, CMS and EWS facilitate collaboration among doctors, embryologists, andconsultants by securely managing and analyzing rich data on one platform, boosting productivity,
minimizing errors, and improving decision-making. Furthermore, the InfansCareU App enriches
patient experiences and doctor-patient interactions, reinforcing IVF center branding.
Infans' diverse products can operate independently or be combined, eliminating integration
challenges between different systems and optimizing data flow.
With its distinctive features and user-friendly interface, Infans Total Solutions is recognized
as a leader in IVF digitization in both Taiwan and Singapore. These solutions have significantly
benefited numerous IVF centers in clinical, educational, and research domains, ultimately
enhancing patient satisfaction.

Booth Number B23

Bio-Match Tech Limited®

Contact Person

Eton OuyangContact Email(s)business@bio-match.com

Contact Number+86 13929558972

Company Address

ROOM 08, 20/F, WITTY COMMERCIAL BUILDING,1A-1L TUNG CHOI STREET, MONGKOK, KL., HK

Company website

https://www.bio-match.com/

Company profile

Bio-match, focuses on providing digital management solutions for Fertility & ART centers.
We independently develop MATCH UNIFIED Management Platform, including:
1. MATCH Witness System
2. MATCH Laboratory Intelligent Monitoring System
3. MATCH Electronic Medical Record System
4. MATCH Cryo-Sample Location Management System
ART Center can establish a complete and unified laboratory operation process throughthe MATCH platform to ensure the seamless interconnection between doctors, nurses,
embryologists and laboratory technicians.
At present, the MATCH Witness system has witnessed 500000 patients accumulatively and150000+ cycles annually, covering more than 10 countries and regions, including Chinese
Mainland, Hong Kong, Taiwan, India, Thailand, Russia, etc.

92

Booth Number B20

BRED Life Science Technology Inc.
Contact Person

Cindy Zhung

Contact Email(s)info@spermfunc.com

Contact Number

0086 755 26656878 / 0086 13534273060

Company Address

Block F, Dongbao Industrial Park, Shasi,Shajing, Bao'an District, Shenzhen, China

Company website

www.spermfunc.com

Company profile

Founded in 2009, BRED is a high-tech enterprise specialized in developing, manufacturing,and marketing lab products for reproductive medicine, with a vast range of reagent kits formale infertility diagnosis and culture media for ART treatment.
There are five brands of BRED:
MaleFree®--- Semen collection devices
SemenAssay®---Semen Bio-immune diagnostic kits
SpermFunc®---Sperm function diagnostic kits
FertiMedium®--- Reproductive media
BredDevice®---Laboratory supplies and equipment
The characteristic products are Sperm DNA fragmentation test kit (SCD), anti-sperm
antibody test kit (MAR IgG) , etc., which have gained good popularity for their superior quality.
Our mission of development is to be devoted to providing the best solutions and products
for the clinical laboratory in reproductive medicine with the aim to promote the developmentof human reproductive health.
For more information, please click our website: www.spermfunc.com
Email: info@spermfunc.com
Address: Block F, Dongbao Industrial Park, Shasi Community, Shajing Subdistrict, Bao’an
District, Shenzhen, China

Booth Number B02

Cariad Medical Technology Co., Ltd
Contact Person

Chiven & Josie

Contact Email(s)chiven@cariad.com.cn / josiehuang@cariad.com.cn

Contact Number+86 (756) 8866017

Company Address

Zhuhai, Guangdong, 5/f., Block 6, 6 Jinyuan 1st Rd., High-tech Zone, China

Company website

https://www.cariad.com.cn/

Company profile

Founded in 2019, CARIAD was established in response to the significant global challenge of
declining birth rates and the need for advancements in reproductive medicine and healthcare.
Our inception is a commitment to the vital field of reproductive health,addressing needs that
affect societies at their core.
Located in Zhuhai,China, CARIAD has quickly become a key player in the global reproductive
medicine arena. Our product range, including analytical diagnostic reagents,flowcytometry,biochemistry,and chemiluminescence products,is the result of meticulous research and development.Our 23,000m2 facility, equipped with a GMP-compliant laboratory and a 4,400m2 reagent
production area,is at the forefront of innovation in our field.
The heart of our innovation lies in our national-level joint engineering laboratory,recognizedby the government. Here,we focus on creating advanced technologies that are crucial in
reproductive medicine.
Quality is a cornerstone of our operations, as evidenced by our TÜV SÜD ISO13485 certification
and adherence to international standards, including CE IVDR, IVDD,FDA, and NMPA approvals.
Our mission is straightforward:to excel in the field of reproductive medicine,combining innovation andreliability. CARIAD is committed to making a significant impact on improving reproductive health globally.

93

Booth Number D07
Carl Zeiss Pte. Ltd
Contact Person

Sabrina Soh

Contact Email(s)sabrina.soh@zeiss.com

Contact Number+65 97114810; +65 90212476

Company Address

CLIPP Center, 11th Avenue Corner 39th Street Bonifacio Global City, Penthouse, Unit A
Taguig 1634, Philippines

Company website

Https://www.zeiss.com.sg/microscopy/home.html

Company profile

As a leading manufacturer of microscopes, ZEISS offers inspiring solutions and services foryour clinical, teaching, life sciences and materials research.
In the niche field of Assisted Reproductive Technologies (ART), ZEISS delivers high-resolution
and high-contrast microscopes that play a crucial role in fertility treatment procedures such
as In Vitro Fertilization (IVF), Intracytoplasmic sperm injection (ICSI), and Intracytoplasmic
morphologically-selected sperm injection (IMSI). Our microscopes, equipped withmicromanipulation, support clinicians in performing precise and critical procedures. Our
technology aids in assessing the quality of oocytes and sperms, thereby increasing the
success rate of fertility treatments. With ZEISS, clinicians and researchers in the IVF field
are equipped with reliable, cutting-edge technology that can make a significant difference inthe lives of individuals and families all around the world.

Booth Number B12
CPG HealthContact Person

Di Wilde and Rhonda Williams

Contact Email(s)di.wilde@cpg.global and rhonda.williams@cpg.global

Contact Number+61 2 7258 6886 and 0412 666 492

Company Address

Suites 3 & 4, 2 Post Office Street. Pymble, NSW 2073, Australia

Company website

https://www.cpg.global

Company profile

Certification Partner Global (CPG) is an Australian owned and operated global Certification
Body. CPG holds a number of accreditations including JAS-ANZ, Exemplar Global, SANAS,
SAC and EIAC.
Globally, CPG offers certification, auditing and training services across a number ofinternational and national standards including the ISO family of standards (ISO 9001,
ISO 14001, ISO 45001, ISO 22000, ISO 27001 to name just some) across a vast range ofindustries.
Within the Asia Pacific region, including Australia, CPG specialises in Reproductive
Technology Assistance Committee (RTAC) including RTAC International since 2012, NSQHS
Standards for day hospitals, hospitals and healthcare, Human Services, and Information
Security.
CPG is approved by health regulators both nationally and internationally e.g. MoH
Singapore, and various state bodies within Australia.
The CPG team have worked together since 2002, with the RTAC and Health Team since2008. We enjoy what we do. We are good at what we do and we work with you as yourCertification Partner.

94

Booth Number B45

Cryos International Sperm & Egg Bank
Contact Person

Martin Lassen; SagharKasiri; MetheeAthichiskul; Jane Zhang

Contact Email(s)mla@cryosinternational.com; ska@cryosinternational.com; mea@cryosinternational.com;
jzy@cryosinternational.com

Contact Number+45 81409509; +44 7399 181570; +66 99-3539829; +45 8676 0699

Company Address

Vesterbro Torv 3, 5th floor, 8000 Aarhus C, Denmark

Company website

www.cryosinternational.com

Company profile

Cryos International is the world’s largest sperm and egg bank. We offer delivery to over 100
countries and have more than 1,000 carefully selected donors of many different ethnicities
and phenotypes for your patients to choose from.
Quality, compliance, and safety are of utmost importance at Cryos, which is why we are
ISO 9001:2015 certified and always committed to meeting the highest quality standards.
We offer an easy ordering process as well as fast and reliable shipping, and the ability toregister pregnancies online. With 35+ years of experience and a professional, dedicatedteam committed to helping others achieve their dreams of becoming parents, you can feel
confident in your decision to choose Cryos as your business partner.

Booth Number B41

Esco Lifesciences Group
Contact Person

Janvie Alvarez, Helena Calista

Contact Email(s)janvie.alvarez@escolifesciences.com, helena.calista@escolifesciences.com

Contact Number+639178068026, +6287874219102

Company Address

19 Changi South Street 1, Singapore 486779

Company website

https://www.esco-medical.com

Company profile

At Esco Medical, Life has begun
Esco Medical is one of the divisions of the Esco Group of companies offering innovativetechnological solutions for fertility clinics and laboratories.
Esco Medical is dedicated to enhancing IVF centers globally by offering cutting-edge fertility
technologies. Our goal is to improve, standardize, and automate processes, ensuring better
clinical outcomes and increased patient satisfaction.
As a leading manufacturer, we create high-quality equipment, including Time-Lapse
Incubators and IVF Workstations, designed in Denmark and produced in the EU.
Visit us at: https://www.esco-medical.com

95

Booth Number B19

Fujifilm Irvine ScientificContact Person

Amelia Zhao

Contact Email(s)yiming.zhao.ra@fujifilm.com

Contact Number(+86)13052081111

Company Address

Apt.2003. No.36 Qianjiatan Rd (Qiantan Crystal Plaza), Pudong District, Shanghai, China

Company website

https://www.irvinesci.com/

Company profile

Discover our Culture: We offer a diverse portfolio of advanced cell culture media solutions
including media products, services, and technologies for bio-processing targeted to meetthe evolving demands of the bio-pharmaceutical, vaccine, and cell &gene therapy industries.
Give them the best start: FUJIFILM Irvine Scientific provides complete workflow solutionsof advanced assisted reproductive technologies (ART) designed to increase pregnancy
rates through innovation, and to safeguard precious life with media of the highest quality,
consistency, and reliability in the industry.
Local Supply. Global Partnership: FUJIFILM Irvine Scientific manufacturing has opened inEurope with the same Quality System, raw materials, and expertise you expect from ourfacilities in the US and Japan - now in Tilburg, Netherlands.

Booth Number B47

GOLDQUEST BIOTECHNOLOGIES INC.
Contact Person

Cheryl Umali

Contact Email(s)sales@goldquestbiotechnologiesinc.com

Contact Number+63 9338226357 / +63-279408180

Company Address

414 San Fernando Street, Binondo, Manila 1006, Philippines

Company website

www.goldquestbiotechnologiesinc.com

Company profile

Goldquest Biotechnologies Inc. was founded and registered in 1997, with its main officelocated in Binondo, Manila, Philippines.
Over the past two decades, Goldquest Biotechnologies Inc. has established a strong andhealthy market trust through its principle that service and care for the people is a way forestablishing a dynamic firm.
Goldquest Biotechnologies Inc. is a leading distributor in the field of diagnostic products
for hospital, research and industrial laboratory use. These products are distributed by
Goldquest Biotechnologies Inc. to all leading laboratories in the country.
The company is consolidating all its resources in order to produce a truly impressive, efficientand useful diagnostic tool according to the name that Goldquest Biotechnologies Inc.
implies. Today, tomorrow and in the future, we commit ourselves to leaving a lasting legacy
of diagnostics as new technologies are developed.
Goldquest Biotechnologies Inc. is in an extensive collaboration with a number of businessalliances that have established the company's reputation as market leaders.
We offer a wide range of laboratory equipment, reagents, consumables and supplies,
which are of the highest quality for chemistry, hematology, immunology, serology, clinicalmicroscopy, blood banking, microbiology and histopathology.

96

Booth Number B32

Guangzhou Nvwa Life Technology Co., Ltd.
Contact Person

Dennis Tang

Contact Email(s)tangx@nvwalife.com

Contact Number+8613592713949

Company Address

Rm 401, Building B7, No.11 Kaiyuan Avenue, Huangpu District, Guangzhou, China

Company website

www.nvwalife.com/enCompany profile

Nvwa Life is a world-leading innovative company with genome epigenetics research andmedical transformation platform. Nvwa Life has established a new generation of ART
with pre-implantation DNA methylation screening (PIMS) of embryos. Pre-Implantation
Methylation Screening (PIMS) can examine both the copy number variation of chromosomes(CNV) and DNA methylation status with a self-developed whole-genome methylation
sequencing method, combined with unique methylation-based AI system, PIMS has broughta new technical theory and solution to the field of assisted reproduction.
Currently, PIMS can increase the first live birth rate by 10-15% compared to conventional
PGT-A. While utilizing big data and AI technology, Nvwa has been collecting epigenetic
data from thousands of families, which could lead to continuous enhancement of PIMS
technology. PIMS is also capable of screening for imprinted genetic diseases, combinedwith AI algorithm to predict the embryo developmental potential, and thus select the most
optimal embryo for implantation.
Nvwa Life strives to revolutionize reproductive health by minimizing infertility and birthdefects. Through cutting-edge epigenetics research and advanced medical testing services,Nvwa Life will be dedicated to improving human health and well-being across the entire
reproductive journey.

Booth Number C01

Hamilton Thorne Group
Contact Person

Phil Crow

Contact Email(s)pcrow@planer.com

Contact Number+44 1932 755000

Company Address

110 Windmill Road, Sunbury-On-Thames, Middlesex, TW16 7HD, United Kingdom

Company website

https://www.hamiltonthorne.ltd/corporate-profile/our-brands/

Company profile

Hamilton Thorne Ltd. (HTL) is a public company traded on the Toronto Venture Exchange.
HTL is a leading global provider of precision instruments, consumables, software andservices to the Assisted Reproductive Technologies (ART), research, and cell biology markets.
The group began accelerating its growth by completing the acquisition of the Gynemed& Co
GmbH (2017), Planer Ltd. (2019), Tek-Event (2021), IVFTechApS (2021) and Microptic S.L.
(2022).
Today, while its primary focus is serving laboratories in the ART field, the products andservices are provided to a diverse customer base, from in vitro fertilization (IVF) clinics
and pharmaceutical companies to animal research facilities and academic establishments
worldwide.

97

Booth Number D08

Horizon Biochip Limited
Contact Person

Daniel Zhang / Dong Wang

Contact Email(s)zhangzhifeng@horizonbiochip.com / wangdong@horizonbiochip.com

Contact Number+86 18319385601 (Mr Zhang) / +852 5423 7989 (Mr Wang)

Company Address

RM 617 06/F 11W Biotechnology, CTR 2, Phase 2, HKSTP, Shatin, Hong Kong

Company profile

Horizon Biochip is an innovative company that specializes in the research and development,
as well as the production, of high-throughput automated equipment in the field of assisted
reproduction. The team consists of Ph.D. graduates from world-renowned universities
such as Harvard University, Tsinghua University, and Hong Kong University of Science andTechnology, as well as industry experts with extensive practical experience in microfluidics
technology, medical device manufacturing, registration, and sales.
Horizon Biochip focuses on high-end equipment for the upstream processes of assisted
reproduction, making it the leading company globally that provides fully automatedequipment for the entire process of oocyte, sperm, and embryo selection and cultivation.
Since its establishment, the company has been dedicated to technological innovation,
guided by technology, and focuses on addressing the challenges associated with thetraditional methods of assisted reproduction, such as fluctuations and low efficiency
in quality control. Through years of exploration, the company has overcome various key
technological barriers, enabling them to enhance embryo development potential, reduce cell
contraction, alleviate the burden on laboratory personnel, significantly improve laboratory
operational throughput, and achieve effective, stable, and reliable quality control.

Booth Number B42
IMT Matcher
Contact Person

Sarah Roberts

Contact Email(s)sarah.roberts@imtinternational.com

Contact Number+447767676118

Company Address

1 Canalside Business Park, Tattenhall, Cheshire, CH39BD

Company website

www.imtmatcher.com

Company profile

IMT Matcher™ is a barcode-based electronic witnessing, labelling, workflow scheduling,
traceability and insights system created to help prevent errors through misidentification ofpatients and their gametes and embryos.
Matcher replaces human double-checking, recording the ‘who, what, where and when’ atevery step, including photographic proof, down to embryo level.
Highly configurable, with no capital cost, Matcher operates throughout the entire fertility
centre, from patient registration through to embryo transfer, PGT and cryo stores.
Matcher’s global customer base work with confidence knowing that they have protected
their staff and patients from the risk of mistakes, that the technology is safe, and they havea quality management system that streamlines their working practices, saving valuable
staff time and money.

98

Booth Number B22
Inti Labs

Contact Person

Tiffany Wang

Contact Email(s)Tiffany@intilabs.com

Contact Number+886988805461

Company Address

7F. -6, No. 66, Shengyi 5th Td., Zhubei City, Hsinchu County, 302041, Taiwan

Company website

www.intilabs.com

Company profile

Inti Labs was built on the shared vision of Dr. Barry Behr and Dr. Eric Pok Yang, long-time industry
professionals representing two ends of the IVF process. Embryologist Dr. Behr sought a betterway to evaluate and select eggs, while Dr. Yang focused on using microRNA (miRNA) to identify apatient’s optimal window of implantation.
Frustrated with stagnating IVF success rates, Dr. Behr and Dr. Yang came together over theirmutual drive to reduce the burden on patients through less invasive, more accurate testing
solutions. Their vision: refining the IVF process to reliably deliver a healthy baby using just a single
egg, embryo, and implantation.
Inti labs has leveraged recent advancements in genetic testing and engineering capability in pursuitof this vision. We have developed solutions that provide more personalized, data-driven insights to
aid IVF specialists and patients in making better-informed decisions regarding treatment.
ora™ is our first-in-class, non-invasive test for optimizing embryo transfer timing. It uses a unique
set of miRNA biomarkers to reliably identify the patient’s window of implantation using only asimple blood sample. When integrated early into the patient’s treatment plan, ora™ can eliminate
the need for a mock cycle.

Booth Number C05
INTESCO - INVITECH
Contact Person

Quang Tuyen, Do (Dang Hoang Nguyen, Nguyen)

Contact Email(s)tuyendq@intesco.com.vn (nguyenndh@intesco.com.vn)

Contact Number+84 913 911 960 (+84 907 509 822)

Company Address

A44 Nguyen Trai Street, Nguyen Cu Trinh Ward, District 1, Ho Chi Minh City, Vietnam

Company website

https://ivf.com.vn

Company profile

Intesco/Invitech: Empowering IVF Centers and Patients
Welcome to Intesco/Invitech, the innovative force behind advanced IVF management
software. Our mission is to streamline fertility treatment with our flagship product, IMS (IVF
Management Software), a comprehensive system designed to simplify clinic operations andenhance patient care.
IMS Checker revolutionizes lab accuracy with its state-of-the-art barcode witnessing
system, ensuring every step in the IVF process is monitored with precision. This tool
minimizes human error and maximizes the integrity of each procedure, providing peace ofmind for both practitioners and patients.
For those embarking on their fertility journey, IVFLife is the companion app that supports
you every step of the way. This user-friendly application offers a personalized experience,
keeping patients informed, involved, and inspired throughout their IVF treatment.
At Intesco/Invitech, we believe in harnessing technology to create a seamless, supportive
environment for fertility clinics and their patients. Our suite of software solutions embodies
our commitment to quality, innovation, and the transformative power of life.

99

Booth Number D09
Jewelry Express Davao
Contact Person

Sonia M. Abubo

Contact Email(s)sonia_abubo@yahoo.com

Contact Number

09177775389

Company Address

Door 63 Hermanos Bldg. Pelayo street Davao city

Booth Number C06

JingFang Precision Medical Device (Shenzhen) Co., Ltd
Contact Person

Cuckoo Du

Contact Email(s)cuckoo@innofine.cn

Contact Number+86-15999508269

Company Address

4/F, Bldg A, Gold Power Industry Park,Qinglan 2nd Road,PingshanDistrict,Shenzhen
518118,China

Company website

www.innofine.cn

Company profile

InnoFine has been designing, manufacturing and marketing ultrasound interventional
products. Around 1400 reusable & disposable models are now available in InnoFine to match
transducers from nearly 40 ultrasound brands worldwide.

Booth Number D05
Kai Health, Inc
Contact Person

INAE NA

Contact Email(s)inae.na@kaihealth.tech

Contact Number+82 10-9212-9745

Company Address

217, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea

Company website

www.kaihealth.tech

Company profile

Kai Health’s embryo analysis AI solution, Vita Embryo, assists embryologists in selecting the
optimal embryos by objectively predicting the likelihood of pregnancy based on AI-analyzed
embryo images.

100Booth Number B33
Kitazato Corporation
Contact Person

Maki Ogawa, Yukari SesekuraContact Email(s)ogawa@kitazato.co.jp, marketing@kitazato.co.jp

Contact Number+81-3-3434-1653

Company Address

1-1-8 Shibadaimon Minato-ku, Tokyo 105-0012 JAPANCompany website

https://kitazato-ivf.com/

Company profile

Kitazato Corporation is a global company based in Japan, dedicated to the assisted
reproductive technologies field. Since our foundation in 1996, we’ve been researching,developing and manufacturing medical devices and media to support a wide range offertility treatments.
Thanks to our strong distribution network, we’re able to cooperate with IVF clinics all over
the world. During the last two decades, thousands of IVF professionals have placed theirtrust in one of our largest contributions to the field, The Cryotop® Method, making it theundisputable market leader in cryopreservation of human gametes.
One of our main pillars is to offer quality, environmentally friendly and constantly improving
devices, in collaboration with scientists, as a way to secure access to the latest technologies.
We’re committed to offering all-year-round training programs to clinical embryologists
and gynecologists in order to expand their knowledge and enhance the benefits that our
products offer in their everyday procedures.
For more information www.kitazato-ivf.com

Booth Number C10
LabIVF

Contact Person

Amira Ammar / Bianca Catajan

Contact Email(s)sales.ph@labivf.com

Contact Number+63 9208505685 / +63 9171022209

Company Address

Units 4 and 5, 5th Floor, BEC Building, Macaria Business Center, Carmona Cavite Philippines 4116

Company website

www.labivf.com

Company profile

LabIVF Group is delighted to be a part of ASPIRE 2024.
In this modern era, LabIVF Group strives to achieve the 5As, Providing:- Accessibility- Alternatives- Advancement- Attention- Application Knowledge Selling
Having comprehensive coverage across 6 countries in South-East Asia namely Singapore,
Malaysia, Taiwan, Thailand, Indonesia and the Philippines; we strive to continue our efforts
in serving our growing IVF communities in the region.
Established from 2002, with the support of our clients, our suppliers and our team members,
we are able to expand our coverage to serve more.
We are pleased to invite you to Booth C10 - C12. We look forward with warm anticipation tocatching up with all of you and to let us be involved in your progression to excellence.

101Booth Number B14
LensHooke

Contact Person

Luke Chen

Contact Email(s)lukechen@bonraybio.com

Contact Number+886-906-823-727

Company Address

4F., No. 118, Gongye 9th Rd., Dali Dist, Taichung City 412, Taiwan

Company website

https://lenshooke.com/

Company profile

Bonraybio® is an established team of skilled engineers & scientists with extensive experiencein vitro diagnostic industry. The company is dedicated to the research, development andcommercialization of high-precision, user-friendly in vitro diagnostic devices to improve
human healthcare.
By leveraging our optical technology development expertise and extensive intellectual
property, Bonraybio® has developed a fully automated and user-friendly microscopic semenquality analyzer (LensHooke®) that can easily determine all of the critical semen quality
parameters such as pH, sperm concentration, motility and morphology. We believe ourLensHooke® semen quality analyzer will benefit physicians in identifying and treating theinfertility problems of their patients.

Booth Number C08
Lenus Pharma
Contact Person

Ms. Anna Lukitsch

Contact Email(s)office@lenuspharma.com

Contact Number+43 1 40514190

Company Address

Seeboeckgasse 59, A-1160 Vienna, Austria

Company website

https://profertil.eu/

Company profile

Lenus Pharma is an innovative Austrian company specialized in evidence-based products for
fertility, distributed in over 70 countries worldwide. With sustained export growth, Lenus Pharma
is represented on 5 continents, making it the global market leader in the treatment of infertility.
PROFERTIL® #1 PROVEN EFFICACY IN FERTILITY
PROFERTIL® – #1 in male fertility
PROFERTIL® is the world leading patented and 8-fold clinically proven formula for the
management of impaired sperm quality. This formula demonstrates synergistic effects,
significantly enhancing male fertility by improving all sperm parameters essential for
successful conception and pregnancy.
https://profertil.eu/
PROFERTIL® female – THE hormone-free fertility pill.
PROFERTIL® female restores female fertility: 3 clinical studies demonstrated that the
chances for conception are improved – especially for women 35+. The specific and studytested composition of PROFERTIL® female covers the increased micronutrient requirementsof women who want to have children.
https://profertil-female.eu/
PROFERTIL® inositol – fertility “easy-to-go”
PROFERTIL® inositol is the newest member of the product family addressing the need ofan adequate formulation for women with PCOS. The stick can be taken without water. The
precisely selected formula of PROFERTIL® inositol supports the hormonal balance of womenwith desire for children and/or PCOS.
https://profertil-inositol.eu/
Quality from Austria | Hormone-free | GMP

102

Booth Number B46
MedEthix, Inc.

MedEthix
INCORPORATE®

D

Contact Person

Marlon R. dela Merced

Contact Email(s)delamerced.mr@medethix.com.ph

Contact Number+63 917 6323 095

Company Address

6F RFM Corporate Center, Pioneer St., Mandaluyong City 1550 Philippines

Company website

www.medethix.com.phCompany profile

With the mission to heal always and in all ways, the company was founded in 2009 as the
ethical marketing firm of Salian Group of Companies. Ten years later, Ayala Corporation's
healthcare holdings company, AC Health, has invested in the company to complement
the growing health portfolio of the company. Today, MedEthix is an emerging leader in
reproductive medicine in the Philippines. It also has ventures in urology, general obstetrics
and gynecology.

Booth Number B11
MiltenyiBiotec
Contact Person

Simona Shenbakar

Contact Email(s)simonas@miltenyi.com

Contact Number+49-15117159273

Company AddressFriedrich-Ebert-Str. 68, 51429 BergischGladbach, Germany

Company website

www.miltenyibiotec.com

Company profile

MiltenyiBiotec is a global provider of products and services that empower biomedical
discovery and advance cellular therapy. Our innovative tools support research at every level,from basic research to translational research to clinical application. This integrated portfolio
enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer
solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 yearsof expertise spans research areas including immunology, stem cell biology, neuroscience,cancer, hematology, and graft engineering. In our commitment to the scientific community,
we also offer comprehensive scientific support, consultation, and expert training. Today,
MiltenyiBiotec has more than 4,700 employees in 23 countries – all dedicated to helping
researchers and clinicians around the world make a greater impact on science and health.

103

Booth Number B13

PHILIPPINE SOCIETY FOR REPRODUCTIVE MEDICINE INC.
Contact Person

Dr. Mary Joyce Flores-Medina

Contact Email(s)psrm.org@gmail.com

Contact Number+63 917 549 4549

Company Address

GF POGS Bldg., 56 Malakas St., Diliman, Brgy. Pinyahan, Quezon City, Philippines, 1100

Company website

https://psrminc.org/

Company profile

The Philippine Society for Reproductive Medicine is a society of world-class experts
committed to the noble promotion of competent and ethical practice of reproductive
endocrinology and infertility. We dedicate ourselves to providing excellent patient-friendly
healthcare by the advancement of professional growth through the development of its
subspecialties, research, continuing medical education, innovative technologies and theregulation of training practice and cost-effective services related to the specialty.

Booth Number D04
Rainie's PearlContact Person

Sittie Rainie Marmar

Contact Email(s)Sittierainiemarmar@gmail.com

Contact Number+63 947 325 3692

Company Address

Greenhills San Juan City

Booth Number B25
REPROLIFE Inc.
Contact Person

MihokoMiyagaki

Contact Email(s)miyagaki.m@reprolife.jp, globalsales@reprolife.jp

Contact Number+81 3 5925 8931

Company Address

9F, 2-5-3 Shinjuku, Shinjuku-ku, Tokyo 160-0022, Japan

Company website

https://reprolife.jp/

Company profile

REPROLIFE Inc. was established in 2010 in Japan by Dr. MasashigeKuwayama, a pioneer ofhuman oocyte and embryo vitrification.
We provide Cryotec product line focused on cryopreservation of human oocytes andembryos, which includes vitrification and warming solutions and equipment used in freezing
and thawing. Together with the products, REPROLIFE developed a highly effective Cryotec
Method, a simple and flexible protocol for embryologists that leads to high survival rates ofoocytes and embryos. Today, Cryotec Method has been used in over 1,000,000 clinical casesin over 60 countries.
We at REPROLIFE believe that no couples should give up on having children even if a motheris undergoing cancer treatment, or simply wants to have more time to concentrate on her
career and have a child later in life. We constantly research and develop advanced assisted
reproductive technologies and work on making our products available around the world tobring joy of having a child to as many people as possible.

104

Booth Number C07

Shivani Scientific Industries Pvt. Ltd
Contact Person

Mr. Amit Sharma

Contact Email(s)amits@shivaniscientific.com

Contact Number+91-9004654097

Company Address

Shivani House, 26/A, Raju Indl. Est., Penkar Pada Road, Mira 401 104, Dist. Thane (Mumbai) INDIA.

Company website

www.shivaniscientific.com

Company profile

Shivani Scientific Industries (P) Ltd is an ISO 9001:2008 and ISO 13485:2012 certified
company having its Head Office in Mumbai, India. We are a highly focused Company
for manufacturing Bio-Medical Equipment with a proven track record of 5 decades. Our
Company has come out with a range of innovative products for IVF Labs designed with
State-of-the-Art Technology to give optimum performance with the ultimate aim of
improving the success rate in ART.

ÛAt Shivani Scientific, we enable and support IVF centers and clinics to impart successful
Assisted Reproductive Treatment by providing turnkey projects, innovative equipment,
services, and timely end-to-end solutions.
Our 50 years of Leadership and Innovation are marked by successfully setting up 1,400+ IVF
Centers in India and across 35+ Countries.

Booth Number B08
TAIWAN IVF GROUP
Contact Person

CHIAO-WEN YEN

Contact Email(s)info@taiwanivfgroup.com

Contact Number+886-3-5586880

Company Address

No.360, Sec. 2, Wenxing Rd., Zhubei City, Hsinchu County 302, Taiwan (R.O.C.)

Company website

https://www.taiwanivfgroup.com/en/index.html

Company profile

Taiwan IVF Group stands out as the sole IVF center in Taiwan in partnership with Stanford
University’s esteemed fertility specialist, Professor Barry Behr.
Within our state-of-the-art facilities, we provide a comprehensive array of fertility services,encompassing IVF, ICSI, PGT-A / PGT-M, vitrification-based egg freezing, and both egg andsperm donation programs. Boasting one of Taiwan’s largest donor egg banks, we also offer
cutting-edge MIRA/ORA (endometrial receptivity analysis) for pinpointing the ideal embryotransfer timing.
With a remarkable IVF pregnancy rate exceeding 75% and a live birth rate surpassing 55%,
our success speaks volumes. This event presents an exclusive opportunity for one-on-one
consultations with Stanford University Adjunct Clinical Assistant Professor and fertility
specialist.
https://www.taiwanivfgroup.com/en/index.html

105Booth Number B30

Towako Repro Biotech Center (Kato Repro Biotech Center)
Contact Person

John Christopher Badiola, Marketing AssistantContact Email(s)marketing@krbc.ph

Contact Number+63 917 4211 528

Company Address

8/F Tower 1, The Enterprise Center, 6766 Ayala Avenue corner Paseo De Roxas, Makati City
1226 Philippines

Company website

www.katoreprobiotechcenter.com

Company profile

Founded in 2012, Kato Repro Biotech Center (KRBC) is an organized private medical facility,
duly-registered with the Securities and Exchange Commission (Reg. Number CS-2010-21115),
accredited as a Medical Tourism Enterprise (Reg. Number 12-01-MT) by the Departmentof Tourism (DOT) and the Philippine Economic Zone Authority (PEZA). It is run by highlytrained Filipino staff who underwent rigorous training, and state-of-the-art facilities andequipment from all over the world. The technology that we use is backed by evidenceinformed protocols, superior technology, and 29 years of experience in assisted reproductive
technology (ART) by the Kato Ladies Clinic (KLC) of the Towako group in Japan. It offers
compassionate patient care in a professional private practice environment. Originatingfrom a well-established fertility center in Japan, KRBC has come to share this expertise andsuccess to Filipino couples.
KRBC focuses in achieving best results while providing the best quality of care to ourpatients. KRBC believes that the ideal conditions for successful pregnancy are conditions
that are closest to the natural processes of the human body, with minimal use of
medications as much as possible. Its unique protocols support and enhance the body’s
natural course in conceiving, thereby maximizing fertility potential without disturbing the
body’s natural balance, leading to a more intrinsic and physiological approach to conception.
KRBC is said to be the only center offering Minimal Stimulation Protocol in the Philippines
and the first to be accredited by the Department of Health (DOH) and the Department ofTourism (DOT).

106

Booth Number D10

UNILAB INC. (Biofemme)Contact Person

Dioseliza A. Caguioa

Contact Email(s)dacaguioa@unilab.com.ph

Contact Number+63 02 88581000

Company Address

66 United St., Mandaluyong City

Company website

https://www.unilab.com.ph/Company profile

The United Laboratories, Inc., commonly known as Unilab, is a Philippine privately held
multinational consumer goods company headquartered in Mandaluyong, specializing in awide range of consumer healthcare, biotechnology, personal care, and veterinary products
OUR PURPOSE
Working towards a healthier Philippines, one quality medicine at a time.
OUR VALUES
Husay
We ensure excellence and quality in everything we do, knowing that each medicine we
provide will promote and enrich lives of communities we serve.
Malasakit
We believe that every Filipino should receive unparalleled care when it comes to health. This means
going above and beyond one’s call of duty to be able to provide for our customer’s health needs.
Bayanihan
We believe in working together for a common goal and purpose, in the service of the Filipino.
Quality is one of the company's priorities. That is, to be able to assure you that our products
are consistently safe and effective, we make sure our facilities go beyond compliance when it
comes to quality control. From research and development to manufacturing, and even up to
distribution of our products to your location - we strive to keep our promise of quality to you.

Booth Number B21

Yikon Genomics (Suzhou) Co., Ltd
Contact Person

Yu SunContact Email(s)sunyu@yikongenomics.com

Contact Number+86 13718949392

Company Address

Room 301, No.A3, SIP BioBay, 218 Xinghu Rd., SIP, Suzhou, Jiangsu, China

Company website

https://en.yikongenomics.com/

Company profile

Yikon Genomics was established in 2012. It is a high-tech enterprise dedicated to thedevelopment and application of single-cell whole-genome amplification and sequencing
technologies, and provides precision medical detection technology for the fields ofreprogenetics.

107

108

109

110

111